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STELLINGEN 
1. Met betrekking tot beïnvloeding van de serumlipoproteïnen in de 
normocholesterolemische mens, is de herkomst van het eiwit in de 
voeding (dierlijk versus plantaardig) van slechts beperkte betekenis. 
Dit proefschrift. 
2. Op basis van de resultaten van een enkel voedingsexperiment met 
proefpersonen kunnen nooit voedingsadviezen worden uitgebracht. 
3. Met betrekking tot de relatie voeding en cholesterolmetabolisme 
mogen resultaten uit dier-experimenteel onderzoek nooit direct 
geëxtrapoleerd worden naar de mens. 
Dit proefschrift. 
4. In het onderzoek naar beïnvloeding van bloedlipiden door de 
samenstelling van de voeding dat in het kader van preventie van 
hart- en vaatziekten wordt uitgevoerd, vormen voedingsexperimenten 
met proefpersonen onmisbare schakels. 
5. De effecten op het serumcholesterolniveau die door het aanbrengen 
van veranderingen in de samenstelling van de voeding bereikt kunnen 
worden, mogen niet onderschat worden. 
Brussaard JE, Katan MB, Knuiman JT. Voeding en coronaire 
hartziekten, een verzekering met slechts gedeeltelijke 
dekking? Ned T Geneesk 1982; 126: 291-296. 
6. In de planning van voedingsexperimenten waarbij effecten van 
diverse proefvoedingen met elkaar worden vergeleken, wordt bij 
de keuze van het proefschema en van het aantal proefpersonen 
onvoldoende rekening gehouden met een te verwachten spreiding 
in waarnemingen ten gevolge van tijdseffecten en verschillen 
tussen personen. 
7. De bewering dat veranderingen in lichaamsgewicht voorspeld kunnen 
worden op basis van veranderingen in energieopneming, is op fysio-
logische gronden onjuist. 
Konishi F, Harrison SL. Body weight gain equivalents of 
selected foods. J Am Diet Ass 1977; 70: 365-368. 
Garrow JS. Treat obesity seriously. A clinical manual, 
pp. 21-23. Edinburgh: Churchill Livingstone, 1981. 
8. In de behandeling van overgewicht door middel van diëten dienen 
gewichtsverliezen van 0,5 tot 1,0 kg per week als optimaal be-
schouwd te worden. Verhalen dat men met succes in één week 5 kg 
kan afvallen, zijn fabeltjes. 
Garrow JS. Treat obesity seriously. A clinical manual, 
pp. 11-13. Edinburgh: Churchill Livingstone, 1981. 
Het sneldieet: vijf kilo mooier in één week! Libelle 1982; 
34; 53-55. 
9. Het erkennen van burgerlijke ongehoorzaamheid door de overheid 
(het ni et-strafbaar stellen van burgerlijke ongehoorzaamheid) 
is een stap voorwaarts naar een rechtvaardiger samenleving. 
Zie ook: Pastorale Paper no. 3 (1981), Studentenpastoraat 
Wageningen. 
10. Het f e i t dat oud-missionarissen ingeschakeld worden in Neder-
landse parochies mag n ie t begrepen worden als een gewijzigde 
v is ie op missie. 
Proefschrift J.M.A. van Raaij 
Influence of human diets containing casein, soy protein isolate, 
and soy protein concentrate on serum cholesterol and lipoproteins 
in humans, rabbits and rats. 
Wageningen, 15 October 1982. 
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VOORWOORD 
In dit proefschrift worden twee voedingsproeven met vrijwilligers en vier 
voedingsproeven met proefdieren beschreven. De proeven zijn uitgevoerd tijdens 
mijn promotie-assistentschap bij de Vakgroep Humane Voeding van de Landbouw-
hogeschool (1978-1981). Velen hebben mij in die jaren met raad en daad ter 
zijde gestaan. 
Als eersten wil ik noemen mijn promotor Prof.Dr. J.G.A.J. Hautvast en 
mijn co-referent Dr. M.B. Katan. Jo Hautvast ben ik dankbaar voor het in 
mij gestelde vertrouwen en voor zijn voortdurend stimulerend enthousiasme. 
Martijn Katan ben ik veel dank verschuldigd voor zijn vele kritische opmer-
kingen, zowel bij het opzetten en uitvoeren van de proeven, als ook bij het 
interpreteren van de resultaten en het schrijven van de publicaties. Ik heb 
erg veel van hem geleerd. 
Aan de discussies voorafgaande aan de proeven met de vrijwilligers hebben 
ook Ruud Hermus, Marianne Stasse-Wolthuis, Clive West en vooral ook Tineke 
Brussaard een belangrijke bijdrage geleverd. Het opzetten en uitvoeren van de 
dierproeven was vooral het werk van Clive West en Ton Terpstra. Voor hun 
kritische opmerkingen in de beginfase van het onderzoek ben ik ook dank ver-
schuldigd aan Renske van Beresteijn van het Nederlands Instituut voor Zuivel-
onderzoek NIZO te Ede en Piet van Stratum van Unilever Research te Vlaardingen, 
als ook aan de statistici van Unilever Research en van de Vakgroep Wiskunde 
van de Landbouwhogeschool. 
De twee voedingsproeven met vrijwilligers zijn uitgevoerd op de Vakgroep 
Humane Voeding. In deze proeven is o.a. gebruik gemaakt van voedingsmiddelen 
die niet in de handel te koop waren en speciaal voor deze proeven ontwikkeld 
en bereid moesten worden. In dit opzicht ben ik dank verschuldigd aan: 
A. Visser, L. Schutte en W.T.M, de Groot van Unimills B.V. te Zwijndrecht; 
F.M.W. Visser en wijlen J. Schut van De Melkindustrie Veghel DMV te Veghel; 
H. Vonkeman, C. Andrea, H. Herstel, G.G. Nijholt en wijlen P. Westdorp van 
Unilever Research te Vlaardingen, en destijds ook Duiven; P. Sluimer van het 
Instituut voor Graan, Meel en Brood IGMB-TNO te Wageningen; J.W. van der 
Kamp en A.P. Ringers van Van Den Bergh & Jürgens B.V. te Rotterdam; H.J. 
van der Stege, J.H. Jansen en G. Kl eter van de Sectie Zuivel van de Vakgroep 
Levensmiddelentechnologie van de LH; en aan H. Mesdom van Purina Protein 
Europe te Brussel. 
De bereiding van de proefvoedingen, als ook de vele voorbereidende werk-
zaamheden met betrekking tot de voedsel verstrekking lag in de vakkundige 
handen van de diëtisten Marita Engelen, Jeanne de Vries en Joke van Jeveren, 
daarbij geassisteerd door de diëtisten Netty van Kaathoven, Geesje Sanderink-
Hulsink, Annelies Geenen, Leny Lamers en Marcella Mager. Bij de uitvoering 
van de proeven met de vrijwilligers heb ik ook veel steun gehad van de docto-
raal -studenten Gisèle Snelder, Marja Markusse, Anke Ekkes, Mary Vlassak en 
Jan de Vries. 
Het slagen van proeven met vrijwilligers ligt grotendeels in handen van 
de deelnemers. Ik ben hen allen zeer dankbaar voor hun nauwgezette en prettige 
medewerking. De ontspannen sfeer die hierdoor mogelijk werd, maakte het uit-
voeren van de proeven voor ons tot een dankbare aangelegenheid. 
De drie proeven met konijnen werden uitgevoerd op het Instituut voor Land-
bouwkundig Onderzoek van Biochemische Producten ILOB-TNO te Wageningen, onder 
toeziend oog van J.B. Schutte en K. Deuring. De proef met de ratten werd uit-
gevoerd op het Centrum voor Kleine Proefdieren van de LH, en was in handen van 
J.W.M. Haas en G. van Tintelen.. 
De verwerking van en de analyses in de vele bloed- en voedselmonsters 
werden voornamelijk gedaan door medewerkers van onze eigen laboratoria: Joke 
Barendse - van Leeuwen, Jannie Bos, Cock Germing - Nouwen, Ans Soffers, Elly 
Koot - Gronsveld, Frans Schouten, Peter van de Bovenkamp en Henny Verwey. 
Van buiten onze Vakgroep kregen wij hulp bij de analyses van: P.H.E. Groot 
en G. Dallinga - Thie van de Erasmus Universiteit te Rotterdam; P.N.M. Demacker 
van de Universiteit van Nijmegen; S. Visser van het NIZO te Ede en H. Koopman 
van de Centrale Dienst Biotechnion van de LH. 
De co-auteurs van de artikelen die in dit proefschrift opgenomen zijn, zeg 
ik dank voor de waardevolle discussies die aan de tot standkoming van de 
artikelen vooraf gingen. 
De leden van de Ethische Commissie bedank ik voor de tijd die zij gestoken 
hebben in de beoordeling van het onderzoeksprotocol van de proeven met vrij-
willigers. 
Het typewerk van de manuscripten was in handen van Gerfriede Hoekendijk -
de Wal, Riekie van der Molen - Janssen en Riet Hoogkamer - Weijman. Helen West 
ben ik dankbaar voor het corrigeren van de Engelse tekst van een groot deel 
van dit proefschrift. Medewerkers van de tekenkamer en reproductie afdeling 
van de Centrale Dienst Biotechnion verzorgden de figuren. Hugo Albers maakte 
de foto's. 
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Ook alle anderen die hier niet genoemd zijn en die mij tijdens het onder-
zoek hebben geholpen, wil ik dankzeggen. 
Tenslotte, maar zeker niet het minst, dank ik mijn vrouw Annelies voor de 
vele uren die zij mij gelaten heeft voor het voltooien van het onderzoek 
en het schrijven van dit proefschrift. 
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SAMENVATTING 
Het is bekend dat wanneer dieren als konijnen overgezet worden van handels-
voer op een semisynthetisch rantsoen met dierlijke eiwitten zoals caseïne, 
dit resulteert in hypercholesterolemia en atherosclerosis. Semisynthetische 
rantsoenen met plantaardige eiwitten zoals soja-eiwit zijn daarentegen in 
staat het cholesterolgehalte in serum laag te houden. Bij de mens is weinig 
bekend over dergelijke effecten van het type eiwit in de voeding. 
Dit proefschrift gaat voornamelijk over de effecten van de voedingseiwitten 
caseïne en soja-eiwit op de gehaltes aan cholesterol en lipoproteïnen in 
serum, zoals deze gevonden werden in twee voedingsproeven met vrijwilligers 
en in vier proeven met proefdieren. In deze proeven werden als voornaamste 
eiwitbronnen gebruikt: caseïnaat; soja isolaat, wat het meest zuivere soja-
-eiwit preparaat is dat in de handel verkrijgbaar is; en soja concentraat, 
wat een minder zuiver soja-eiwit preparaat is. 
Aan de eerste proef met de vrijwilligers (Chapter 2) namen 69 studenten 
deel in de leeftijd van 18 tot 28 jaar. Zij gebruikten gedurende 38 dagen 
een voeding waarin 13% van de energie door eiwit geleverd werd. Van het 
eiwit was 65% afkomstig uit 8f caseïnaat, óf soja isolaat, óf een 2 op 1 
mengsel van caseïnaat en soja isolaat. Gedurende de eerste 10 dagen, de 
controle periode, kregen alle proefpersonen de gemengde caseïne-soja voeding, 
waarna zij ingedeeld werden in 3 groepen. Gedurende de hierop volgende test-
periode van 28 dagen, gebruikte iedere groep één van de 3 test voedingen. 
Aan de tweede proef met vrijwilligers (Chapter 3) namen 57 personen deel in 
de leeftijd van 29 tot 60 jaar. Zij gebruikten gedurende 45 dagen een voeding 
waarin 16% van de energie door eiwit geleverd werd. Van het eiwit was 60% 
afkomstig uit óf caseïnaat, óf soja isolaat, óf soja concentraat. Alle proef-
personen gebruikten gedurende de controle periode van 17 dagen de caseïne 
voeding, waarna ook zij ingedeeld werden in 3 groepen. Gedurende de test 
periode van 28 dagen gebruikte iedere groep één van de 3 test voedingen. 
Voor beide proeven geldt dat de test voedingen volledig identiek waren met 
uitzondering van het gebruikte eiwit preparaat. Afgezien van 0.5 MJ (120 kcal) 
per dag in de eerste proef, en 1.0 MJ (240 kcal) per dag in de tweede, werden 
aan de deelnemers volledige dagvoedingen verstrekt, overeenkomstig ieders 
energiebehoefte. Onder andere aan het eind van de controle en test perioden 
werd bloed afgenomen ten behoeve van analyses. 
Gedurende de proeven met vrijwilligers werden dubbele porties van de test 
voedingen verzameld. Met deze voedingen werden na afloop 2 konijnenproeven 
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en één rattenproef uitgevoerd. Tenslotte werd nog een derde konijnenproef 
uitgevoerd waarbij gebruik gemaakt werd van semisynthetische rantsoenen. 
Van het eiwit in deze rantsoenen was 100% afkomstig uit ôf caseïnaat, óf 
soja isolaat, óf soja concentraat. De proefschema's van de dierproeven 
waren gelijk aan die van de vrijwilligers (Chapter 4). 
In beide proeven met vrijwilligers werd tussen de caseïne en soja 
voedingen geen duidelijk verschillend effect gevonden op het totaal serum-
cholesterolniveau. Vergeleken met de caseïne voeding werd op de soja isolaat 
voeding een kleine daling waargenomen in het cholesterolgehalte in de lage-
-dichtheids-lipoproteïnen (LDL) en een kleine stijging in het cholesterol-
gehalte in de hoge-dichtheids-lipoproteïnen (HDL). De apolipoproteïne-B en 
-A, resultaten wijzen erop dat deze veranderingen waarschijnlijk veroorzaakt 
worden door veranderingen in de aantallen lipoprotéine deeltjes en niet door 
veranderingen in de samenstelling van deze deeltjes. De genoemde effecten 
werden echter alleen gevonden met soja isolaat en niet met soja concentraat. 
Met betrekking tot het risico voor hart- en vaatziekten mogen deze effecten 
met soja isolaat als gunstig bestempeld worden, maar ze zijn klein vergeleken 
met de effecten van de vetsamenstelling of het cholesterolgehalte van de 
voeding. 
De resultaten met de proeven met konijnen en ratten op menselijke voedingen 
bevestigen wat al eerder gevonden was met semisynthetische rantsoenen: in 
konijnen doet caseïne het cholesterolgehalte in serum zeer sterk toenemen 
vergeleken met soja eiwit, terwijl in ratten deze effecten veel minder zijn. 
De resultaten wijzen er op dat men met betrekking tot de relatie voedings-
eiwit en serum cholesterol voorzichtig moet zijn in het extrapoleren van 
resultaten uit dierexperimenteel onderzoek naar de mens. 
In de literatuur zijn enkele studies beschreven waarin bij hypercholes-
terolemische patiënten op soja-eiwit voedingen zeer grote dalingen in 
serumcholesterolniveau waargenomen werden. Met het oog op preventie van 
hart- en vaatziekten is daarom wel eens gesuggereerd dat het goed zou zijn 
als dierlijke eiwitten in onze voeding vervangen werden door plantaardige. 
De resultaten van onze proeven met gezonde vrijwilligers wijzen er echter 
op dat de normocholesterolemische mens waarschijnlijk vrij ongevoelig is 
voor het type eiwit in de voeding. Wel moet gezegd worden dat onze proeven 
van relatief korte duur waren en dat de proefpersonen volwassenen waren. 
Lange termijn effecten als ook de effecten bij groeiende kinderen dienen 
nog nader onderzocht te worden. 
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Hoewel de effecten van het type eiwit in de voeding bij de normocholes-
terolemische mens waarschijnlijk klein zullen zijn, zal een vervanging van 
eiwitrijke dierlijke producten door eiwitrijke plantaardige producten in 
de praktijk toch gunstige effecten kunnen hebben omdat dierlijke producten 
veelal ook rijk zijn aan verzadigd vet en cholesterol. 
Als men met het oog op beïnvloeding van bepaalde fysiologische parameters 
bepaalde veranderingen in de voeding aanbrengt, dient men zich te realiseren 
dat ook andere parameters beïnvloed kunnen worden. Een voorbeeld hiervan 
is gegeven in Chapter 5. Caseïnaten zijn vrijwel vrij van purines. De 
gebruikte soja preparaten bevatten echter, net zoals vlees, aanzienlijke 
hoeveelheden purines. Daar voedingspurines in het lichaam omgezet worden 
in urinezuur, werden bij de proefpersonen op de soja voedingen significant 
hogere serum uraat spiegels gevonden dan bij de proefpersonen op de caseïne-
voeding. Zoals bekend is het ontstaan van jicht direct afhankelijk van het 
serum uraat niveau. 
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SUMMARY 
It is well known that feeding animals such as rabbits with semi purified 
diets containing animal proteins, as for example casein, results in hyper-
cholesterolemia and atherosclerosis. On the other hand, diets containing 
vegetable proteins such as soybean protein maintain low levels of serum 
cholesterol. Little is known about the effects of the type of protein in 
the diet in humans. 
This thesis deals with the effects of casein and soy protein on serum 
cholesterol and lipoproteins, as observed in two experiments with human 
subjects and four experiments using animals. Three principle sources of 
protein were compared: caseinate; soy protein isolate, which is the purest 
soy protein preparation available commercially; and soy protein concentrate, 
a less refined soy protein preparation. 
In the first human experiment (Chapter 2), 69 young healthy students 
aged between 18 and 28 years were given for a period of 38 days diets con-
taining 13% of energy as protein of which 65% consisted of protein from 
caseinate, or soy protein isolate, or a 2:1 mixture of caseinate and soy 
protein isolate. After a control period of 10 days during which all the 
subjects received the casein-soy diet, the subjects were divided into three 
groups, each group receiving one of the test diets for a test period of 
28 days. In the second human experiment (Chapter 3), 57 healthy subjects 
aged between 29 and 60 years were given for a period of 45 days diets con-
taining 16% of energy as protein of which 60% consisted of protein from 
caseinate, or soy protein isolate, or soy protein concentrate. After a 
control period of 17 days during which they received the casein diet, the 
subjects were divided into three groups, each group receiving one of the 
test diets for a test period of 28 days. Subjects in both studies were under 
strict dietary control. Apart from 0.5 HJ (120 kcal) per day in the first 
study and 1.0 MJ (240 kcal) per day in the second, all of the food eaten 
was supplied daily to the subjects in amounts appropriate to individual 
energy requirements. Food records and chemical analysis of the diets indi-
cated that within each study, there were essentially no differences between 
the experimental diets except for the type of protein and/or the amount of 
non-protein material derived from the protein preparations. Blood samples 
were taken at the end of the control and test periods. 
During the experiments with human volunteers, two extra portions of each 
diet were collected. These were later homogenised and fed to animals in 
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two experiments with rabbits and one with ra ts . A fur ther experiment with 
rabbits was carried out using semipurif ied d ie ts , the to ta l protein content 
of which was test prote in. The designs of the animal experiments were simi-
la r to those of the human experiments (Chapter 4) . 
In the two human studies, there was no clear difference in response with 
respect to to ta l serum cholesterol between the casein and the soy d ie ts . 
A decrease in low-density- l ipoprotein (LDL)-cholesterol and an increase in 
high-densi ty- l ipoprotein (HDL)-cholesterol were observed in those on the 
soy isolate d ie t when compared with those on the casein d ie t . The results on 
apolipoprotein-B and -A, suggest that the changes in cholesterol concentra-
t ions in the l ipoprotein fract ions resulted mainly from changes in the 
number of l ipoprotein par t ic les . However, these effects were only observed 
in those on the diets containing soy isolate and not in those on diets con-
taining soy concentrate. With regard to the r isk of coronary heart disease, 
the soy isolate d iet can be considered to be bene f i c ia l , but the effects 
are small when compared with the effects of the fa t composition and choles-
terol content of the d ie t . 
The results of the animal studies using human diets confirm the results 
reported for semipurif ied d ie ts . In rabbi ts , casein was found to be highly 
hypercholesterolemic when compared with the soy preparations, while in rats 
the effects were much smaller. The results stress the danger of extrapolating 
too readi ly from data from animal experiments on the ef fect of protein 
on serum cholesterol d i rec t l y to man. 
Large decreases in level of serum cholesterol have been reported in 
hypercholesterolemic patients on diets containing soybean prote in. Therefore, 
with regard to prevention of coronary heart disease, i t has been suggested that 
animal protein in the d iet should be replaced by vegetable prote in. However, 
the results of the present studies with healthy subjects suggest that the 
normocholesterolemic human is probably re la t i ve ly insensi t ive to the type of 
protein in his d ie t . I t should be noted, however, that these experiments 
were of short duration and that the subjects were adults. Effects of a 
long-term intake of various proteins commencing at an early age have s t i l l 
to be determined. 
Although the effects of the type of protein are probably small in normo-
cholesterolemic subjects, the replacement of foods containing animal protein 
with foods containing vegetable protein in the normal diet may s t i l l lead to 
changes in the concentration of serum l i p i d s , because the main sources of 
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animal protein are often also rich in saturated fat and cholesterol. 
In modifying the diet in order to influence certain physiological para-
meters, it should be realised that other parameters may also be affected 
(see Chapter 5). Caseinates are practically free of purines, while soy 
protein preparations like other protein sources such as meat, contain con-
siderable amounts of purines. Uric acid is the end product of human purine 
metabolism and the subjects on the soy diets showed significantly higher 
levels of serum urate than the subjects on the casein diets. It is well 
known that the prevalence of gout is directly related to serum urate con-
centration. 
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1. INTRODUCTION 
Diet, serum cholesterol, lipoproteins and coronary heart disease [CHD) 
Atherosclerosis and complications, that is coronary heart disease (CHD), 
stroke, and peripheral vascular disease, are main causes of death in many 
Western countr ies. Present evidence strongly supports the concept that the 
composition and quanti ty of dietary constituents can influence atherosclerosis 
and the r isk of developing CHD. Cholesterol in serum probably plays a 
crucial role in the relat ionship between d ie t and atherosclerosis. 
Cholesterol is transported through the blood stream in l ipoprote ins. 
Lipoproteins which contain l ip ids and apolipoproteins are discrete par t ic les 
with f i n i t e dimensions. The main classes of l ipoproteins which can be d is -
tinguished are: chylomicrons, the l igh tes t l ipoprote ins; very-low-density 
l ipoproteins (VLDL); low-density- l ipoproteins (LDL); and h igh-densi ty- l ipo-
proteins (HDL). Lipoproteins d i f f e r in composition and have d i s t i nc t physio-
logical ro les. The main carr iers of cholesterol are LDL and HDL, LDL trans-
port ing about 70% of the serum cholestero l , and HDL about 15-30%. 
A high concentration of LDL-cholesterol is atherogenic, and is used as a 
r isk indicator for CHD. Since most of the cholesterol in serum is in the 
LDL, the to ta l cholesterol concentration in serum is also often used as 
a r isk indicator . A high concentration of HDL-cholesterol is a negative r isk 
indicator fo r CHD ( 1 , 2 ) . High concentrations of LDL are known to promote 
deposition of cholesterol in the a r te r i a l wall and other t issues, while HDL 
may do the reverse. 
In the prevention of CHD, current dietary modifications are based on 
the concept that modif ication of r isk indicators should decrease the r isk 
of CHD. I t is well established that dietary modifications may influence 
levels of serum cholesterol and l ipoprote ins, and that high to ta l choles-
tero l and LDL-cholesterol levels in serum contribute d i rec t l y to athero-
sclerosis and CHD. However, i t has not been proven convincingly in humans 
that lowering of level of cholesterol in serum can prevent or delay cardio-
vascular disease. The "ideal experiment" which would reveal such information 
is p rac t i ca l l y impossible to carry out (2 , 3) . However, the evidence from 
many animal experiments, epidemiological surveys and c l i n i ca l t r i a l s , 
indicates that such a l i nk is almost inescapable ( 1 , 2 ) . 
On the other hand, the protection against CHD which can be obtained by 
dietary means, must not be overstated. Dietary modifications may lead to 
a decrease in level of serum cholesterol and to a decrease in morta l i ty 
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from CHD when the population as a whole is considered. However, for the 
individual only the effects on the risk of CHD can be estimated. Even 
dramatic changes in food habits will not give an individual 100% protection 
against CHD (3). Furthermore, it should be clearly recognised that apart from 
serum cholesterol, there are many other factors involved in cause of athero-
sclerosis and its complications. 
Dietary protein, serum cholesterol and lipoproteins 
The influence of dietary factors such as type and amount of dietary fat 
and amount of cholesterol on serum cholesterol and lipoproteins are well 
established. Recently more attention has been given to the role of dietary 
fiber and the type of protein in the diet. 
In animal studies, dietary proteins derived from animal sources are 
generally found to be hypercholesterolemic when compared with proteins from 
plant sources. In man, epidemiological studies and nutritional studies in 
vegetarians have also suggested that there is a relationship between intake 
of animal protein and serum cholesterol. Such epidemiological observations 
should be interpreted with caution as there may also be differences in other 
nutritional factors. Only a few controlled trials on the relationship 
between dietary protein and serum cholesterol have been carried out in humans, 
mainly with hypercholesterolemic subjects (for a review,see Ref. 4). On the 
basis of the results of animal studies and several studies on hypercholes-
terolemic patients, it has been suggested that replacing animal protein in 
the diet by vegetable protein will be beneficial in the prevention of 
atherosclerotic diseases (5). However, more information on the possible 
effects of the type of protein on normocholesterolemic subjects is required. 
Experiments described in this thesis 
In the experiments described in this thesis, the effects of three sources 
of protein on serum cholesterol and lipoproteins were compared: caseinate; soy 
protein isolate, the purest soy protein preparation available commercially, 
and soy protein concentrate, a less refined soy protein preparation. These 
protein preparations were chosen because the proteins they contain produce 
largely different effects in certain animal species and because these pre-
parations are available cornmercially in a highly purified form suitable 
for human consumption. 
In the first experiment with human volunteers (Chapter 2 ) , three diets 
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were compared: a casein diet, a soy isolate diet, and a diet containing a 
2:1 mixture of casein and soy isolate. The last diet was included because 
in animal experiments it has been observed that the addition of a relatively 
small amount of soy protein to casein eliminates the effect casein has of 
raising cholesterol levels. As the possible effect of soy protein on cho-
lesterol may be influenced by the type of protein preparation used, a second 
experiment with volunteers (Chapter 3) was carried out, in which in addition 
to the casein and soy isolate diets, a soy concentrate diet was included. This 
experiment was carried out with middle-aged volunteers because the possible 
effect of soy protein may be dependent on the lipid status of the subjects; 
it is known that in Western countries cholesterol levels increase with age. 
In order to compare the results of experiments carried out with humans and 
those with animals, diets collected during the human experiments were given 
to rabbits and rats. In addition an experiment with rabbits was carried out 
in which the protein preparations were incorporated into semipurified 
diets (Chapter 4). Most of the results presented in this thesis have been 
published or presented earlier (6-11). 
The casein and soy protein preparations differed not only in the type 
of protein, but also in a number of other substances, the nucleic acid content 
for example. The purine bases of dietary nucleic acids are degraded in man 
to uric acid. Soy protein preparations unlike caseinates contain considerable 
amounts of nucleic acids. Therefore the effects of soy protein preparations 
on levels of serum urate were also measured (Chapter 5). 
It has been suggested that an increased consumption of animal protein 
is accompanied by increased blood pressure (12). In the first study, the 
effects of the various test diets on blood pressure were systematically 
investigated, but no differences were observed between those on the casein 
diet and those on the soy test diet. These results have been published 
elsewhere (13). 
The results of many nutritional experiments would have been more 
meaningful if more appropriate designs had been used. The advantages 
and disadvantages of experimental designs often used in dietary trials are 
discussed in Appendix I. The planning, preparation and carrying out of 
strictly controlled nutritional experiments with humans are discussed in 
Appendix II. 
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2. Effects of casein versus soy protein diets on 
serum cholesterol and lipoproteins in young 
healthy volunteers1 2 
Joop M. A. van Raaij, M.Sc, Martijn B. Kat an,3 Ph.D., 
Joseph G. A. J. Hautvast, M.D.D.N. (Cantab), and Ruud J. J. Hermus,4 Ph.D. 
ABSTRACT The effects of casein and soy protein on serum cholesterol levels and lipoprotein 
composition were studied in 69 healthy volunteers ( 18 to 28 yr of age) under strict dietary control. 
Subjects were fed for 6 wk on diets containing 13% of energy as protein, 38% as fat (P/S ratio = 
0.6) and about 380 mg cholesterol per day. Of the protein in the diets 65% consisted of casein or 
soy protein or a 2:1 mixture of casein and soy protein. After a control period of 10 days during 
which all the subjects received the casein-soy diet, 20 subjects continued on this diet for the next 4 
wk as a base-line control, 25 subjects switched to the casein diet, and the remaining 24 subjects 
switched to the soy diet. Both food records and chemical analysis of double portions revealed that 
the diets were completely identical except for the type of protein. Average serum cholesterol levels 
at the end of the control period were 152 ± 27 mg/dl (3.93 ± 0.69 mmol/1) and 153 ± 23 mg/dl 
(3.95 ± 0.60 mmol/1) (mean ± SD) for the casein and soy group, respectively. At the end of the test 
period the levels were 149 ± 24 and 150 ± 23 mg/dl, respectively; thus there was no significant 
change on either diet. On the casein diet there was no change in the low-density lipoprotein 
cholesterol concentration, and only a slight, nonsignificant increase in the high-density lipoprotein 
cholesterol concentration. On the soy diet, however, there was a significant decline in low-density 
lipoprotein-cholesterol (—6.6 mg/dl; —0.17 mmol/1) and a significant increase in high-density 
lipoprotein-cholesterol (+5.8 mg/dl; +0.15 mmol/1). The decline in low-density lipoprotein choies 
terol in the soy group was significantly different from the small change in the casein group, but the 
difference in increase in high-density lipoprotein cholesterol in the soy and the casein group was 
only weakly significant. This suggests that soy protein could have a slight beneficial effect on the 
distribution of cholesterol over the various lipoprotein fractions, even at constant total cholesterol 
concentration. Am. J. Clin. Nulr. 34: 1261-1271, 1981. 
KEY WORDS Cholesterol, serum lipids, casein, soy protein 
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serum cholesterol is observed with proteins 
from plant sources (1-5). Similar effects have 
been observed in rats (6) and pigs (7); the 
data for chickens are conflicting (8, 9). 
In man, epidemiological data show a strong 
positive correlation between animal protein 
consumption and mortality from coronary 
heart disease (10). Furthermore, in several 
countries the trend toward increasing mortal-
ity from coronary heart disease during this 
century coincides with a doubling in the ratio 
of animal to vegetable protein in the diet (11-
13). In nutritional studies of vegetarians, 
Hardinge and Stare (14) found lower serum 
cholesterol levels among those who were pure 
vegetarians than among lacto-ovo-vegetar-
ians. Both groups had significantly lower 
levels than non-vegetarians. Sacks et al. ( 15) 
found similar effects in vegetarians. 
In humans, only a few controlled trials 
relating dietary protein to serum cholesterol 
have been carried out. While differences in 
the concentrations of serum cholesterol have 
been consistently produced in rabbits (2-5, 
16), the results of studies on humans are 
conflicting (17-19). We have, therefore, in-
vestigated the effect of casein and soy protein 
on the concentrations of serum cholesterol 
and lipoproteins in healthy young volunteers 
using highly purified proteins and with strict 
control of nutrient intake. 
Subjects and methods 
Subjects 
Forty-six male and 30 female university students, 
aged 18 to 28 yr, volunteered and were selected for the 
study. All subjects were healthy and had normal values 
for serum cholesterol, serum triglycerides, blood pres-
sure, and percentage of body fat as described for previous 
experiments (20). In addition the subjects were found to 
have normal values for blood hemoglobin and erythro-
cyte sedimentation rate and to have no detectable glucose 
or protein in the urine; none had received any medication 
known to affect serum lipids for at least 2 months before 
the study. 
The experimental protocol was fully explained to the 
participants and informed consent was obtained. The 
subjects were not offered payment and were free to stop 
participating at any moment. They were seen daily by 
one of the investigators (J.M.A.v.R.) and by two research 
dietitians. During the experiment two subjects became 
ill, two decided to withdraw, and three did not fully 
adhere to the dietary protocol; their data were elimi-
nated. 
Diets and control of food intake 
The amount (and type) of fat, cholesterol, protein, 
and carbohydrates in the diets were planned to simulate 
an average Western diet (11). The diets were completely 
identical except for the type of dietary protein. Of the 
protein 65^ was replaced by either casein (casein diet), 
soy protein (soy diet), or a 2:1 mixture of casein and soy 
protein (cassoy diet). To keep the diets acceptable 35% 
of the protein came from other sources (mainly from 
wheat, rice, potatoes, and other vegetables). 
The 65% replacable protein was incorporated as cas-
emate or soy isolate (Table 1) into specially developed 
products. Milk like beverages were prepared from butter 
concentrate, lactose, milk minerals and test protein (cas-
emate or soy isolate, 4.4% by weight); these beverages 
were in part fermented to yoghurts; both were developed 
by Unilever Research Laboratory, 3130 AC Vlaardingen, 
and by DMV-Veghel, and manufactured by the.Depart-
ment of Food Technology of the Agricultural University. 
The Institute for Cereals. Flour and Bread (IGMB-
TNO), 6701 AN Wageningen, prepared brown breads 
from flour, bran, and test protein (75, 10, and 15 parts-
respectively) and small amounts of minerals, yeast, etc.; 
gluten-free breads from gluten-free four and test protein 
(85 and 15 parts, respectively) and small amounts of 
minerals, yeast, etc; cookies from gluten-free flour, test 
protein, sugar, and fat (51, 10, 22, and 17 parts, respec-
tively). Sandwich spreads were manufactured by DMV-
Veghel and by Unilever Research, and consisted of test 
protein (14% by weight), fat (16% by weight) and either 
vegetables or fruits plus sugar. Cheese was used in the 
casein and the cassoy diets because it contains casein as 
practically the only protein. For the soy diet, a gelated 
product was prepared by Unilever Research from soy 
isolate (20% by weight) flavoring and spices (2.5% by 
weight) and water; butterfat was also added to the soy 
diet to balance the fat in cheese. Fresh egg yolk was used 
in all diets to adjust cholesterol intakes and each subject 
consumed one multivitamin tablet per day. Each diet 
met the nutritional requirements for adults (21). Special 
margarines were prepared by VanDenBerg & Jürgens 
B.V., 3000 AD Rotterdam. All supplies were purchased 
in bulk except for fresh products which were purchased 
from the same distributors throughout the experiment. 
TABLE 1 
Composition of casein and soy protein isolate 
used in the experimental diets 
Protein (N X 6.25):): 
Water 
Lactose 
Fat 
Ash 
Casein* 
90.5 
3.0 
<0.2§ 
<0.8S 
4.2 
g/imi 
Soy isolate} 
! 
92.8 
3.1 
<0.1§ 
3.5 
* Calcium and sodium caseinate (spray dried, bland), 
DMV Milk Industries, 5460 BA Veghel. Data expressed 
as mean value for calcium and sodium caseinate. 
fUNlSOL NH 70, UNIMILLS B.V., 3330 AA 
Zwijndrecht. 
$ The true Kjeldahl nitrogen-to-protein conversion 
factors for casein and soy protein are 6.38 and 5.70, 
respectively (52). Using the figure of 5.70 the protein 
content of soy isolate is 84.6 g/100 g, which by difference 
gives an unavailable carbohydrate content of about 8.8 
g/100g. 
s
 Data provided by manufacturer. 
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The three diets consisted of the same regular food-
stuffs and of highly similar special products. Breakfast 
and evening meal consisted of breads, margarine, 
spreads, sweetenings, fruit and fruit juices. The hot meal 
at noon consisted of soup, potatoes (or rice), other veg-
etables, sauces, egg yolk, cheese (or gelated soy product), 
and dessert. The soups, sauces, and desserts were pre-
pared from the analogs of milk and yoghurt. None of 
the following products was used: dairy products (except 
for cheese), meats, egg white, fish, legumes, onions, and 
garlic. 
All foodstuffs were weighed out for each person in 
quantities appropriate to his or her energy needs, except 
for 500 kJ (120 kcal) per day, which the subjects were 
free to choose from a list of foodstuffs not containing 
protein. Individuals were allowed unlimited tea, coffee 
and selected low-calorie beverages. Sugar was provided 
and up to 6 g/day of coffee whitener was allowed. Hot 
meals were served on weekdays at noon in the depart-
ment. All other foods were provided as packages daily; 
food for the weekend including ingredients for midday 
hot meals, was provided each Friday afternoon. Food 
rejections or deviations of any kind were recorded in 
diaries. Most of the special products were well accepted 
and adherence to the diets was excellent. 
During the control and test period the actual intake 
of nutrients was calculated for each individual on 2 and 
4 separate days, respectively, by multiplying the weights 
of foods on the questionaire by values on a computerized 
food composition table (22). In addition, double portions 
of each diet were analyzed as described earlier (20, 27). 
Experimental design 
All subjects consumed the cassoy diet for a control 
period of 10 days, after which they were divided into 
three groups; the groups were matched for initial serum 
cholesterol, energy intake, and sex. During the test period 
of 28 days, the casein group (n = 25) received the casein 
diet, the soy group (n = 24) received the soy diet, and 
the cassoy group (n = 20) continued on the cassoy diet, 
as shown in Figure 1. 
Body weight was recorded weekly. For each individ-
ual, energy intake was adjusted to avoid changes in body 
weight of more than 2 kg/2 wk. Puring the control 
period body weights decreased by 1.1, 0.8, and 1.1 kg in 
the casein, cassoy, and soy group, respectively. These 
slight weight losses continued during the test period, with 
mean weight reductions of 1.3, 1.0, and 1.6 kg, respec-
tively. The largest declines were found in three subjects 
on the soy diet (3.1, 4.0, and 4.1 kg). There were no 
differences in weight loss between the groups during the 
test period. 
The subjects were asked to note in diaries illness, drug 
use and departures from the diets. Hemoglobin and 
erythrocyte sedimentation rate were measured fort-
nightly and found to remain normal. 
Blood sampling and analysis 
Specimens of blood were obtained from an arm vein 
after an overnight fast. Blood was collected weekly and 
serum was obtained by low-speed centrifugation. All the 
samples were assayed for total cholesterol and high-
density lipoprotein (HDL)-cholesterol. At the end of the 
control and test period two samples were taken at 1 -day 
intervals (Fig. 1), and the results for total cholesterol and 
HDL-cholesterol were averaged. Serum cholesterol was 
measured with the reagent of Huang et al. (23) using 
serum calibrators as described earlier (24). Reproduci-
bility for blind control sera provided by the Center for 
Disease Control, Atlanta, G A, was ± 1.4% (CV) and 
accuracy was within 1.8% of the "true" (target) values. 
HDL-cholesterol was determined after Mn-heparin pre-
cipitation of low-density lipoprotein (LDL) and very 
low-density lipoprotein (VLDL) (24, 25) at an Mn-con-
centration of 92 mmol/1. At the end of both periods, 
lipoproteins in sera of the subjects from the casein and 
soy group were separated by density gradient ultracen-
trifugation (26-28). Before preparing the gradient prior 
to the ultracentrifugation, Sudan Black was mixed with 
the serum in order to stain the lipoproteins (28). After 
centrifugation the lipoprotein bands were photographed 
and then separated by use of a tube sheer into VLDL (d 
< 1.015 g/ml), LDL (1.015 < d < 1.060), and HDL (d 
> 1.060 g/ml). For each individual the mean LDL 
density (center of the colored LDL band) was calculated 
from the photograph with the aid of the known density 
gradient in the centrifuge tubes (A. H. M. Terpstra, C. J. 
H. Woodward, and F. J. Sanchez-Muniz, unpublished 
data). Lipoprotein fractions were assayed for cholesterol 
by an enzymatic method (29) using a kit (No. 124087, 
Boehringer-Mannheim GmbH, West Germany) and us-
ing serum calibrators as described earlier (24). 
The mean recovery was 97.8% (CV = 4.6%). Day-to-
day reproducibility was ±1.0% (CV) and bias was less 
than 1.0% compared with values obtained by the Abell 
method (30). Apolipoprotein-B was measured in whole 
sera by rocket immunoelectrophoresis as described pre-
viously (27). For one person the samples obtained at the 
Time (Weeks) 
Control 
Period 
1 
I 
2 
I 
Test Period 
3 L 
I I 
5 
I 
T Î î Î 
C a s e i n G r o u p (n = 25) Cassoy Diet Case in Diet 
C a s s o y G r o u p ( n = 2 0 ) |Cassoy Diet 
Soy Group (n = 24) Cassoy Diet 
C a s s o y Diet 
Soy Diet 
FIG. 1. Experimental design. Blood sampling is indicated by arrows. 
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start and at the end of the test period were always 
analyzed on one plate in order to minimise the effect of 
interassay variability. Analytical error was monitored by 
analysing a sample from a control pool on each plate. 
The combined within-day and between-day coefficient 
of variation for this control serum was 7%. 
Statistical evaluation 
The major hypothesis to be tested was that soy protein 
would lower serum cholesterol concentration, if com-
pared with casein. A minor hypothesis was that a 2:1 
mixture of casein and soy protein would also lower 
serum cholesterol, when compared with casein. The ef-
fect of diet was examined by testing the difference be-
tween the mean responses of the groups by unpaired one 
tailed t tests (31 ). The experiment was designed to protect 
against an error of the second type, i.e., missing a sig-
nificant difference through chance fluctuations: it was 
calculated that the casein and the soy group would each 
need to contain at least 24 subjects in order to detect 
differences between groups in total cholesterol response 
of at least 0.25 mmol/1 (10 mg/dl) at a significance level 
a of 5% and with a power ß of 80%. The effect of sex 
was examined by analysis of variance (31). 
Results 
Nutrient intake 
The results of nutrient intake, as measured 
by food records, are shown in Table 2. Food 
records and the chemical analysis of double 
portions indicated that there were essentially 
no differences between the experimental diets 
with respect to the amount of protein, fat, 
carbohydrate, alcohol, cholesterol, and die-
tary fiber and to the composition of the fatty 
acids, plant sterols and carbohydrates. The 
calcium content of the casein diet was slightly 
higher than that of the soy diet, but it is 
unlikely that this influenced serum lipids. 
The analysis did reveal a slightly higher total 
protein content and a lower sugar content 
than the calculations based on the records for 
all diets. The amino acid composition of ca-
sein was, as expected considerably different 
from that of soy protein (Table 3). The amino 
acid composition of the whole diet was di-
luted by those proteins that were already 
present and similar for all diets. However, the 
differences between the diets were still pro-
nounced (Table 3) and established beyond 
doubt that the planned differences in protein 
amino acid composition had been achieved. 
Both from the food records and from the 
amino acid analysis it could be calculated 
that about 65% of the total dietary protein 
consisted of soy protein or casein. 
Serum total cholesterol 
The time course of the mean serum total 
cholesterol concentration is presented for 
each group in Figure 2. The values of the 
TABLE 2 
Mean daily intake of nutrients before and during the experiment 
according to individual food records* 
Energy' (kcal) 
(MJ) 
Total fat (energy %) 
Saturated 
Mono-unsaturated 
Poly-unsaturated 
Carbohydrates (energy %) 
Sugars 
Polysaccharides 
Protein (energy %) 
Casein 
Soy protein 
Alcohol (energy %) 
Cholesterol (mg/day) 
Dietary fiber (g/day) 
Habitual 
intake 
before 
experiment! 
2710 
11.3 
33.1 
15.7 
12.0 
5.4 
49.3 
22.6 
26.7 
13.7 
3.9 
334 
38.2 
Control period 
Cassoy 
diet£ 
2595 
10.8 
38.5 
13.8 
17.0 
7.7 
47.4 
23.3 
24.1 
12.6 
5.6 
2.6 
1.6 
394 
28.8 
Casein 
diet'' 
2515 
10.5 
38.2 
13.2 
17.0 
7.9 
47.2 
23.2 
24.0 
12.9 
8.8 
1.7 
387 
28.7 
Test period 
Cassoy 
diet" 
2670 
11.2 
38.6 
13.8 
17.0 
7.8 
47.5 
23.4 
24.1 
12.3 
5.4 
2.5 
1.6 
398 
29.4 
Soy 
diet" 
2565 
10.7 
38.4 
12.9 
17.4 
8.1 
47.4 
22.4 
25.0 
12.6 
8.4 
1.7 
365 
28.2 
* The food records were elaborated using Netherlands food composition tables supplemented with analyses of 
special products. 
t Three-day records. 
^ Two-day records. 
8
 Four-day records. 
11
 1000 kcal = 4.2 MJ. 
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TABLE 3 
Amino acid composition of casein, soy protein isolate, and the 
duplicate portions of the diets*' f 
Amino 
L-alanine 
L-arginine 
L-aspartic acid" 
L-glutamic acid" 
Glycine 
L-histtdine 
L-isoleucine 
L-leucine 
L-lysine 
L-methionine 
L-phenylalanine 
L-proline 
L-serine 
L-threonine 
L-tyrosine 
L-valine 
•.-cystine:): plus L 
acid 
tryptophan^ 
Pure 
Casein" 
2.8 
3.3 
6.5 
21.4 
1.7 
2.8 
5.1 
8.8 
7.6 
2.5 
4.7 
9.5 
5.5 
3.9 
5.2 
6.4 
3 
100 
protein 
Soy 
Isolate 
4.1 
7.6 
11.3 
19.6 
4.0 
2.5 
5.0 
7.8 
6.2 
1.2 
5.2 
4.9 
5.3 
3.7 
3.6 
5.0 
3 
100 
Casein 
g/100 g amino acid 
3.2 
3.8 
7.5 
23.2 
2.3 
2.7 
4.7 
8.3 
6.4 
2.0 
4.6 
9.0 
5.5 
3.7 
4.1 
6.0 
3 
100 
Complete diets 
Cassoy 
3.5 
4.8 
8.5 
22.9 
2.9 
2.7 
4.6 
8.0 
6.1 
1.6 
4.7 
8.1 
5.6 
3.7 
3.7 
5.5 
3 
100 
Soy 
4.0 
6.8 
10.8 
22.1 
3.9 
2.5 
4.7 
7.6 
5.5 
1.2 
4.9 
5.8 
5.1 
3.6 
3.3 
5.0 
3 
100 
* Amino acid analysis of a hydrochloric acid digest of the lyophilized material using a Jeol JLC-5AH amino acid 
analyzer. 
t Expressed as g amino acid per 100 g amino acid. 
if. Cystine and tryptophan were not analyzed; their total contribution was estimated (52) as 3 g/100 g. 
8
 Average value for sodium and calcium caseinate. 
1
 Including amide. 
mmol/l 
5 0 , — — 
Control Period 
(C 
mg/dl 
180 
160 
_rr 0 1 2 3 1 5 
Time on experimental diets iweeks) 
FIG. 2. Effects of casein and soy protein diets on 
mean total serum cholesterol concentrations in humans 
throughout the experiment. Vertical bars indicate 1 SEM. 
• • , casein group (25 subjects); O O, cassoy 
group (20 subjects); A A, soy group (24 subjects). 
mean concentrations at the end of both pe-
riods are shown in Table 4. During the cassoy 
control period of 10 days serum total choles-
terol concentration decreased slightly in all 
groups compared with the uncontrolled 
preexperimental situation. The control group 
that continued on the cassoy diet did not 
show any change in serum total cholesterol 
during the test period, proving that levels had 
stabilized already at the end of the base-line 
TABLE 4 
Effects of casein and soy protein diets on serum 
total cholesterol concentrations 
(Mean ± SD)* 
Control period 
Test period 
Change 
Casein group 
(n - 25) 
152 ± 27 
149 ± 24 
- 3 ± 14 
Cassoy group 
(n - 20) 
mg/dn 
153 ± 24 
150 ± 25 
- 3 ± 13 
Soy group 
(n - 24) 
153 ± 23 
150 ± 23 
- 3 ± 10 
* Each value represents the average of two separate 
determinations at the end of the respective period. 
t 100 mg/dl = 2.59 mmol/l. 
period of 10 days. The soy and the casein 
diets also induced hardly any change in av-
erage cholesterol concentrations, except for 
minor oscillations of about 4 mg/dl (0.1 
mmol/l). No sex effects were found. 
Distribution of cholesterol over the lipoprotein 
fractions 
The mean cholesterol concentrations in the 
lipoprotein fractions are given in Table 5. 
Comparison of HDL-levels determined by 
ultracentrifugation and by the Mn-heparine 
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TABLE 5 
Effects of casein and soy protein diets on cholesterol 
concentrations in lipoprotein fractions and 
on serum apolipoprotein-B 
levels (mean ± SD) 
Casein group 
(n - 23) 
Soy group 
( n - 2 3 ) 
Cholesterol 
Ultracentrifugation: 
VLDL control period 
test period 
change 
LDL control period 
test period 
change 
HDL control period 
test period 
change 
Mn-heparin precipitation: 
HDL control period 
test period 
change 
Serum apoprotein-B 
control period 
test period 
change 
mg/dl* 
8 ± 3 
10 ± 5 
+ 1.5 ± 5.8 
80 ± 17 
79 ± 16 
-0.4 ± 12.4 
59 ± 16 
62 ± 15 
+2.3 ± 8.5 
58 ± 12 
60 ± 12 
+ 1.9 ±5.4 
488 ± 119 
441 ±99 
-47 + 52ft 
mg/l 
10 ± 3 
10 ± 5 
+0.8 ± 5.0 
88 ± 19 
81 ± 19 
-6.6 ± 9.3f t 
57 : 
62 : 
+ 5.8: 
10 
12 
5.0t 
55 ± 9 
58 ± 8 
+3.1 ±3.5t 
462 ± 107 
447 ± 107 
- 1 5 ± 51^ 
* 100 mg/dl = 2.59 mmol/1. 
f Significantly different from 0 (paired I test; p < 0.05). 
t Significantly different from casein group (unpaired l test; p < 0.05). 
procedure yielded a correlation coefficient of 
r = 0.91, which is similar to published values 
(32, 33). Values obtained by the ultracentrif-
ugational method were in general a few per-
cent higher than those obtained by the pre-
cipitation procedure (cf. Table 5). This is a 
common finding (32, 33) and is probably 
explained by the presence of small amounts 
of sinking pre-/? lipoprotein (lipoprotein (a)) 
in the ultracentrifugal HDL fraction when 
isolated within the classical density limits of 
1.063 and 1.210 g/ml. In the casein group 
there were no significant changes in concen-
trations in any of the lipoprotein fractions. In 
the soy group, however, there was a signifi-
cant decline in LDL-cholesterol and a sig-
nificant increase in HDL-cholesterol. 
There were no changes in VLDL-choles-
terol concentration. The decline in LDL-cho-
lesterol in the soy group is significantly dif-
ferent from the small change of LDL-choles-
terol in the casein group, but the difference 
in increase in HDL-cholesterol in the soy and 
the casein group is only weakly significant 
according to the ultracentrifugal data and not 
significant according to the precipitation 
method. Analysis of variance failed to show 
significant sex effects on the changes during 
the test period. The individual changes in 
serum total cholesterol, HDL- and LDL-cho-
lesterol were not correlated with the initial 
values (at the end of the control period). 
Serum apolipoprotein-B concentration 
In both the casein and the soy group the 
apoprotein-B concentration declined during 
the test period (Table 5), but the decline in 
the casein group was significantly greater 
than that in the soy group. In the casein 
group the LDL-cholesterol/apoprotein-B ra-
tio increased significantly from 1.64 to 1.79 
g/g (p < 0.01), and in the soy group this ratio 
declined from 1.90 to 1.81 g/g (p < 0.05). 
It should be noted that at the end of the 
control period the soy group happened to 
have a lower mean concentration of apo-B 
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and a higher concentration of LDL-choles-
terol than the casein group. This resulted in 
a significantly higher initial LDL-choles-
terol/apo-B ratio in the soy group than in the 
casein group. Such a difference is not sur-
prising, because we did not explicitly match 
the groups for this ratio. 
During the test period the mean densities 
of the LDL particles of the subjects in the 
casein group declined significantly from 
1.039 ± 0.005 to 1.036 ± 0.003 g/ml (mean 
± SD; paired t test; p < 0.05). In the soy 
group, the slight increase in mean densities 
from 1.036 ± 0.002 to 1.037 ± 0.002 g/ml 
was not significant. 
Discussion 
Recent experiments, both in various ani-
mal species (2, 3, 6, 7) and in humans (17, 
18) have shown profound effects on serum 
cholesterol levels of soy versus meat and/or 
milk proteins. This has led to the expectation 
that replacement of animal by vegetable pro-
tein in the human diet might aid in lowering 
serum total cholesterol levels, thereby provid-
ing an extra tool in the prevention of ather-
osclerotic vessel disease. Our results do not 
provide support for these expectations: in a 
carefully controlled short-term trial using 
nearly 70 healthy young subjects we found 
no effect on serum total cholesterol of either 
casein or soy protein compared with a 2:1 
mixture of these proteins. However, when 
duplicate portions of the same diets were fed 
to 12 New Zealand White rabbits the casein 
diet caused much higher serum cholesterol 
concentrations than the soy diet; the differ-
ence was already significant after 2'/2 wk (Fig. 
3; Reference 34). 
There are several ways to explain the dif-
ferences in response between humans and 
animals. It is known that animal species differ 
greatly in resistance to diet-induced hyper-
cholesterolemia. Apparently, healthy humans 
are less sensitive to changes of dietary protein 
than rabbits, rats, or pigs. Furthermore, most 
animal experiments have used young animals 
which have spent a considerable part of their 
lifespan on the test diets. Our results do not 
rule out the possibility that a long-term intake 
of animal protein, starting at an early age, 
will reveal similar cholesterol-raising effects 
in normocholesterolemic humans. All the 
FIG. 3. Effects of casein and soy protein diets on 
mean total serum cholesterol concentrations of rabbits. 
Vertical bars indicate I SEM. Throughout the experi-
ment on humans, duplicate portions of the casein and 
soy diets were collected and stored at —40°C. These were 
homogenized, freeze-dried, and pelletted afterward, and 
fed to 12 New Zealand White rabbits (3 months of age). 
Before and after the test period of 2'k wk the rabbits 
were fed a commercial rabbit pellet diet. The increase in 
serum total cholesterol on the casein diet was signifi-
cantly greater than that on the soy diet (p < 0.05). As the 
groups had unequal variances ; was tested at 5 instead of 
10 degrees of freedom, as suggested by Cochran (Refer-
ence 31, p. 115). After switching back to the commercial 
diet serum cholesterol concentrations returned to base-
line values. • • . casein group (n = 6); A A, soy 
group (n = 6). 
same, our results do stress the risk of extrap-
olating too readily animal data concerning 
the effect of protein on serum cholesterol 
directly to man. However, these species dif-
ferences may provide clues to the mechanism 
of cholesterol homeostasis. 
Epidemiological studies have suggested, 
when comparing nations or whole popula-
tions, a relation between intake of animal 
protein, serum cholesterol level, and cardio-
vascular disease (10). 
Epidemiological data, however, should be 
interpreted with caution as differences in 
other nutritional factors may be present. As 
an example, the main sources of animal pro-
tein (meat and dairy products) also contain 
much saturated fat and cholesterol. 
Very few strictly controlled experiments in 
man relating the source of dietary protein to 
the concentration of cholesterol in serum 
have been carried out, and the sparse results 
are contradictory (Table 6). No clear effects 
of the type of dietary protein were found by 
Walker et al. (35), Campbell et al. (36), An-
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derson et al. (37), and Shorey and Davis (19). 
On the other hand, small but significant ef-
fects have been observed by Carroll et al. 
(18), while striking cholesterol-lowering 
properties of soybean protein have been re-
ported by Sirtori et al. (17, 38). How can one 
explain these different results? 
Many soy products contain appreciable 
amounts of nonprotein material and it has 
been suggested that this is partly responsible 
for the observed effects in some experiments 
(39-45). Even the soy protein isolate used in 
our experiment, which is representative of the 
purest commercially available material, still 
contains about 10% of nonprotein material, 
mainly carbohydrates. The customary Kjel-
dahl nitrogen-to-protein conversion factor of 
N X 6.25 obscures this fact (Table 1). It has 
also been suggested that the form in which 
the soy protein is incorporated in the diets is 
important (46). The test diets in some studies 
differed not only in the source of protein but 
also in cholesterol content and the amount 
and composition of fat because of the strong 
coupling of protein with other nutrients in 
ordinary foodstuffs (17). The lipid status of 
the subjects could be an important factor: our 
subjects had low to very low serum choles-
terol levels, while Sirtori et al. (17,38) studied 
hypercholesterolemic patients. Normocholes-
terolemic subjects are possibly less sensitive 
to changes in dietary protein than hypercho-
lesterolemic individuals (38), which remains 
to be established. All these factors may have 
played a role in producing conflicting results 
in the different studies with humans. 
Another important factor is the use in the 
studies of widely different "animal" and 
"vegetable" proteins. It has been shown that 
animal or vegetable proteins cannot be 
grouped in that way regarding their choles-
terolemic action in rabbits (1, 3, 41, 43). 
Animal experiments suggest that effects of 
dietary protein on serum cholesterol can be 
explained, at least partly, by the amino acid 
composition of the proteins (2, 3, 34, 43, 45, 
47-49). The role of the individual amino 
acids or of specific combinations of amino 
acids, however, still remains unclear. Atten-
tion has been particularly focused upon the 
lysine/arginine ratio (3, 49, 50), glycine (43, 
49), glutamic acid (51), and methionine (39) 
but the results are not conclusive (49). The 
amino acid composition of soy protein is 
intermediate in many regards between casein 
and meat protein (52). As a result, our soy 
protein diet contained more alanine, arginine 
and glycine and less glutamic acid, tyrosine, 
and valine than the casein diet, but the re-
verse was true for the plant protein diet (con-
taining soy protein) in Carrol's experiment 
(18); there was less alanine, arginine, and 
glycine and more glutamic acid, tyrosine, and 
valine in their plant protein diet than in their 
meat/milk protein diet. Therefore, it is con-
ceivable that had we chosen other plant and 
animal proteins, we might have been able to 
demonstrate an effect on the concentration of 
cholesterol in serum. 
Our data suggest a small decline in LDL-
cholesterol and a small increase in HDL-cho-
lesterol concentration on soy protein but not 
on casein. In view of the inverse relation 
between HDL-cholesterol concentration and 
obesity, the lipoprotein data were reanalyzed 
after exclusion of possible interference by 
weight loss. Deletion of the results of the 
subjects who lost more than 2 kg of body 
weight during the test period (six subjects 
from the casein and nine from the soy group) 
left the conclusions essentially unchanged. 
The effect on HDL- and total cholesterol 
remained the same after exclusion of those 
people who lost more than 2 kg. Only the 
difference in the effect on LDL-cholesterol 
became less pronounced (3 instead of 6 mg/ 
dl). Sirtori et al. (38) found that soybean 
protein exerted its hypocholesterolemic effect 
mainly by lowering LDL-cholesterol, while 
only a minor decline of HDL-cholesterol was 
observed. Our results for the LDL-choles-
terol/apoprotein-B ratio suggest that ingest-
ing the casein diet caused a shift to LDL-
particles richer in cholesterol, while consum-
ing the soy diet caused a shift to LDL-parti-
cles containing less cholesterol. The interpre-
tation of these changes is complicated, how-
ever, because persons randomized into the 
soy group happened to have higher LDL-
cholesterol/apoprotein-B ratios than the sub-
jects in the casein group; thus the starting 
levels were not comparable, although the di-
rection of the individual diet effects was un-
mistakeable. These findings are confirmed by 
the changes in the density of the LDL. The 
data on the LDL composition and density are 
30 
preliminary only and this finding should be 
investigated further. However, it seems clear 
that the absence of an effect on total choles-
terol levels by dietary casein and soy protein 
does not rule out the possibility that changes 
in composition and/or concentration of in-
dividual cholesterol-transporting lipoproteins 
do occur. Although it has not definitely been 
"proven" that an increase of the HDL/LDL 
cholesterol ratio by dietary manipulation will 
decrease the incidence of coronary artery dis-
eases, it is a fact that high HDL/LDL choles-
terol ratios are predictive for lower risk for 
these diseases (53, 54). If our results can be 
confirmed, this would suggest that soy protein 
could have qualitatively a beneficial effect, 
even at constant total cholesterol concentra-
tions. E3 
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3. Influence of diets containing casein, soy isolate, 
and soy concentrate on serum cholesterol and 
lipoproteins in middle-aged volunteers1 2 
Joop M. A. van Raaij,3 M.Sc, Martijn B. Katan, Ph.D., Clive E. West, Ph.D., and 
Joseph G. A. J. Hautvast, M.D., Dip.Nut.(Cantab) 
ABSTRACT Fifty-seven healthy volunteers (mean age 46 yr) were fed for 45 days on diets 
containing 16% of energy as protein, 35% as fat (polyunsaturated/saturated fat ratio = 0.5) and 
about 375 mg cholesterol/day. Of the protein in the diets 60% was provided as caseinate, as soy 
protein isolate, or as soy protein concentrate. After a control period of 17 days during which all the 
subjects received the casein diet, 17 subjects continued on this diet for the next 28 days (test period), 
20 subjects switched to the soy isolate diet, and the remaining 20 subjects switched to the soy 
concentrate diet. Serum cholesterol levels at the end of the control period were 207 ± 36, 205 ± 40, 
and 199 ± 35 mg/dl (mean ± SD) for the casein, isolate, and concentrate groups, respectively. 
Mean changes over the test period were - 2 ± 10, - 8 ± 12, and +1 ± 10 mg/dl, respectively. 
Compared with the casein diet, the isolate diet caused a small, nonsignificant decline in both serum 
total cholesterol and low-density lipoprotein cholesterol (-6.5 mg/dl) and an increase in high-
density lipoprotein cholesterol (+5.8 mg/dl) (p < 0.05). These effects may have been more obvious 
if there had been no differences between groups in weight loss. No correlation was found between 
the response and the initial cholesterol level. No differences in lipoprotein composition were found 
between the casein and soy concentrate groups. Our data suggest that soy protein preparations do 
not have dramatic effects on the serum total cholesterol concentration in healthy subjects. However, 
pure soy protein might have some beneficial effect on the distribution of cholesterol over the 
lipoproteins. The lack of effect of the less refined soy protein concentrate suggests that the dietary 
fiber and other nonprotein components of soy concentrate do not have, at least in the short-term, 
a favorable effect on serum cholesterol and lipoproteins in healthy adults. Am J Clin Nutr 
1982;35:925-934. 
KEY WORDS Casein, soy protein, serum cholesterol, serum lipoproteins, high-density lipo-
proteins, dietary fiber 
Introduction increase in the ratio of high-density lipopro-
tein (KDL) over low-density lipoprotein cho-
Several clinical investigations in hypercho-
 l e s t e r o l o n t h e s o y p r o t e i n d i e t ( 7 ) 
lesterolemic patients have shown that re- Several factors, such as the lipid status of 
placement of animal proteins in the diet by
 t h e s u b j e c ts and the type of soy protein used, 
textured soy protein can lower the concentra-
 m a y e x p i a i n t h e difference in results between 
tion of serum low-density lipoprotein (LDL)
 t h e s t u d i e s o f o t h e r w o r k e r s and ourselves, 
cholesterol to a marked degree (1-3). This
 T h i s i s s u p p o r t e ( j by the results of Sirtori et 
had led to the expectation that the replace-
ment of animal protein by vegetable protein 
in the human diet might aid in lowering , 'Froni the Department of Human Nutrition, Agricul-
, , , , , P . . . , ° tural University, De Dreiien 12, 6703 BC Waeeningen, 
serum total cholesterol levels, and hence, be x^e Netherlands. 
of benefit in the prevention of atherosclerosis Supported in part by grants from the Netherlands 
(4-6). However, we were unable to confirm Institute for Dairy Research (NIZO) and the Nether-
the hypocholesterolemic effect of soy protein l ands Hear t Foundation (79.045,26.003). 
j -.r • • . • .i . ,, , Author to whom requests for reprints should be 
compared with casein in a strictly controlled
 a<jdressed 
nutritional trial with 69 volunteers aged 18 to Received July 9,1981. 
28 yr. We did observe a small but significant Accepted for publication October 27, 1981. 
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al. (8, 9) who found that the therapeutic 
response was related to the initial serum cho-
lesterol level of their patients. In our previ-
ously reported study, the volunteers were stu-
dents with low serum cholesterol levels. Thus 
it seemed appropriate to examine whether the 
results of our earlier experiment could be 
confirmed in subjects with a higher mean 
serum cholesterol level. As serum cholesterol 
increases with age in Western countries we 
decided to repeat out previous experiment 
with middle-aged volunteers. We also de-
cided to examine if different types of soy 
preparation vary in effectiveness in lowering 
serum cholesterol. In addition to the highly 
purified soy protein preparation that we used 
previously (soy isolate), a diet containing soy 
preparations with substantial amounts of 
nonprotein material (soy concentrate) was 
now also tested. It has been suggested that 
the nonprotein material from legumes such 
as dietary fiber and saponins may lower se-
rum cholesterol and might be responsible for 
the observed effects in some studies (10-14). 
Subjects and methods 
Subjects 
Thirty-two male and 29 female volunteers were re-
cruited from the town of Wageningen and surrounding 
areas through advertisements in local newspapers. The 
subjects ranged in age from 29 to 60 yr (mean 46 ± 9 
yr). They were apparently healthy as determined by a 
medical questionnaire and were found to have normal 
values for blood Hb and no detectable glucose or protein 
in their urine. Erythrocyte sedimentation rate was 
slightly but persistently elevated (20 to 30 mm/h) in five 
subjects, while another six subjects showed a slightly 
elevated blood pressure (diastolic between 95 and 105 
mm Hg or systolic between 150 and 160 mm Hg). Four 
men and eight women were overweight (weight/height2 
more than 27 and 26 kg/m2, respectively). Serum total 
cholesterol in casual blood samples ranged from 135 to 
305 mg/dl (mean 215 mg/dl) and HDL-cholesterol from 
34 to 86 mg/dl (mean 55 mg/dl). None had received any 
medication known to affect serum lipids for at least 2 
months before the study. 
Before approval for the study was obtained from the 
Ethical Committee of the Department of Human Nutri-
tion of the Agricultural University. The experimental 
protocol was fully explained to the participants and 
informed consent was obtained. The subjects were not 
offered payment and were free to end their participation 
at any moment wanted. They were seen by one of the 
investigators (JMA van R) and by four research dietitians 
each day during the week. During the experiment, two 
subjects decided to withdraw. Participants were asked to 
note in diaries any illness, drugs use, and departures 
from the diets. On the basis of this information, it was 
decided to eliminate the data of another two subjects 
from the analysis, so that data on 57 subjects were used. 
Diets and control of food intake 
The amount (and type) of fat, cholesterol, protein, 
and carbohydrates in the test diets were planned to 
simulate an average Western diet, but with slightly higher 
intakes of protein and polyunsaturated fatty acids. Of 
the protein 60% was replaced by protein from caseinate 
(casein diet), from soy protein isolate (isolate diet), or 
from soy protein concentrate (concentrate diet). Details 
of these proteins are given in Table 1. To keep the diets 
palatable, it was necessary to provide 40% of the protein 
from other sources (mainly from wheat, rice, potatoes, 
and other vegetables). The caseinates, isolates, and con-
centrates were incorporated into highly similar specially 
developed products. Brown bread and gluten-free bread 
and analogues of milk and yogurt were prepared as 
described previously (7). Half of the protein in brown 
breads consisted of test protein; the protein in the gluten-
free breads and in the milk-like beverages consisted of 
test protein alone. The analogues of milk and yogurt 
were incorporated into soups, sauces, puddings, and 
sandwich spreads. Cheese was used in the casein diet 
because it contains casein as practically the only protein. 
A gelated product was prepared from soy isolate as a 
counterpart for cheese in the isolate diet (7), and a 
commercial textured product was used in the concentrate 
diet. Butter fat was added to both soy diets to balance 
the fat in cheese. The gelated and textured soy products 
were added to sauces and sandwich spreads. Fresh egg 
yolk was used in all diets to adjust cholesterol intakes, 
and each subject consumed one multivitamin tablet 
(Davitamon 10. N.V. Organon, 5349 AB Oss) per day. 
TABLE 1 
Composition of the protein preparations used 
Soy 
isolate! 
Soy 
concentrale-t 
Protein 
Moisture 
Fat 
Ash 
Carbohydrates 
g/IOOg 
92.4§ 
3.0 
0.3 
4.2 
0.211 
g/l()()g 
79.7§ 
5.5 
0.5 
4.0 
10.31 
gl I no g 
57.2§ 
5.9 
1.6 
6.4 
28.9H 
* Calcium and sodium caseinate (spray dried, bland), 
DMV Milk Industries, 5460 BA Veghel. Data expressed 
as mean of the values for calcium and sodium caseinate. 
t Soy protein isolate PP500E and PP6I0, Purina Pro-
tein Europe, B-1050 Brussels, Belgium. Data expressed 
as mean of the values for PP500E and PP6I0. 
% Soy protein concentrates Unico (powder) and Dubit 
(textured, prepared from Unico), Unimills BV, 3330 AA 
Zwijndrecht. Data expressed as mean of the values for 
Unico and Dubit. 
§ Kjeldahl nitrogen-to-protein factors of 6.38 for ca-
, sein and 5.70 for soy protein were used. The'convential 
factor of 6.25 would have given values of 90.5 for casein, 
87.4 for soy isolate and 62.7 for soy concentrate. 
|| Lactose. 
I By difference. 
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Only small amounts of meat (providing about 1% of total 
protein intake) and no egg white, fish, legumes, or dairy 
products apart from cheese were used in the preparation 
of the diets. Each diet met the recommended nutritional 
allowances for adults (15). The daily menu is given in 
Table 2. As the purity of the protein preparations differed 
(see Table I), it was necessary to incorporate different 
amounts of the protein preparations in the diets in order 
to keep the proportion of protein constant. The diets 
were completely identical except for the type of protein 
and the amount of nonprotein material derived from the 
preparations used, because the diets consisted of the 
same regular foodstuffs and similar special products. 
Total diets wire provided for the participants except 
for 240 kcal/day, which the subjects were free to choose 
from a list of foodstuffs not containing protein. All 
foodstuffs were weighed out for each person in quantities 
appropriate to his or her energy needs. Hot meals were 
served on weekdays in the evening at the Department. 
TABLE 2 
Example of a daily menu for a subject consuming 2240 
kcal/day* 
Breakfast and 
lunch 
Dinner 
Snacks 
Total (kcal) 
Item 
Brown breadf 
Gluten-free 
breadf 
Margarine 
Sandwich spreadf 
Meats 
Sugarj: 
Soupf 
Potatoes (or rice) 
Other vegetables 
Soy saucef 
(or Casein 
saucef 
plus cheese 
Egg yolk 
Salad 
Puddingf 
Fruit§ 
Juice:}: 
Amount 
Total 
S 
245 
80 
30 
75 
30 
25 
200 
100 
175 
150 
125 
40 
20 
30 
175 
2000 
Test 
protein 
S 
18 
6 
6 
6 
13 
3 
10) 
6 
55 
* Food provided for subjects. In addition to these 
items subjects were allowed to choose 240 kcal/day of 
foodstuffs from a list of low-protein products. Subjects 
were allowed unlimited tea, coffee, selected low-calorie 
beverages, and up to 6 g of coffee-whitener/day. 
t Special product containing test protein. 
$ Sugar was provided as sugar, apple syrup, honey, 
apple juice, or grapefruit juice, as determined by individ-
ual preference. 
§ The amount of fruit varied with the type of fruit 
provided. 
All other foods were provided as packages daily; food 
for the weekend including ingredients for the hot meals 
was provided each Friday. Nonadherence to the diets 
was recorded in diaries. The special products were well 
accepted and adherence to the diets was excellent. Each 
subject weighed and recorded his or her food intake on 
2 random days during the control period and on 4 
random days during the test period. The actual nutrient 
intake was calculated for each individual from these food 
records using a computerized food composition table 
supplemented with analyses of special products (16). In 
addition, double portions of each diet were collected and 
analyzed as described earlier (17, 18). 
Experimental design 
All subjects consumed the casein diet for a control 
period of 17 days after which they were divided into 
three groups; the groups were matched for initial serum 
total cholesterol, HDL-cholesterol, energy intake, and 
sex. During the test period of 28 days, the soy isolate 
group (n = 20) received the soy isolate diet, the soy 
concentrate group (n = 20) received the soy concentrate 
diet, and the casein group (n = 17) continued on the 
casein diet, as shown in Figure 1. 
Body weight was recorded weekly. For each individ-
ual, energy intake was adjusted to avoid changes in body 
weight of more than 2 kg/2 wk. During the control 
period, body weights decreased by 0.8, 0.7, and 0.4 kg in 
the casein, isolate, and concentrate groups, respectively. 
These weight losses continued during the test period, 
with mean weight losses of 1.9, 1.4, and 1.2 kg, respec-
tively. The mean weight reduction in the casein group 
was significantly higher than in the concentrate group 
(p < 0.01). Sixteen subjects lost more than 3 kg of weight 
over the entire experimental period; two of them, both 
from the casein group, lost more than 5 kg (5.4 and 5.6 
kg, respectively). 
Blood sampling and analysis 
Blood samples were obtained fortnightly from an arm 
vein after an overnight fast. At the end of the control 
period, and also at the end of the test period, two samples 
were taken at 1-day intervals (Fig. I). Serum was ob-
tained by low-speed centrifugation and all serum samples 
were assayed for total cholesterol and HDL-cholesterol. 
At the end of both periods, lipoproteins in sera were 
separated by density gradient ultracentrifugation, and 
recovered by aspiration into very low-density lipoprotein 
(d < 1.006 g/ml), LDL + sinking pre-/3 lipoproteins 
(1.006 < d < 1.075 g/ml). HDL-2 ( 1.075 < d < 1.125 g/ 
ml) and HDL-3 (d > 1.125 g/ml). The mean recovery of 
cholesterol was 97.2 ± 5.0%. All methods used were 
those described for our previous experiment (7). Com-
parison of HDL-levels determined by ultracentrifugation 
and by the Mn-heparin procedure yielded a correlation 
coefficient of r = 0.91. Values obtained by the ultracen-
trifugation method were about 3% higher than those 
obtained by the precipitation procedure. The sera of 16 
of the 57 subjects showed a sinking pre-/? lipoprotein 
band with a mean density of 1.064 ± 0.005 g/ml [calcu-
lated as described (7)]. In order to partition this lipopro-
tein band completely into the LDL-fraction, we used a 
boundary between HDL and LDL of 1.075 g/ml instead 
of the usual density of 1.063 g/ml. 
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Statistical evaluation Results 
The response to the test diet was calculated per subject 
as the change from the end of the control to the end of 
the test period. Differences in diet effects were examined 
by comparing the mean responses of the groups by 
unpaired t tests. The effects of sex, initial cholesterol 
levels, and weight changes were examined by analysis of and chemical analysis of double portions in-
covariance and by correlation analysis (19). dicated that there were essentially no differ 
Nutrient intake 
The nutrient intake as measured by food 
records is shown in Table 3. Food records 
Time (weeks) 
Blood sampling 
Control Period 
1 2 
I 1 
Test Period 
3 4 5 
1 1 I 
6 
1 
ft ft 
Casein group Casein diet Casein diet (n=17) 
Iso la te group Casein diet Isolate diet (n=20) 
Concentrate group Casein diet Concentrate diet (n=20) 
FIG. 1. Experimental design. 
TABLE 3 
Mean daily intake of nutrients before and during the experiment according to individual food records 
Energy (kcal/day) 
(mJ/day) 
Protein (% of energy) 
Casein 
Soy protein 
Other animal proteins 
Other vegetable proteins 
Total fat (% of energy) 
Saturated 
Monounsaturated 
Polyunsaturated 
Carbohydrates (% of energy) 
Sugars 
Starch 
Alcohol (% of energy) 
Cholesterol (mg/day)§ 
Dietary fiber (g/day) 
Habitual intake 
before experiment' 
2265 
9.5 
13.8 
t 
t 
8.3 
5.5 
36.6 
15.9 
13.1 
7.6 
45.0 
21.5 
23.5 
4.6 
297 
32 
Control period 
Casein diel 
2140 
9.0 
16.2 
9.8 
0.0 
1.4 
5.0 
34.1 
14.8 
11.7 
7.6 
46.2 
21.2 
25.0 
3.5* 
369 
36 
Casein diet 
2116 
8.9 
15.9 
9.6 
0.0 
1.4 
4.9 
34.5 
15.3 
11.5 
7.7 
48.0 
22.3 
25.7 
1.6 
374 
37 
Test period 
Isolate diet 
2166 
9.1 
16.2 
0.0 
9.8 
1.2 
5.2 
34.5 
15.0 
11.6 
7.9 
45.1 
20.0 
25.1 
4.2 
381 
48« 
Concentrate 
diet 
2244 
9.4 
16.1 
0.0 
9.8 
1.1 
5.2 
34.9 
14.9 
12.0 
8.0 
45.6 
20.7 
24.9 
3.4 
382 
69f 
* 3-day records. 
t Not measured. 
% Percentages of energy during the control period were 2.1, 4.5, and 3.8 for the casein, isolate and concentrate 
groups, respectively. 
§ Mean plant sterol intake was 320 mg/day (/8-sitosterol, 50%; campesterol, 22%; stigmasterol, 6%; others, 22%). 
|| Included 6.8 g of unavailable carbohydrates from soy protein preparations. 
f Included 27.8 g of unavailable carbohydrates from soy protein preparations. 
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ences between the experimental diets with 
respect to the amount of protein, fat, carbo-
hydrate, and cholesterol and to the composi-
tion of the fatty acids, carbohydrates, and 
plant sterols. The amount of cholesterol in 
the experimental diets was about 75 mg/day 
higher than in the preexperimental diet. The 
differences between groups in alcohol con-
sumption during the test period were similar 
to those during the control period. From the 
food records it could be calculated that about 
60% of the total dietary protein consisted of 
either casein or soy protein. Analysis of the 
soy isolates and soy concentrates used re-
vealed only negligible differences in amino 
acid composition. Although the amino acid 
composition of the whole diet was diluted by 
those proteins that were common to all diets, 
the calculated differences between the casein 
and soy diets were still pronounced and sim-
ilar to those described previously (7). As ex-
pected the test diets differed greatly in dietary 
fiber content. The mean protein consumption 
was about 90 g/day, of which about 55 g 
were derived from the test protein. This cor-
responded to about 60 g caseinate, 70 g soy 
isolate, or 100 g soy concentrate. Therefore 
the isolate and concentrate provided the sub-
jects daily with about 7 and 28 g of dietary 
fiber (Table 1), including about 0.1 and 0.5 g 
of polygalacturonic acid (pectin), respec-
tively. The calcium content of the casein diet 
was slightly higher than that of the soy diets, 
and the concentrate diet had a lower sodium 
content and a higher potassium content than 
the casein and isolate diet. However, it is 
unlikely that these slight differences in min-
eral composition influenced the level of se-
rum lipids. Chemical analysis of double por-
tions revealed a slightly higher fat content 
and a lower oligosaccharide and cholesterol 
content in all diets than did the calculations 
based on records plus food tables. This was 
in agreement with our previous findings (7, 
17, 18). 
Serum total cholesterol 
The time course of the mean serum total 
cholesterol concentration is presented for 
each group in Figure 2. The values of the 
mean concentrations at the end of the control 
and test period are given in Table 4. During 
the casein control period of 17 days serum 
cholesterol concentration decreased in nearly 
all subjects compared with the uncontrolled 
preexperimental situation by on average 12 
mg/dl (0.30 mmol/1). Changes in serum cho-
lesterol were negatively correlated with the 
initial levels (r = -0.40; p < 0.001); thus the 
largest declines in cholesterol were found in 
the subjects with the highest initial levels. It 
is difficult to explain the cholesterol changes 
by differences between the nutrient compo-
sition of the test diets and the preexperimen-
tal self-selected diets (Table 3). It may well 
be that the controlled nutritional conditions 
and/or the habituation to the new menu- and 
mg/dl 
240 
£220 
Ol 
Ô Ol 
"5)200 
Ol 
o 
ü 
§180 
( 
Control Period 
^ ^ - 0 - ° 
' . . 
D 1 2 
Test Period 
I 1 1 
3 4 5 
I 
* ^ 
1 
6 
_ 
-
f 
7 
mmol/l 
6.0 
5.5 
5.0 
' 
Time on experimental diets (weeks) 
FIG. 2. Effects of casein and soy protein diets on mean serum total cholesterol concentrations in humans 
throughout the experiment. Vertical bars indicate 1 SEM. • • , casein group (17 subjects); A A, soy isolate 
group (20 subjects); O O, soy concentrate group (20 subjects). 
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TABLE 4 
Effects of rasein and soy protein diets on cholesterol concentration in whole serum (mean ± SD); each individual 
value represents the average of two separate determinations at the end of the respective period 
All subjects 
Control period 
Test period 
Change 
Initial cholesterol level 
Highest 25% 
Control period 
Test period 
Change 
Lowest 25% 
Control period 
Test period 
Change 
Wt loss during study 
Less than 3 kg 
Control period 
Test period 
Change 
More than 3 kg 
Control period 
Test period 
Change 
Casein group 
mg/dl' 
( n = 17) 
207 ± 36 
205 ± 35 
-2.3 ± 10.1 
(n = 5) 
240 ± 34 
235 ± 39 
-5.3 ± 15.1 
(n = 5) 
168 ± 19 
170 ± 15 
+ 1.6 ±6.5 
(n = 10) 
214 ±35 
214 ±38 
-0.3 ± 7.2 
(n = 7) 
197 ± 38 
192 ± 29 
-5.4 ± 13.3 
Isolate group 
mg/dl 
(n = 20) 
205 ± 40 
197 ± 43 
-7.7 ± 12.0f 
(n = 5) 
248 ± 24 
243 ± 26 
-4.3 ± 18.8 
(n = 5) 
157 ± 23 
145 ± 19 
-11.5 ±8.3^ 
(n = 15) 
205 ± 39 
199 ± 44 
-6.3 ± 12.5 
(n = 5) 
202 ± 45 
189 ±41 
-12.6 ± 9.0f 
Concentrate group 
mg/dl 
(n = 20) 
199 ± 35 
200 ±38 
+ 1.2 ± 10.4 
(n = 5) 
235 ± 30 
244 ± 31 
+9.2 ± 15.7 
(n = 5) 
164 ±37 
159 ±31 
-4.6 ± 7.4 
(n = 16) 
204 ±35 
205 ± 38 
+ 1.5 ± 11.3 
(n = 4) 
180 ±32 
179 ± 34 
-0.8 ± 7.7 
* 100 mg/dl = 2.59 mmol/1. 
t Significantly different from concentrate group (p < 0.05). 
^ Significantly different from casein group (p < 0.05). 
eating-pattern and the special products 
played a role. 
The control group that continued on the 
casein diet did not show any further change 
in serum total cholesterol which showed that 
levels had stabilized at the end of the base-
line period of 17 days. The soy concentrate 
diet also induced hardly any change in aver-
age cholesterol concentration, but the soy 
isolate diet caused a small decline in total 
cholesterol of about 8 mg/dl (0.20 mmol/1). 
Analysis of the individual responses during 
the test period failed to show effects of sex, 
but revealed a significant diet effect. It ap-
peared that the decline on the soy isolate diet 
was significantly different from the small in-
crease on the concentrate diet (p < 0.05) but 
not from the small decline on the casein diet. 
In the casein group changes in serum choles-
terol during the test period were negatively 
correlated with initial levels (r = -0.37; p = 
0.07). However, in the isolate and concentrate 
group the relationships were positive (r = 
+0.25; p = 0.14 and r = +0.35; p = 0.07, 
respectively). Thus, in both soy groups the 
largest declines in serum cholesterol were 
observed in subjects with the lowest initial 
levels (see also Table 4). 
Although every effort was made to adjust 
energy intake as required to control body 
weight, weight losses were observed in nearly 
all subjects. It has been reported that weight 
loss can decrease serum total cholesterol (20) 
and increase HDL-cholesterol (21) but that a 
considerable amount of weight must be lost 
(10 to 15%) to produce noticeable effects. 
Although in our study none of the correla-
tions between changes in either serum total 
HDL-cholesterol and variation in body 
weight was significant at the 5% confidence 
level, Table 4 does suggest some relation 
between weight loss and decrease of serum 
cholesterol. Changes in HDL-cholesterol for 
those subjects who lost less than 3 kg of body 
weight over the whole experiment are given 
in a footnote to Table 5. Weight loss was 
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TABLE 5 
Effects of casein and soy protein diets on cholesterol concentration in lipoprotein fractions of serum (mean ± SD) 
Ultracentrifugation: 
Very low-density lipoprotein 
Control period 
Test period 
Change 
LDL 
Control period 
Test period 
Change 
Total HDL 
Control period 
Test period 
Change 
HDL-2 
Control period 
Test period 
Change 
Mn-heparin precipitation: 
HDL§ 
Control period 
Test period 
Change 
Casein group 
(n = 16) 
mg/dl' 
14 ± 7 
14 ± 8 
+0.0 ± 5.3 
127 ±31 
130 ± 33 
+2.8 ± 12.0 
62 ± 14 
58 ± 11 
-4.5 ± 9.2 
37+ 13 
33 ± 10 
-4.0 ± 8.4 
58 ± 11 
58 ± 10 
-0.4 ± 4.6 
Soy isolate group 
(n = 20) 
mg/dl 
15 ± 10 
14 ± 8 
-0.9 ± 5.4 
128 ± 33 
124 ± 33 
-3.7 ± 15.lt 
58 ± 11 
59 ± 11 
+•1.3 ± 5.9$ 
30 ± 9 
31 ± 9 
+0.3 ± 5.0$t 
56 ± 10 
58 ± 10 
+ 1.9±5.8t 
Soy concentrate group 
(n = 20) 
mg/dl 
15 ± 9 
16 ± 9 
+0.3 ± 3.9 
119 ± 29 
126 ±31 
+7.6 ± 11.5 
58 ± 15 
56 ± 14 
-1.7 ±5.5 
31 ± 12 
29 ± 12 
-2.8 ± 4.3 
57 ± 13 
55 ± 13 
-1.9 ±3.1 
• 100 mg/dl = 2.59 mmol/1. 
t Significantly different from concentrate group (p < 0.05). 
t Significantly different from casein group (p < 0.05). 
§ For those subjects who lost less than 3 kg of wt for the whole experiment average changes over the test period 
amounted to -1.2 mg/dl (n = 10) in the casein group, +2.0 mg/dl (n = 15) in the isolate group, and -1.8 mg/dl (n 
= 16) in the concentrate group. 
most serious in subjects in the casein group, (p < 0.05) relative to the soy concentrate 
Therefore, it is possible that the effects of soy group, and of 6.5 mg/dl (NS) relative to the 
protein on serum total cholesterol and HDL- casein group. HDL-cholesterol results after 
cholesterol would have been somewhat larger ultracentrifugation revealed that the average 
if there had been no differences between HDL-cholesterol concentration had in-
groups in weight loss. creased by 5.8 mg/dl relative to the casein 
group (p < 0.5) and had not changed signifi-
Distribution of cholesterol between the c a n t l v relative to the concentrate group. 
lipoprotein fractions Changes in HDL-cholesterol occurred mainly 
in the HDL-2 fraction. The HDL-cholesterol 
The mean cholesterol concentrations in the results after Mn-heparin-precipitation were 
lipoprotein fractions are given in Table 5. In similar to those found after ultracentrifuga-
the casein group and soy isolate group there tion. With the precipitation method there was 
were no appreciable changes in concentra- no noticeable difference in response between 
tions in any of the fractions. In the soy con- the isolate and the casein group, but the 
centrate group, however, there was an in- difference between the isolate and the con-
crease in LDL-cholesterol (+7.6 mg/dl or centrate group now reached statistical signif-
+0.20 mmol/1). Comparison of the changes icance (+3.8 mg/dl or +0.10 mmol/1). No 
in LDL-cholesterol concentration on the var- differences in distribution of cholesterol over 
ious diets showed that there had been a de- the serum lipoprotein classes were found De-
cline in the soy isolate group of 11.3 mg/dl tween the casein and concentrate group. 
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TABLE 6 
Effects of casein and soy protein diets on serum HDL-cholesterol/total cholesterol ratio (mean ± SD)* 
Casein group (n = 17) Isolate group (n = 20) Concentrate group (n = 20) 
Start of control period 
End of control period 
End of test period 
Change over 
Control period 
Test period 
0.27 ± 0.08 
0.29 ± 0.08 
0.29 ± 0.07 
+0.02 ± 0.02 
-0.00 ± 0.02 
0.26 ± 0.08 
0.28 ± 0.07 
0.30 ± 0.07 
+0.02 ± 0.03 
+0.02 ± 0.02f 
0.26 ± 0.06 
0.29 ± 0.07 
0.28 ± 0.06 
+0.03 ± 0.03 
-0.01 ± 0.02 
* HDL-cholesterol values obtained by the Mn-heparin precipitation method were used for this calculation. 
t Significantly different from casein and concentrate group (p < 0.01). 
Analysis of the individual responses failed to 
show a sex effect. 
The overall changes in the distribution of 
cholesterol over the lipoproteins can be sum-
marized by the HDL-cholesterol/total-cho-
lesterol ratio. The mean of the individual 
ratios at the start and at the end of the control 
period and at the end of the test period are 
presented for each group in Table 6. During 
the control period there was a significant 
increase in the ratio in all three groups, 
mainly because of a decrease in LDL-choles-
terol. During the test period the ratio re-
mained unchanged in most subjects from the 
soy groups and in nearly all subjects from the 
casein group. However, nine subjects from 
the isolate group showed an increase of the 
ratio by more than 10%, and six subjects from 
the concentrate group showed a similar de-
cline of the ratio. The mean response on the 
soy isolate diet was significantly different 
from the response on either the casein or the 
concentrate diet. No differences were found 
between the casein and concentrate group. 
Discussion 
In our present study with middle-aged vol-
unteers we failed to find a marked effect on 
serum total cholesterol of diets containing 
either soy isolate or soy concentrate when 
compared with a diet containing casein. 
These results confirm our previous study with 
younger volunteers (aged 18 to 28 yr) who 
had lower serum cholesterol concentrations 
(7). Our results are in marked contrast with 
those of Sirtori et al. (1, 2), who observed 
dramatic decreases in serum cholesterol levels 
in hypercholesterolemic patients on diets con-
taining soy protein. Other studies on hyper-
and normocholesterolemic subjects have re-
vealed smaller (22, 23), inconsistent (24), or 
no effects (25-27) when soy protein diets were 
fed in comparison with control diets contain-
ing animal protein. Consumption of plant 
proteins other than those from soybean has 
not been demonstrated to have a hypocholes-
terolemic effect in humans either (28-31). 
In our earlier work (7), we suggested that 
one explanation for the discrepancy between 
our results and those of the Italian workers 
might be that our subjects had comparatively 
low initial levels of serum cholesterol. How-
ever, our present study fails to confirm this 
explanation. Although clinical hypercholes-
terolemic subjects were not involved, the av-
erage initial cholesterol level was appreciably 
higher (55 mg/dl) than in our previous study 
and we still failed to observe dramatic 
changes in total serum cholesterol concentra-
tions. In fact, those subjects from the soy 
isolate group with the highest initial levels 
showed less of a decline than did the subjects 
with lower initial levels (Table 4). The pa-
tients studied by Sirtori et al. (1) had still 
higher values (mean 342 mg/dl), so we still 
cannot exclude a specific cholesterol-lowering 
effect of soy protein in overt type II hyper-
cholesterolemic patients. However, we prefer 
to think that other properties of the diets used 
by Sirtori et al. (1) apart from the nature of 
the protein were responsible for the remark-
able efficacy of these diets in combating hy-
percholesterolemia. A case in point might be 
the almost complete absence of cholesterol 
from these diets. 
Earlier we suggested a role for the nonpro-
tein components in soy products in lowering 
cholesterol levels (7). For this reason, our 
present experiment compared not only a rel-
atively pure soy protein product (soy isolate) 
with casein, but also a more crude product 
(soy concentrate) that still contained most of 
the dietary fiber of the soybean. However, 
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serum cholesterol levels on the concentrate 
diet were actually increased when compared 
with the isolate diet. A cholesterol-lowering 
action has been described for viscous fiber 
compounds such as pectin and guar gum but 
not for those consisting mostly of cellulose 
and hemicelluloses (32). Earlier work from 
our laboratory demonstrated that fiber from 
wheat bran raised cholesterol levels in hu-
mans (17). H should be noted that fiber in 
bran, like that in soy concentrate, consists 
mostly of hemicelluloses and contains little 
or no pectin; the main fiber types in soy are 
arabinogalactans (33, 34), while in bran they 
are arabinoxylans (32). Decreases of serum 
cholesterol concentrations after addition of 
legumes to the diet have been reported (32). 
However, dietary constituents such as 
amount and type of fat may also have 
changed in these experiments (32). Thus the 
lack of a specific cholesterol-lowering action 
of the dietary fiber in soy protein prepara-
tions is not in conflict with other experimental 
evidence in humans on this point. 
Although we did not find a marked change 
in total cholesterol concentrations, our data 
do show a small decline in LDL-cholesterol 
and a small increase in HDL-cholesterol on 
the soy isolate diet when compared with the 
casein control group, but there was no effect 
with the soy concentrate diet. These effects of 
the soy isolate diet are identical with our 
previous findings in young adults with low 
serum cholesterol levels (7). Changes in HDL 
were confined mainly to the HDL-2 subfrac-
tion. This agrees with the role of HDL-2 as 
the variable component of HDL (35, 36). 
Because an increase in the ratio of serum 
HDL to total cholesterol could be associated 
with a lower risk of coronary artery disease 
(37, 38) the significant increase in this ratio 
on the isolate diet suggests that soy protein 
could have a small beneficial effect even 
when the concentration of total cholesterol 
remains constant. Yet, it must be noted that 
in our studies these favorable effects were 
only observed with the rather pure soy pro-
tein isolate. 
In summary, we believe that there is as yet 
no evidence that a moderate replacement of 
animal by vegetable protein in diets of other-
wise normal composition will have an effect 
on the concentration of serum total choles-
terol comparable to that observed with 
changes in the fat composition of the diet. 
However, a small favorable effect on the 
distribution of cholesterol over the various 
lipoprotein classes cannot be excluded. More-
over, one would expect that in practical situ-
ations the replacement of animal protein by 
vegetable protein containing foodstuffs 
would lead to changes in the concentration of 
serum lipids because the main sources of 
animal protein are often also rich in saturated 
fat and cholesterol. E3 
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SUMMARY 
This paper reports the results of studies in which the effect of casein and 
soy protein on serum cholesterol and lipoprotein concentrations were compared in 
humans, rabbits and rats using human diets. In the human studies, no marked 
effect of diets containing either soy isolate or soy concentrate on serum total 
cholesterol was observed when compared with a diet containing casein. When 
rabbits and rats were fed the human diets, lower serum cholesterol levels were 
found on both the soy diets when compared with the casein diet. The differences 
being much more pronounced in rabbits than in rats. These results confirm 
differences in susceptibility between species, and that the normocholesterolemic 
human appears to be relative insensitive to changes in these dietary proteins. 
Although in humans no effects on serum total cholesterol level were observed, 
the soy isolate diet did cause a small decline in cholesterol concentration in 
the low-density lipoprotein fraction (LDL) and a small increase in cholesterol 
concentration in the high-density lipoprotein fraction (HDL) when compared with 
the casein diet. However, there was no effect with the soy concentrate diet. 
Analysis of apolipoprotein concentrations suggested that the changes in chole-
sterol concentrations in the lipoprotein fractions resulted mainly from changes 
in the number of lipoprotein particles, but minor effects on the composition of 
the LDL could not be excluded. The lack of a cholesterol-lowering effect of the 
less refined soy concentrate when compared with soy protein isolate in both the 
human and animal studies suggest that the non-protein part of the soy prepara-
tions probably does not have a specific cholesterol-lowering effect. Our studies 
stress the risk of extrapolating animal data concerning the effect of protein on 
cholesterol metabolism to man. 
_ 
Supported in part by grants from the Netherlands Institute for Dairy Research 
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INTRODUCTION 
In animal studies, dietary proteins derived from animal sources are 
generally found to be hypercholesterolemia when compared with proteins from 
plant sources (Carroll, 1978; Kritchevsky, 1979; Terpstra et al., 1982b). 
Epidemiological studies (Stamler, 1979) and nutritional studies in vegetarians 
(Hardinge and Stare, 1954; Sacks et ai., 1975; Burslem et al. 1978) have also 
suggested a relation between intake of animal protein and serum cholesterol. 
Such epidemiological observations, however, should be interpreted with caution 
as differences in other nutritional factors may be present. In humans, only a 
few controlled trials relating dietary protein to serum cholesterol have been 
carried out, and the results are conflicting (Anderson et ai. , 1971; Carroll 
et al., 1978; Sirtori et al., 1979; Shorey and Davis, 1979; Descovich et ai., 
1980; Vessby et ai., 1980; Holmes et ai., 1980; Bodwell et ai., 1980; Wolfe 
et ai., 1981). 
We have recently investigated, in strictly controlled dietary studies, the 
effects of diets containing casein and soy protein on the concentration of 
serum cholesterol and lipoproteins in large groups of young students and middle-
-aged subjects. During our studies with humans, duplicate portions of the test 
diets were collected and were later fed to rabbits and rats. In this paper the 
results of the human and animal studies are discussed. Some of the results have 
been published previously (Van Raaij et al., 1981, 1982). 
MATERIALS AND METHODS 
Human subjects, animals and diets 
In the experiments to be described, three principle sources of protein have 
been used: casein; soy protein isolate, which is the purest form of soy protein 
commercially available; and soy protein concentrate, which contains more dietary 
fiber (Table 1). Six studies have been carried out and they can be divided into 
two groups on the basis of the diets fed (Table 2 and Figure 1). 
The first group of studies (Van Raaij et al., 1981; referred to in this 
paper as group I) consisted of a study with humans (I-Human) and a study with 
rabbits (I-Rabbit). In I-Human, 69 young healthy students aged 18 to 28 years 
were fed for 38 days on diets containing 13% of energy as protein of which 65% 
was replaced by protein from casein, from soy protein isolate, or from a 2:1 
mixture of casein and soy protein isolate. After a control period of 10 days 
during which all the subjects received the casein-soy diet, 20 subjects 
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continued on this diet for a test period of 28 days, 25 subjects switched to 
the casein diet and the remaining 24 subjects switched to the soy diet. 
Throughout the experiment duplicate portions of the diets were collected, and 
these were later homogenized in order to carry out a study with rabbits 
(I-Rabbit). Twelve male New Zealand White rabbits were maintained on a 
commercial diet (Cunicon I, Trouw and Co., 3881 LP Putten) until 3 months of 
age (control period-1). Half were transferred to the homogenized casein diet 
and half were transferred to the soy isolate diet for a test period of 2J weeks 
before both groups were transferred back to the commercial diet for 2\ weeks 
(control period-2). The homogenate was supplied freeze-dried and pelleted 
during the first 12 days of the test period and as a wet mash during the 
remaining 6 days. 
Table 1 
COMPOSITION OF THE PROTEIN PREPARATIONS USED 
Caseinate Soy isolate 
UNISOL 
NH 70b 
PP500E, 
PP610C 
Soy concentrate 
Protein6 
Moisture 
Fat 
Ash 
Carbohydrates 
92.4 
3.0 
0.3 
4.2 
0.2f 
84.6 
3.1 
0.1 
3.5 
8.7g 
g/100g 
79.7 
5.5 
0.5 
4.0 
10.3s 
57.2 
5.9 
1.6 
6.4 
28.98 
a) Calcium and sodium caseinate (spray dried, bland), DMV Milk Industries, 
5460 BA Veghel. Data expressed as mean of the values for calcium and sodium 
caseinate. 
b) UNISOL NH 70, UNIMILLS BV, 3330 AA Zwijndrecht (used in I-Human and I-Rabbit). 
c) Soy protein isolate PP500E and PP610, Purina Protein Europe, B-1050 Brussels, 
Belgium (used in II-Human, II-Rabbit, II-Rat and II-Rabbit-SP). Data 
expressed as mean of the values for PP500E and PP610. 
d) Soy protein concentrates Unico (powder) and Dubit (textured, prepared from 
Unico), UNIMILLS BV. Data expressed as mean of the values for Unico and 
Dubit. 
e) Kjeldahl nitrogen-to-protein factors of 6.38 for casein and 5.70 for soy 
protein have been used. 
f) Lactose; data provided by manufacturer. 
g) By difference. 
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The second group of studies (group II) included a study with humans 
(II-Human), one study with rats (II-Rat) and two studies with rabbits 
(II-Rabbit and II-Rabbit-SP). In II-Human (Van Raaij et ai., 1982), 57 healthy 
subjects aged 29 to 60 years were fed for 45 days on diets containing 16% of 
energy as protein of which 60% was replaced by protein from casein, from soy 
protein isolate or from soy protein concentrate. After a control period of 17 
days during which all the subjects received the casein diet, 17 subjects 
continued on this diet for a test period of 28 days, 20 subjects switched to 
the soy isolate diet, and the remaining 20 subjects switched to the concentrate 
diet. As during the first study with humans, duplicate portions of the diets 
were collected, homogenized and freeze-dried in order to carry out a study with 
male New Zealand White rabbits (II-Rabbit) and also with female lean Zucker 
strain rats (II-Rat). The experimental design of these two studies was essen-
tially the same as II-Human. Before the control periods, the rats and rabbits 
were maintained on commercial rat and rabbit pellets respectively (Trouw and 
Co.). In addition a further experiment with rabbits (II-Rabbit-SP) was carried 
out according to a similar design, but this time we used semi purified diets in 
which 100% of the protein was supplied by the same preparations of casein, soy 
isolate and soy concentrate as used in II-Human, II-Rat and II-Rabbit. At the 
beginning of the control periods, the rabbits and rats in the second group of 
experiments were 10-13 and 4 weeks ot age, respectively. 
For the two human experiments, food records and chemical analysis of the 
diets indicated that within each study, there were essentially no differences 
between the experimental diets except for the type of protein and/or the amount 
of non-protein material derived from the protein preparations used. Apart from 
120 kcal per day in I-Human and 240 kcal per day in II-Human, all of the food 
eaten was daily supplied to the subjects in amounts appropriate to each 
individual's energy requirements. The composition of the diets is given in 
Table 2, but more details about the diets have been described previously (Van 
Raaij et ai., 1981, 1982). 
In the animal studies water was provided ad libitum. In I-Rabbit and II-Rat, 
the casein and soy diets were provided ad libitum, while in II-Rabbit and 
II-Rabbit-SP, the diets were fed on a restricted basis to supply the rabbits in 
each experiment with equal amounts of protein. 
The animals were maintained as described by Katan et al. (1982) except that the 
rats as well as the rabbits were housed individually. The individual body 
weights were recorded weekly. 
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Sampling of blood and liver and biochemical analysis 
Blood samples were collected throughout the experiments as shown in Figure 1. 
Blood was taken after an overnight fast as described earlier for humans (Van 
Raaij et ai., 1981), rabbits (Terpstra and Sanchez-Muniz, 1981) and rats 
(Terpstra et ai., 1982a). Serum was obtained by low speed centrifugation, and 
all the serum samples were assayed for total cholesterol. 
At the end of both periods, in both human studies and in II-Rat and 
II-Rabbit-SP, the lipoproteins of the serum were isolated by density gradient 
ultracentrifugation using a modification (Terpstra et al., 1981b) of the method 
described by Redgrave et al. (1976). An SW50 rotor (Beekman Inc., Palo Alto Ca. 
94304, USA) was used for the separation of lipoprotein classes from 1 ml serum 
samples, as in II-Rat, and an SW41 rotor was used for the separation from 2 ml 
samples, as in all other studies. The lipoproteins in the gradient were 
visualized by prestaining the serum with Sudan Black prior to ultracentrifuga-
tion. Lipoprotein fractions were removed either by tube-slicing (I-Human) or by 
aspiration (all other studies). 
In the human studies the following lipoprotein fractions were collected from 
individual sera; in I-Human: VLDL (d < 1.015 g/ml), LDL (1.015 < d < 1.060), 
and HDL (d > 1.060 g/ml), and in II-Human: VLDL (d < 1.006 g/ml, LDL + sinking 
pre-bèta lipoproteins (1.006 < d < 1.075) and HDL (d > 1.075). In I-Rat, the 
serum samples were pooled per group at the end of the control period and again 
at the end of the test period. Nine lipoprotein fractions were collected, eight 
of which floated above the following densities (d, g/ml) respectively, 1.016, 
1.032, 1.045, 1.060, 1.078, 1.102, 1.128 and 1.146, while the ninth fraction 
had a d > 1.146 g/ml. In II-Rabbit-SP analyses were carried out on pooled 
samples with similar cholesterol concentrations. At the end of the control 
period, 6 pools each of 6 sera were formed and at the end of the test period 
there were 4 pools within each group with each pool consisting of 3 sera. Three 
lipoprotein fractions were collected: VLDL (d < 1.006), LDL (1.006 < d < 1.063) 
and HDL (d > 1.063 g/ml). 
At the end of experiment II-Rabbit-SP, that is after 5 weeks on the test 
diets, the concentration of cholesterol and the proportion present as the 
ester was measured in the livers of the rabbits. The animals were first stunned 
by a blow to the head and then killed by severing the major blood vessels in 
the neck and draining the blood from the body. The livers were removed 
immediately, dried off and weighed. The liver was then homogenized with a 
Potter-Elvehjem homogenizer and lipids were extracted from a 10 g aliquot 
50 
(Folch et ai., 1957). We measured total cholesterol in one part of the extract 
with Liebermann-Burchard reagent (Huang et al., 1961) after alkaline hydrolysis. 
Another part of the extract was used for separating and quantitating free and 
esterified cholesterol by thin-layer chromatography (West and Rowbotham, 1967). 
In both human studies serum cholesterol was measured with the reagent of 
Huang et ai. (1961) with strict standardization (Katan et ai., 1982); animal 
sera and lipoprotein fractions were assayed for cholesterol by an enzymatic 
method (Röschlau et ai., 1974) using a kit (Catalase kit, no. 124087, 
Boehringer-flannheim GmbH, West Germany). Apolipoprotein-B (I-Human and II-Human) 
and apoprotein-A (II-Human) were measured in whole serum by rocket Immuno-
electrophoresis (Laurell, 1972) largely as described previously (Brussaard 
et al., 1980). Rabbit antibody against apolipoprotein A was kindly donated by 
Dr. P. Demacker. 
The response to the test diet was calculated per subject or animal as the 
change from the end of the control to the end of the test period. Differences 
in diet effects were examined by comparing the mean responses of the groups by 
unpaired two-tailed t-tests (Snedecor and Cochran, 1967). 
RESULTS 
Human experiments 
The concentrations throughout experiments I-Human and II-Human of cholesterol 
in whole serum, HDL and LDL and of apoproteins A (II-Human only) and B are given 
in Tables 3 and 4, and in Figure 2. In both studies, there was no clear 
difference in response with respect to serum total cholesterol between the 
casein and soy isolate groups. In both studies a decline in LDL cholesterol and 
an increase in HDL cholesterol was observed on the soy isolate diet when 
compared with the casein diet, but only in I-Human the difference with respect 
to LDL cholesterol reached statistical significance (Figure 2, and Van Raaij 
et al. , 1981, 1982). 
In I-Human an increase in apolipoprotein-B and a decline in the LDL chole-
sterol/apo-B ratio was observed on the isolate diet when compared with the 
casein diet, suggesting that the decline in LDL cholesterol on the isolate diet 
had not been caused by a decline in the number of LDL particles, but in the 
composition of the LDL. These findings are confirmed by the changes in the 
density of LDL (Van Raaij et al., 1981). 
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Table 3 
THE EFFECT OF CASEIN AND SOY PROTEIN DIETS ON SERUM CHOLESTEROL CONCENTRATIONS 
IN HUMANS, RABBITS AND RATS 
Experiment 
I- Human 
I- Rabbit 
II-Human 
II-Rat 
II-Rabbit 
II-Rabbit-SP 
Group 
Casein 
Isolate 
Cassoy 
Casein 
Isolate 
Casein 
Isolate 
Concentrate 
Casein 
Isolate 
Concentrate 
Commercial 
Casein 
Isolate 
Concentrate 
Commercial 
Casein 
Isolate 
Concentrate 
n 
25 
24 
20 
6 
6 
17 
20 
20 
11 
12 
12 
7 
8" 
7 
8_ 
6 
12 
12 
12 
Serum 
Ini1 
162 
159 
160 
211 
219 
215 
96 
95 
95 
95 
45 
45 
63 
54 
65 
:hol 
tial 
+ 
+ 
+ 
c 
c 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
32 
26 
27 
38 
42 
41 
7 
9 
10 
10 
12 
13 
26 
17 
38 
estero ( :oncentrati 
End Control 
Period 
152 
153 
153 
30 
32 
207 
205 
199 
62 
63 
63 
74 
160 
60 
121 
117 
120 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
27 
23 
24 
7 
12 
36 
40 
35 
7 
9 
7 
12h 
54 
17h 
44 
48 
51 
End 
Per 
149 
150 
150 
120 
55 
205 
197 
200 
53 
51 
50 
60 
62 
278 
92 
95 
on (mg/d 
Test 
od 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
24 
23 
25 
65 
18 
35 
43 
38 
5 
5 
6 
7h 
26 
±119 
+ 
+ 
41f 
37f 
Ct 
T< 
-
-
+ 
+ 
-
-
+ 
-
-
-
-
+ 
+ 
-
-
;mean±SD ) 
lange over 
?st Period 
3 
3 
3 
89 
24 
2 
8 
1 
9 
13 
13 
14 
2 
L57 
26 
26 
± 14 
± 10 
± 13 
± 74 
± 20e 
± 10 
± 12g 
± 10 
± 5 
± 6d 
± 5e 
± 9 
± 22 
±118 
± 46 f 
± 57 f 
a) Diets indicated under Group were given in the test period; for diets given 
in the control period, see Figure 1. 
b) 100 mg/dl =2.59 mmol/1. 
c) Not determined. 
Statistical comparison with the casein group by Student's t-test: 
d) P < 0.075; e) P < 0.05; f) P < 0.001; with the concentrate group: 
g) P < 0.05; and with all test groups: h) P < 0.05. 
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FIG. 2. The effect of casein and soy protein diets on the 
concentration of cholesterol in lipoproteins in humans 
(experiments I-Human and II-Human). The shaded areas 
right of the vertical line represent an increase over 
the test period, and those left of the vertical line 
a decrease; changes less than 1 mg/dl are not shown. 
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In II-Human a decline in apolipoprotein-B, an increase in apolipoprotein-A , 
and no clear differences in LDL cholesterol/apo-B and HDL cholesterol/apo-A 
ratios were observed on the soy isolate diet when compared with casein. These 
results suggest that the decline in LDL cholesterol and the increase in HDL 
cholesterol were caused by a decline in the number of LDL particles and an 
increase in the number of HDL particles, rather than by changes in the lipo-
protein composition. The correlation coefficients between LDL cholesterol and 
serum apo-B at the end of the control and test period were r = 0.86 (n=56) and 
r = 0.90 (n=56), respectively. The correlation coefficients between HDL chole-
sterol and serum apo-A were r = 0.60 (n=55) and r = 0.67 (n=55), respectively. 
Compared with soy protein concentrate, soy protein isolate produced a 
decrease in serum total cholesterol, LDL cholesterol, apolipoprotein-B, and LDL 
cholesterol/apo-B ratio, an increase in HDL cholesterol and apolipoprotein-A , 
but had no effect on the HDL cholesterol/apo-A ratio. These results suggest 
that the increase in HDL cholesterol has been caused by an increase in the 
number of HDL particles, and that the decline in LDL cholesterol has been 
caused by a decline in both the number of LDL particles and in their cholesterol 
content. No differences in lipoproteins were found between the casein and the 
soy protein concentrate group. 
The overall changes in lipoproteins can be summarized by the HDL cholesterol/ 
total cholesterol ratio and by the apo-A /apo-B ratio. In experiment II-Human, 
significant increases in both ratios were observed on the soy isolate diet when 
compared with the casein or concentrate diet (Table 4 and Van Raaij et al., 
1982). 
Feed consumption and growth of the experimental animals 
The feed consumption and growth of the rabbits and rats throughout the 
experiments are presented in Table 5. In all of the experiments, except in 
II-Rabbit, feed consumption and growth were satisfactory. In II-Rabbit, the 
animals consumed all their feed under the restricted feeding regime throughout 
the control period and for the first two weeks of the test period. However, 
after that, twelve rabbits failed to eat all the feed provided, their growth 
faltered and their health deteriorated. Four of the rabbits lost hair. It may 
well be that the human diets, either before or after freeze-drying, contained 
insufficient vitamins and minerals for the growth of rabbits. When the 
experiment was completed, the rabbits were transferred to the commercial rabbit 
diet, and the growth and health of the less severely affected animals improved 
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Table 5 
FEED INTAKE AND WEIGHT GAIN IN RABBITS AND RATS 
Experiment Groups 
I - Rabbit0 Test ( a l l ) 6 
I I -Rabb i t d Test ( a l l ) 6 
Commercial 
I I-Rabbit-SPd Test ( a l l ) 6 
Body weight 
(g) 
2322 
1481 
1503 
1834 
Feed intake Weight gain 
Control 
Period 
57 
85 
67 
Test 
Period 
Control 
Period 
75' 
57 
85 i 
67 j 
h , i 
18.2 
22.4 
Test 
Period 
(g/day) (g/day) (g/day) (g/day) 
12.5 
28.71 
25.8i 
17.1 
I I -Ra t ' Test ( a l l ) 
Commercial 
70 
68 
9.3 
11.8 
10.6 
14.0 
2.6 
2.1 
1.8 
1.7 
a) At start control period (II-Rabbit and II-Rat) or at start test period 
(I-Rabbit and II-Rabbit-SP). 
b) Dry matter contents of the diets were: 94.5% for the pelleted human diets 
(I-Rabbit and II-Rabbit); 99.5% for the unpelleted human diets (II-Rat); 
91.5% for the semipurified diets (II-Rabbit-SP); and 89.0% for the commercial' 
rabbit and rat diets. 
c) Diets were provided ad libitum. 
d) Diets were provided restricted. 
e) Mean data of the test groups are given except for the food intake during the 
test period in which data for the casein group are given; there were no 
differences between group means for body weight and weight gain. 
f) Not measured 
g) Food intake was 83 g per day for the isolate group. 
h) Food intake was 58 and 61 g per day for the isolate and concentrate group. 
i) During first two weeks of test period. 
j) Food intake was 67.5 and 69.5 g per day for the isolate and concentrate 
group. 
k) Food intake was 11.0 and 11.3 g per day for the isolate and concentrate 
group. 
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markedly. Because of the problems encountered, data obtaining during the test 
period of experiment II-Rabbit were deleted in the subsequent analysis of the 
results. In all other studies, the experimental diets were well accepted, and 
the feed offered was consumed. 
Serum cholesterol and lipoproteins and liver cholesterol in the experimental 
animals 
The concentrations of total cholesterol in serum in the experiments with 
rabbits and rats are shown in Table 3. When rabbits were fed semipurified 
diets (experiment II-Rabbit-SP), the diet containing casein produced a marked 
increase in serum cholesterol concentration; most of the increased cholesterol 
being found in the LDL fraction (Table 6). The declines in concentration of 
cholesterol after the casein control period seen on the two diets containing 
soy isolate and soy concentrate, respectively, were identical; these declines 
were observed in the LDL fraction. The higher concentration of cholesterol in 
the serum on the casein diet compared with the two soy diets, is reflected in 
the concentration of cholesterol in the liver (4.5 ± 1.3 mg cholesterol/g liver, 
mean ± SD) although the difference was only significant (p < 0.05) when 
compared with the soy concentrate group (3.3 ± 1.0 mg/g) and not with the soy 
isolate group (3.6 ± 1.6 mg/g). Most of the additional cholesterol which is 
found in the liver at increasing serum cholesterol concentrations is in the 
form of cholesteryl ester. This is seen from the relationships between serum 
cholesterol concentration and liver cholesteryl ester concentration (Figure 3) 
and between liver cholesterol concentration and the proportion of cholesterol 
in the liver that is esterified (Figure 4). 
In the first experiment with rabbits using the human diets (experiment 
I-Rabbit), the rabbits were transferred straight from the commercial diet to 
the test diets containing either casein or soy protein isolate. After 2\ weeks 
of test period, the casein diet produced significantly higher increases in 
cholesterol than did the soy isolate diet (Table 3). When the rabbits were 
subsequently returned to the commercial diet, the concentration of cholesterol 
in the serum of both groups of rabbits fell to a mean value of about 30 mg/dl 
(Van Raaij et ai., 1981). Thus the human diet containing casein has a pronounced 
hypercholesterolemic effect in rabbits when compared with the soy protein diet. 
In the second experiment with rabbits using the human diets (experiment II-
Rabbit), the rabbits were transferred from the commercial diet to the human 
diets for a control period of Z\ weeks before being transferred to the test 
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Table 6 
THE EFFECT OF CASEIN AND SOY PROTEIN DIETS ON THE CONCENTRATION OF CHOLESTEROL 
IN LIPOPROTEINS IN RABBITS ON SEHIPURIFIED DIETS (EXPERIMENT II-RABBIT-SP) 
Lipoprotein 
fraction 
VLDL 
LDL 
HDL 
Whole serumc 
Control 
Casein d 
n=36 
17 
74 
25 
119 
Period 
iet Casein diet 
n=12 
mg/100 
33 
223 
41 
278 
Test Period 
Soy isolate 
dietb 
n=12 
ml 
17 
48 
31 
92 
Soy concentrate 
dietb 
n=12 
18 
55 
31 
95 
a) Mean values of six pools, each of serum from 6 animals. 
b) Mean values of four pools, each of serum from 3 animals. 
c) Mean values from serum of individual animals. 
diets for a subsequent 4 weeks. On the casein control diet, the concentrations 
of cholesterol in serum increased steeply and significantly when compared with 
the cholesterol levels of the rabbits that continued on the commercial diet. 
After 4-5 weeks on the human diets, the rabbits began to show signs of ill-
-health such as reduced appetite, reduced growth and hair loss. As discussed 
earlier, this may have been due to a mineral or vitamin deficiency, which did 
not become manifest within the 2\ week period that the rabbits in experiment 
I-Rabbit were on the human diets. 
In the experiment with rats using the human diets (II-Rat), the rats were 
transferred from the commercial diet to the human casein diet for a control 
period of 2| weeks before being transferred to the human test diets. Concentra-
tion of cholesterol in serum was declining in the rats used, as shown by the 
rats that continued on the commercial diet for the whole experiment. On the 
casein control diets significant lower concentrations of cholesterol in serum 
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were observed than on the commercial diet. During the test period the declines 
in serum cholesterol on the human test diets were similar to those on the 
commercial diet; however, the declines on both soy protein diets were more 
pronounced than that on the casein diet (Table 3). The larger declines on the 
soy protein diets occurred mainly in the lipoprotein fractions with densities 
between 1.060 and 1.128 g/ml (Table 7). 
DISCUSSION 
In our studies with young and middle-aged adults we failed to find a marked 
effect on serum total cholesterol of diets containing either soy isolate or soy 
concentrate when compared with a diet containing casein. When the soy prepara-
tions were incorporated into semi purified diets and fed to rabbits, we obtained 
results similar to those reported previously (for a review, see Terpstra et ai., 
1932b): casein was found to be strongly hypercholesterolemic when compared 
with the soy preparations. Similar results were observed when rabbits were fed 
the human diets: a human diet containing soy isolate resulted in significantly 
lower cholesterol concentrations than the human diet containing casein 
(experiment I-Rabbit). In experiment II-Rabbit, the rabbits also showed a 
marked increase in serum cholesterol concentration after they had been trans-
ferred from the commercial diet to the casein-containing human diet (Table 3). 
As discussed before, it is unfortunate that in experiment II-Rabbit no 
comparisons could be made between the casein and the soy protein diets. In rats, 
the differences between the human diets containing either casein or soy nrotein 
were small, but marginally significant. 
How can one explain these different results between humans and animals? 
Species effects 
Animal species differ greatly in their resistance to diet-induced hyper-
cholesterolemia. For example, rabbits are highly susceptible to hyperchole-
sterolemia by dietary means; the replacement of protein in semipurified diets 
by casein and the addition of small amounts of cholesterol have both been shown 
to be very effective. Although most studies with rabbits have been carried out 
with semipurified diets, our studies clearly indicate that human diets give 
similar results. In our studies the effects with the human diets were less 
pronounced than with the semipurified diets, but this can be explained, at 
least partly, by the fact that in the human diets only 65% of the protein 
60 
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consisted of test protein compared with 100% in the semi purified diets, while 
the total proportion of protein in the two types of diets was about the same. 
The hypercholesterolemic effect of casein increases when the amount of casein 
in the diet is increased (Terpstra et ai., 1981a). The amount of linoleic acid 
in the diet may also be a contributing factor as the casein-induced hyper-
cholesterolemia in rabbits disappears when increased amounts of linoleic acid 
are included in the diets (Lambert et ai., 1958; Wigand, 1959; Carroll and 
Hamilton, 1976; Beynen and West, 1981). In our human diets, the proportion of 
polyunsaturated fat in the diet was about 4% by weight, while in the semi-
purified diets the proportion was less than \%. The differences in results 
between the human and semi purified diets can probably not be explained by 
difference in duration, because after 2| weeks on the semipurified diets the 
difference in effects between the casein and soy protein diets was already 
greater than on the human diets (data not shown). 
In rats fed semipurified diets the effects of dietary proteins are only 
observed when considerable amounts of cholesterol (approximately 1%) are added 
to the diets (Terpstra et ai., 1982a). In our experiments only 0.07% of 
cholesterol was present, and this explains why the observed effects in rats 
were so small. Our studies with humans suggest that normocholesterolemic adults 
are also relatively insensitive to changes in dietary protein, and one might 
speculate that in humans, diets have to contain considerable amounts of 
cholesterol before the differential effect of casein and soy protein on the 
level of serum cholesterol is expressed. It should be noted, however, that in 
the experiments of Sirtori et al. (1979) the cholesterol-lowering effect of the 
soy diet in hypercholesterolemic patients was most pronounced against a high-
-linoleic acid low-cholesterol background, i.e. the opposite of the conditions 
under which the effects of dietary proteins are seen most clearly in animals. 
Age of the animals 
Animal studies in general and our studies in particular, have been carried 
out with young growing animals, while in most human studies, including those 
reported here, adults were used. It has been reported that dietary casein-
-induced hypercholesterolemia in male rabbits occur only in young growing 
animals (West et ai., 1982), and similar results have been observed in rats 
(McGregor et al., 1971). Such animals spend a considerable proportion of their 
lives on the experimental diets. Therefore, our results on humans do not rule 
out the possibility that a long-term intake of animal protein starting at an 
early age, will cause similar cholesterol-raising effects in normocholesterol-
emic humans. 
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Differences in lipoprotein metabolism 
A point to keep in mind in extrapolating animal data to man concerns the 
differences in the distribution of cholesterol over the various lipoprotein 
fractions. In healthy humans, most of the serum cholesterol is transported in 
the LDL fraction, whereas in normocholesterolemic rabbits and rats the HDL 
fraction is the main carrier of cholesterol (Terpstra et al., 1982c). 
Furthermore, hypercholesterolemic diets in animals often cause the appearance 
of an unusual lipoprotein with the density of VLDL but with a much higher 
cholesterol content and with a higher proportion of apolipoprotein E (Ross and 
Zilversmit, 1977; Mahley et al., 1980; Terpstra et al., 1982a; Scholz et al., 
1982). In human such a particle is seen only in type III hypercholesterolemia, 
a fairly rare disease. In healthy humans we did not find any marked abnormal-
ities of the lipoprotein spectrum after 6 weeks on the casein diet. 
In comparison, however, the subjects who had received the soy isolate diet 
showed slightly lower LDL and higher HDL cholesterol levels. Apart from slight 
changes in the composition of LDL in I-Human, our apoprotein measurements did 
not point to marked effects of dietary proteins on lipoprotein composition in 
man. Thus at the level of the separate lipoproteins, casein-fed rabbits and 
rats appear to be different from humans. 
Possible mechanisms 
The mechanisms underlying the cholesterolemic properties of dietary protein 
are not clearly understood. Probably several mechanisms are involved. The amino 
acid composition of the proteins plays a role (Carroll, 1978; Kritchevsky, 1979; 
Hermus, 1975; Terpstra et ai., 1982c), but how amino acids might influence 
cholesterol metabolism remains to be established. Differences in amino acid 
composition between casein and soy protein, however, cannot fully explain the 
different results (Carroll, 1978; Terpstra et al., 1982c). It has been 
suggested that some substances in the non-protein part of the soy Dreparations 
such as fiber or saponins might be partly responsible for the observed effects 
(Potter et al., 1980; Topping et ai., 1980), but our human and animal studies 
clearly indicate that the non-protein part of soy concentrate did not influence 
serum cholesterol when compared with soy isolate. Similar results were found by 
Hamilton and Carroll (1976) in rabbits. As discussed previously (Van Raaij et al. 
1982) the type of dietary fiber present in soy concentrate is not likely to 
exert a marked hypocholesterolemic effect. As casein increases the concentration 
of cholesterol in both the liver and in serum (experiment II-Rabbit-SP), a 
redistribution of cholesterol between the serum and liver would not appear to bè 
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involved as is the case with the difference between rabbits which are hypo- or 
hyperresponsive to cholesterol (West and Roberts, 1974). Perhaps the differential 
effect of casein and soy protein on serum cholesterol levels in rabbits may be 
attributible to differences in the digestibility of the two proteins. As has been 
postulated elsewhere (Terpstra et al., 1982c) soy protein may be less digestible 
than casein in rabbits and the undigested protein could bind bile acids, thus 
facilitating their excretion and preventing their reabsorption. It may well be 
that in humans, soy protein is not significantly less digestible than casein or 
that the binding of soy protein to bile acids does not have a significant effect 
on the excretion of bile acids either because of the presence of other materials 
in the gut or because of the nature of the bile acids involved. 
Although we did not find a marked change in serum total cholesterol 
concentrations in humans on the casein and soy diets, our data do show a small 
decline in LDL cholesterol and a small increase in HDL cholesterol on the soy 
isolate diet when compared with the casein diet, but there was no effect with 
the soy concentrate diet. Apart from small changes in the composition of LDL in 
I-Human, the apoprotein results suggest that the changes in cholesterol 
concentrations in the lipoprotein fractions resulted from changes in the number 
of lipoprotein particles. 
An increase in the ratio of HDL cholesterol/total cholesterol has been 
associated with a lower risk of coronary heart disease (Blackburn et ai., 
1977; Miller and Miller, 1975), so it may well be that the increase in this 
ratio on the soy isolate diet could have a beneficial effect even when the 
concentration of total cholesterol remains constant. Yet it must be noted 
that in our studies these favorable effects were only observed with the rather 
pure soy protein isolate and not with the soy concentrate. Thus the dramatic 
effects observed by Sirtori et al. (1979) with textured soy protein not only 
on HDL cholesterol/total cholesterol ratio but also on the concentration of 
total cholesterol eluded us when we used the soy concentrate diet. 
An expectation has developed that the replacement of animal proteins by 
vegetable proteins in human diets might aid in lowering serum total cholesterol 
levels, thereby providing a very useful tool in the prevention of coronary 
heart disease (Lewis, 1980). This expectation is based on the many studies with 
animals, particularly the rabbit, and a limited number of studies with humans, 
particularly hypercholesterolemic patients (Sirtori et al., 1979; Descovich et 
ai., 1980; Wolfe et al., 1981) in which diets containing animal proteins, 
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particularly casein, have been compared with diets containing vegetable 
proteins, particularly soy protein. However, the results of most studies with 
normocholesterolemic humans, including our two studies, do not provide support 
for this expectation: the normocholesterolemic human appears to be relatively 
insensitive to changes in the type of protein in the diet. However, a small 
favorable effect on the distribution of cholesterol over the various lipo-
protein classes cannot be excluded. 
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5. INFLUENCE OF DIETS CONTAINING CASEIN, SOY 
ISOLATE AND SOY CONCENTRATE ON THE 
LEVEL OF URATE IN THE SERUM OF HEALTHY 
HUMANS 
J.M.A. VAN RAAIJ and M. VLASSAK 
Department of Human Nutrition, Agricultural University, De Drei jen 12, 
6703 BC Wageningen, The Netherlands 
SUMMARY 
Hyperuricemia as a prerequisite for the development of gout is well 
established, and as a result, prudent advice for hyperuricemia individuals is 
the avoidance of dietary conditions which elevate serum urate concentration, 
such as high intakes of purines. Two strictly controlled nutritional studies 
with large groups of young students and middle-aged subjects have been carried 
out. The test diets differed only in respect of the type of protein preparation 
used, that is caseinate, soy protein isolate, or soy protein concentrate. Both 
studies revealed a significant increase in level of serum urate, between 0.60 
and 0.74 mg/dl, in those on the soy protein diets compared to those on the 
casein diets. The purine content of the soy preparations possibly explains only 
part of the observed effects. An effect of the difference in amino acid 
composition between casein and soy protein cannot be excluded. It can be 
concluded that soy protein preparations may cause a substantial increase in 
level of serum urate when compared with dairy foods. No substantial difference 
in level of serum urate may be expected when soy protein preparations are 
compared with other protein sources such as meat. 
INTRODUCTION 
Recently the results were published of two human experiments in which the 
effects of diets containing either casein or soy protein were compared on serum 
cholesterol and lipoproteins (1,2). In order to control the diets, the 
participants were provided with almost complete daily diets. Hot meals were 
served on weekdays in the Department of Human Nutrition and all other food, 
including food for the weekend, was provided as package issues. In such studies 
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it is difficult to ascertain whether or not subjects confine themselves strictly 
to the diet given or whether they eat other items. It appears however, that 
individuals who agree to take part in studies of this nature do so with the best 
intentions. With proper encouragement, the incidence of cheating appears to be 
rare. Nevertheless, it is always desirable that some type of objective check be 
made that the participants actually eat all of the diet provided. The experimental 
diets used differed only in the type of protein preparation: caseinate, or 
soy protein isolate, or soy protein concentrate (1,2). Caseinates are 
practically free of purines, but both soy preparations contain considerable 
amounts of nucleic acids, and also purines. Uric acid is the end product of 
human purine metabolism (3), and it is well established that dietary purines 
increase the level of urate in serum (4-8). Thus the level of serum urate may 
provide a rough check on the adherence of the subjects to the diets. 
The medical importance of urate is derived from its low solubility at the 
pH of body fluids, and its relatively poor excretion by the kidney. If the level 
of serum urate is elevated, crystals may form in the joints, as occurs in gout, 
and with excessive renal clearance loads, stones may be deposited in the urinary 
tract (3). The prevalence of gout is directly related to serum urate 
concentrations, and most cases occur in association with concentrations over 
7.0 mg/dl in men and 6.0 mg/dl in women (9). These borderlines are often used 
to define hyperuricemia. Hyperuricemia was observed in 14% of white men and 
women in the Evans County Study (10); a lower percentage, 6%, was reported in 
the Tecumseh Study (11); but Persky et ai. (12) in Chicago observed levels of 
serum urate greater than 7.0 mg/dl in more than 23% of the white men aged 18-64 
years. The second reason for studying the level of serum urate is to quantify 
the hyperuricemic effects of soy protein preparations. It has been recommended 
that animal protein be replaced by vegetable protein, e.g. soy protein,because 
of the supposed benefical effects on serum cholesterol (13). However, in 
Western countries levels of serum urate are relatively high, and the effects on 
levels of serum urate by replacing animal protein with vegetable protein should 
also be considered. 
SUBJECTS AND METHODS 
In the two studies carried out, three principle sources of protein were 
used: caseinate; soy protein isolate, the purest soy protein preparation 
available commercially; and soy protein concentrate, a less refined soy protein 
preparation (1,2). In the first study, 69 healthy students (18-28 yr of age) 
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were given for 38 days diets containing 13% of energy as protein of which 65% 
consisted of protein from casein, from soy isolate, or from a 2:1 mixture of 
casein and soy isolate. After a control period of 10 days during which all the 
subjects received the casein-soy (cassoy) diet, 20 subjects continued on this 
diet for a test period of 28 days, 25 subjects changed to the casein diet, and 
the remaining 24 subjects changed to the soy isolate diet (Figure 1; Ref. 1). 
In the second study, 57 healthy middle-aged subjects (29-60 yr of age) were fed 
for 45 days a diet containing 16% of energy as protein of which 60% consisted 
of protein from casein, from soy protein isolate or from soy protein concentrate. 
After a control period of 17 days during which all the subjects received the 
casein diet, 17 subjects continued on this diet for a test period of 28 days, 
20 subjects changed to the soy isolate diet, and the remaining 20 subjects 
changed to the soy concentrate diet (Figure 1; Ref. 2). 
TIME (weeks) 
STUDY 1 
Casein 
Isolate 
Cassoy 
STUDY 2 
Casein 
Isolate 
Concentrate 
(n) 
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24 YMMMV///////////////A 
tt tt 
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FIG. 1. Experimental designs. Blood sampling for serum urate 
analysis is indicated by arrows. 
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Food records and chemical analysis of the diets indicated that within each 
study there were essentially no differences between the experimental diets 
except for the type of protein preparation used. Details of the composition of 
the diet, daily regimen and food supply have been described previously (1,2). 
Levels of serum urate were determined at the end of the control and the 
test period, as indicated in Figure 1. Steady-state levels of serum urate after 
dietary modifications are usually obtained within 7 to 10 days (8). Specimens 
of blood were obtained from a vein in the arm after an overnight fast, and serum 
was obtained by low-speed centrifugation. Serum samples were stored for no 
longer than two months at -80°C, before assaying for serum urate in duplicate by 
an enzymatic method (14) using a kit (No 124.761, Boehringer Mannheim GmbH, 
West Germany). Samples obtained for each person at the end of both the control 
and test period were analysed within the same run. Equal numbers of sera from 
subjects from the three diet groups were assayed in each run. Within-run 
reproducibility for control sera was ±2.6% (C.V.). The response to the test diet 
was calculated for each subject from the values of the end of the control and 
the end of the test period. The effect of diet was examined by testing the 
difference between the mean responses of the groups by unpaired two-tailed 
t tests (15). In the second study, the data on one of the subjects were 
eliminated from the analysis because he had been using a hypouricenn'c drug. The 
results of another subject were lost. Thus data on only 55 subjects were 
analysed. 
RESULTS 
All levels of serum urate measured were below the hyperuricemia border-
lines of 7.0 mg/dl for men and of 6.0 mg/dl for women. The values of the mean 
urate concentrations in serum at the end of the control and test periods are 
given in Table 1. 
The group means at the end of the control periods were not completely 
comparable because the groups were not matched for level of serum urate. 
As expected, women had lower levels of urate in serum than men (10,11,16,17). 
Values at the end of the control periods were 4.26 ± 0.63 mg/dl and 3.70 - 0.82 
mg/dl (mean ± SD) for women, and 5.26 ± 0.72 mg/dl and 4.54 ± 0.81 mg/dl for 
men in both studies respectively. Both men and women had higher values in the 
first study. This was probably because control diets were different in the two 
studies; the cassoy control diet in which soy protein isolate was incorporated 
contained more purines than the casein control diet. Serum urate appears not 
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Table 1 
THE EFFECT OF CASEIN AND SOY PROTEIN DIETS ON SERUM URATE CONCENTRATIONS IN 
HUMANS (MEAN - SD; mg/dl; 
STUDY 1 
(young adults) 
Cassoy control period 
Test period 
Casein diet 
4.57 ± 0.66 
4.37 t 0.91 
Cassoy diet 
4.94 ± 1.06 
4.97 ± 1.33 
Soy isolate 
diet 
5.12 ± 0.82 
5.56 ± 0.99 
Change over test period 
All subjects15 
Women 
Men 
-0.19 i 0.69 
-0.30 t 0.42 
-0.12 Î 0.83 
+0.03 t 0.69 
-0.28 Î 0.65 
+0.23 t 0.67 
+0.45 i 0 .71 d 
+0.07 Î 0.55 
+0.68 t 0.70d 
STUDY 2 
(middle-aged adults) 
Casein control period 
Test period 
Casein d ie t 
4.20 t 0.84 
4.37 ± 0.69 
Soy iso late 
d iet 
3.68 Î 0.82 
4.59 ± 0.81 
Soy concentrate 
d ie t 
4.42 t 0.99 
5.19 ± 0.97 
Change over test period 
All subjects0 
Women 
Men 
+0.17 i 0.30 
+0.18 ± 0.34 
+0.15 t 0.29 
+0.91 t 0.40d 
+0.91 i 0.44d 
+0.89 Î 0.40d 
+0.77 i 0.52d 
+0.54 i 0.45 
+0.96 Î 0.50d 
a) 5 mg/dl = 297 umol/1 
b) After deleting the results of the 10 subjects who lost more than 3 kg body 
weight during the whole experimental period, values were -0.21, +0.03, and 
+0.29 mg/dl, respectively. 
c) After deleting the results of 16 subjects who lost more than 3 kg body 
weight during the whole experimental period, values were +0.24, +0.99, and 
+0.72 mg/dl, respectively. 
d) Significantly different from casein group (two-tailed t test; p < 0.01). 
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to be age-related in adult men and women, although it may increase in women at 
the menopause (10,12,16,17). Because the subjects in both studies were adults, 
it is most unlikely that the difference in age of the subjects in the two 
studies would explain the observed differences in levels of serum urate. 
In both studies the increase in level of serum urate during the test period 
for those on the soy protein isolate diets was significantly different to the 
changes observed in those on the casein diets ( +0.64 mg/dl ; p < 0.05, and 
+0.74 mg/dl; p < 0.05, respectively). The increase in level of serum urate in 
those on the soy protein concentrate diet in the second study was also 
statistically significant when compared with the changes on the casein diet 
(+0.60 mg/dl; p < 0.05). As shown in Table 1, these effects were observed both 
in men and women, although the effects are more pronounced in men. Perhaps, the 
men were more responsive to the various protein preparations. Another 
explanation may well be the difference between men and women in absolute intake 
of protein preparation. Although the composition of the diet expressed in 
percentages of energy was identical for each subject, the absolute energy intake 
of men was higher. 
Weight loss has been associated with a decline in the level of serum urate 
(18). In the first study mean weight losses over the test period were 1.3, 1.0 
and 1.6 kg for those on the casein, cassoy and soy isolate diets, respectively. 
In the second study, the weight losses were 1.9, 1.4 and 1.2 kg for those on 
the casein, soy isolate, and soy concentrate diet, respectively. It is unlikely 
that these differences in weight loss confound the results on the level of 
serum urate, and, as shown in Table 1, deleting the results of the subjects who 
lost more than 3 kg body weight over the whole experimental period does not 
substantially change the overall results. 
DISCUSSION 
In the experiments described, the only difference between the test diets 
was the protein preparation used. Caseinates are practically free of purines. 
The soy concentrates used contained about 8.5 mg RNA and about 0.5 mg DNA per 
gram protein, and thus about 2 mg purines per gram protein (data provided by 
Dr. A.M. Ledeboer and Drs. P. van Stratum, Unilever Research Laboratory, 
VIaardingen). No data are available on the purine content of the soy isolates 
used. As the subjects in both studies consumed on average about 55 g protein 
from the protein preparations per day, the difference in nucleic acid intake 
between the soy and casein fed subjects is estimated to be about 0.5 g per day. 
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It has been reported that for normal healthy adults, levels of serum 
urate are increased by 0.6 to 0.9 mg/dl for each gram of dietary RNA (5,7,8). 
However, extrapolation to the present studies should be done with great 
caution as yeast RNA was used in those experiments. A difference in nucleic 
acid intake of about 0.5 g per day may result in a difference in level of 
serum urate of about 0.3 to 0.45 mg/dl. In both of the present studies with 
normouricemic adults, an increase in level of serum urate of 0.60 to 0.74 mg/dl 
was observed in those on the soy protein diets when compared with those on the 
casein diets. Similar results have also been reported by Rauch-Janssen et ai. 
(19). They compared the effects of a soy protein diet (diet contained about 
44 mg purines per 1000 kcal) with a formula diet virtually free of purines on 
level of serum urate in 10 healthy subjects, and observed that levels were 
about 0.8 mg/dl higher in those on the soy protein diet. These results and 
those of the present studies suggest that the observed effects with the soy 
protein preparations may not be fully explained by the nucleic acid content 
of these preparations. 
Increasing dietary protein intake has been reported to increase urate 
excretion (4,5) and to decrease serum levels (4), but serum levels are not 
always reported to decline (20). The increased excretion may well reflect a 
simultaneous increase in urate production and in renal excretion (20). An 
increased purine synthesis may be caused by the increase in supply of amino 
acids involved in purine synthesis, e.g. glycine and aspartic acid (20,21). 
The increase in amino acid degradation on increasing protein intake will 
result in increased urea and keto acids in serum, and these substances may 
increase renal excretion of uric acids (6). It should be noted that soy protein 
contains more glycine and aspartic acid than casein, and both of these amino 
acids are involved in purine synthesis. In addition, in the present studies 
those on soy protein diets had increased levels of serum urea when compared 
with those on the casein diets (Van Raaij and De Vries, unpublished results). 
Therefore, for theoretical reasons, it cannot be excluded that part of the 
observed effects are caused by differences in amino acid composition of the 
diets. 
Extrapolation of the results of these studies to other dietary conditions 
should be done with extreme caution. For example, 60-65% of the total protein 
in the test diets consisted of soy protein, which is not a common situation. 
In addition, soy protein was compared with casein, which is almost free of 
purines. It should be noted that the purine content per g protein of soy 
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concentrate is less than half of that of meat and poultry (8). Therefore, when 
soy concentrate is compared with meat or poultry, the effect of increasing serum 
urate may disappear, or the reverse may occur. Van Stratum (22) described an 
experiment with 82 subjects in which the effects on levels of serum urate by 
replacing 25% of the animal protein in the diet with soy protein mainly from 
soy concentrates, were compared. No differences were observed. 
In conclusion, soy protein preparations in the diet may cause a substantial 
increase in level of serum urate compared to dairy foods. This increase is 
probably no different from the expected increase in level of serum urate with 
conventional protein sources such as meat. The effect of amino acid composition 
of proteins on the level of serum urate should be further investigated. 
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6. GENERAL DISCUSSION 
In the strictly controlled trials carried out with normocholesterolemic 
subjects (Chapters 2 and 3) marked effects on levels of serum cholesterol 
of diets containing either soy isolate or soy concentrate were not observed 
when compared with diets containing casein. A small decrease in LDL-choles-
terol and a small increase in HDL-cholesterol were observed in those on the 
soy isolate diet when compared with those on the casein diet. No such 
beneficial effects were observed in those on the soy concentrate diet. 
However, these effects are small when compared with the effects that can 
be achieved by changing the fat composition of the diet or the amount of 
dietary cholesterol. The studies on the animals fed the human diets 
(Chapter 4) confirm the results reported for semipurified diets. Rabbits 
appear to be highly susceptible to hypercholesterolemia as a result of 
dietary protein, whereas rats are much less sensitive. It is clear that 
extrapolation of the results of animal experiments on the effect of protein 
on serum cholesterol directly to man should be done with extreme caution. 
The results of the studies with humans were in line with other recent 
studies on normocholesterolemic subjects which revealed small (1) or no 
effects (2, 3) when soy protein diets when compared with control diets 
containing animal protein. However, these results are in marked contrast 
with those reported by Italian and Swiss workers (4, 5), who observed 
dramatic decreases in serum cholesterol levels in hypercholesterolemia 
patients on diets containing soy protein. Other studies on hypercholeste-
rolemia subjects have revealed smaller (6, 7), inconsistent (8), or no 
effects (9). 
The results of the various studies are difficult to compare because in 
each study: different soy protein products have been used; soy protein was 
compared with other animal proteins; the overall composition of the diets 
were different; and the studies differed in degree of protein 
replacement. In addition, the results of some studies are difficult to 
interpret since the diets compared did not only differ as to the type of 
protein they contained, but also as to other dietary factors. Furthermore, 
the experimental design and the number of subjects used did not always 
allow for an accurate and precise estimation of the diet differences (for 
a more detailed discussion, see Appendices I and II). 
A limitation of most studies cited, including the present studies, is 
that the experiments were of short-duration and that the subjects were 
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adult humans. Most animal experiments on the relationship between dietary 
protein and level of serum cholesterol have been undertaken on growing ani-
mals which have been fed on the test diets for the greater part of their 
lives. It takes longer to reveal effects of protein in adult rabbits than 
in young rabbits, and the observed effects are much less (10). Thus, the 
effects of the long-term intake of various proteins, beginning at an early 
age, have yet to be determined in humans. 
Furthermore, as the subjects in most controlled trials seldom form a 
representative sample of a specified population, extrapolation of the 
results should be done with extreme caution. The results of studies 
in which proteins were tested in diets of a specific overall composition 
should also be extrapolated to other dietary conditions with great care. 
The "ideal" experiment which takes account of all these difficulties, is 
difficult to carry out for a number of practical reasons. With all their 
limitations, human experiments as described in this thesis, remain a 
valuable adjunct to animal experiments and epidemiological studies. 
The present evidence suggest that soy protein when compared with animal 
protein has a small but real effect on cholesterol metabolism in man. 
Normocholesterolemic subjects appear to be relatively insensitive to the 
type of protein in the diet, while hypercholesterolemic subjects seem more 
responsive. More research is needed to clarify the reasons for this dif-
ference in responsiveness. Then it may become possible to characterise 
people according to their degree of responsiveness which would be of great 
value in making dietary recommendations. However, this research is hampered 
by the fact that the mechanisms by which soy protein exerts its effects 
still remain to be elucidated (Chapters 2-4). 
On basis of the results of animal studies and studies on hypercholes-
terolemic subjects with respect to dietary protein and serum cholesterol, 
it has been suggested that animal protein in the diet should be replaced by 
vegetable protein as a beneficial dietary modification in the prevention 
of atherosclerotic diseases (11). On basis of the present evidence on 
normocholesterolemic subjects, such suggestions cannot be accepted as 
general dietary recommendations, although changing the type of protein in 
the diet may be beneficial to overt hypercholesterolemic subjects. On the 
other hand, in practice, replacing foods containing animal protein with foods 
containing vegetable protein may also be beneficial to normocholesterolemic 
subjects, because the main sources of animal protein are also often rich in 
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saturated fat and cholesterol. It is well established that these dietary 
components increase serum lipids. 
It should be stressed that dietary modifications may affect several 
physiological parameters, and not only the parameters under investigation. 
In making dietary recommendations, all foreseeable consequences should be 
considered. In the present studies, for example, the test proteins differed 
in amount of nucleic acids. The consequence was that the subjects on the 
soy protein diets had higher levels of serum urate than the subjects on 
the casein diets (Chapter 5). An elevated level of serum urate is a well-
established risk factor for gout. 
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APPENDIX 
DESIGNS FOR EXPERIMENTS COMPARING THE 
EFFECTS OF DIFFERENT DIETS 
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1. INTRODUCTION 
In principle, many nutritional experiments with humans and animals are 
similar. A number of subjects are given one or more diets, the assignment of 
diets to subjects is controlled, and specified variables in the subjects are 
measured. The object of the experiment is often simply to compare the effects 
of various diets. 
If the value of a variable is only dependent on the diet, then all the 
subjects receiving the same diet will have the same value for the variable, and 
an observed difference in values between two different diets can safely be 
assumed to be caused by the difference in diets. In reality, however, the value 
of a variable may not depend on the diet alone, but also on other factors. For 
example, subjects receiving the same diet may show some variation in values of 
a variable by reason of variations between subjects and between periods of 
consumption. Even if these sources of variation did not exist, the values of a 
variable are not necessarily identical because of laboratory variations and 
biological variations within subjects. Thus, it would seem that it is almost 
inevitable that a certain amount of variation may be present in the values of a 
variable from subjects receiving the same diet. Since these sources of 
variation are outside the experimenter's control, this variation is often 
referred to as uncontrolled variation. When such uncontrolled variation is 
negligible or minor in comparison with the effects of the diets, the observed 
difference in values obtained on two different diets may still be assumed to be 
caused by the difference in diets. However, in nutritional experiments the 
amount of uncontrolled variation may be comparable to the effects of the diets 
and may have consequences for the experimental design to be used. 
Sources of uncontrolled variation can lead to the introduction of systematic 
errors in the comparison of the effects produced by different diets. This com-
parison is often referred to as the diet comparison. The situation may arise, for 
example, in which subjects are given two different diets during separate periods 
(case 1) or in which two diets are qiven simultaneously to two groups of subjects 
(case 21. The diet difference, that is the difference in the effects produced by 
the two diets, can be estimated by comparing the mean value obtained on each diet. 
However, comparison of the diets becomes complex because of the possible 
differences between the two periods in case l,and in case 2, because of the 
possible differences between groups of subjects. In other words, factors such 
as time and between-subject variation may affect the diet comparison. 
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A further consequence of uncontrolled variation concerns the precision with 
which a diet difference can be estimated. As mentioned above, subjects 
receiving the same diets may show some variation in the values for a variable. 
Thus any estimation of diet difference is also subject to variation and hence, 
to some degree of uncertainty. The probable magnitude of the variation in the 
estimate of a particular diet difference can be determined from the data by 
calculating the standard error for the estimate of the particular diet 
difference (see Snedecor & Cochran: Ch 2.11 and Ch 4). The size of the standard 
error is dependent partly on the number of subjects receiving each diet, andpartl} 
on the amount of uncontrolled variation affecting the estimate of the diet 
difference. This uncontrolled variation is the variation in results of all 
subjects afterpossible diet effects have been eliminated. When the standard 
error is calculated, the estimate of the diet difference can be tested for 
statistical significance (see Snedecor & Cochran: Ch 4). The attained level 
of significance depends on the size of the standard error and decreases at 
smaller values of the standard error. The level of significance measures the 
•probability of observing a diet difference equal in magnitude to the estimated 
diet difference when the true diet difference is zero (or in the opposite 
direction). If the estimated difference is significant at say the 1% level, 
then there is little doubt that the true difference is not zero. If, however, 
the estimated difference is not significant at a lowlevel of significance (in 
other words, if the estimated difference is consistent with a true zero 
difference), then it is still possible that a true diet difference of 
physiological importance exists. However, as a result of a large variation in 
the estimate of a diet difference (that is, large standard error), even estimated 
differences of the size of the true diet difference may be considered to be 
consistent with a true zero difference. It is clear that if the true difference 
is sufficiently different from zero to be of physiological importance, then the 
estimated difference must have a good chance of being statistically significant. 
This means that the standard error of the estimate should be sufficiently small, 
and thus the diet difference can be estimated with a reasonable degree of 
precision (for a detailed discussion, see Cox: Ch 8). 
An estimate of a diet difference is subject to variation. If the experiment 
could be repeated many times, then the mean estimate of the diet difference 
could be considered to be the true value of the diet difference. 
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It should be clearly recognized that in the foregoing discussion the tests 
of significance are the basis for statements in respect of the population 
of experiments which could be carried out under exactly the same conditions, 
and of which the data are a sample. The purpose of the statistical analysis 
is to reveal what the results of the experiment can tell about the true 
diet difference. In such problems the sample is concrete, but the population 
may appear to be hypothetical. Therefore, the precision of an experiment 
may give little indication of practicality of reproducing the results. 
Of course, it is possible to repeat an experiment with similar or the 
same subjects and diets, but it has to be carried out during another time 
period. The researcher should consider carefully whether it is reasonable 
to assume that a repeated experiment can be regarded as belonging to the 
same population of experiments. 
A quite different situation arises when the population is concrete and 
definite, e.g. all inhabitants of the town of Wageningen, and the problem 
posed is to obtain specific information about it (for methods for selecting 
a sample and for estimating population characteristics from the data 
obtained in the sample, see Snedecor & Cochran: Ch 17). 
The following sections show how, in the planning of an experiment, selection 
of an appropriate design can eliminate the effects of between-subject 
variation, time trends, and also uncontrolled diets prior to the experiment, 
firstly, from the diet comparisons in order to avoid systematic errors; 
and secondly, from the uncontrolled variation in order to increase precision 
(for the effect of the number of subjects on the precision with which a diet 
difference can be estimated, see Cochran & Cox: Ch 2.2, Cox: Ch 8, and 
Snedecor & Cochran: Ch 4.13). 
It is not the intention to give complete descriptions of all possible 
designs and their methods of analysis, but to provide background information 
on some of the advantages and disadvantages of designs often used in 
nutritional experiments. 
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2. BASIC ASSUMPTIONS UNDERLYING THE EXPERIMENTAL DESIGNS DESCRIBED 
In the designs discussed, the value of a variable obtained when a specified 
diet is given to a particular subject at a specified time in the experiment is 
considered as: 
a quantity \ / a quantity \ / a quantity 
depending on the ! + depending on the I + depending on the 
^particular subject / \ specified diet / \ specified time 
The following basic assumptions have been made. 
a) There is an individual intrinsic level of the variable for each subject on 
a specified diet under stable conditions. Between-subject variation refers 
to deviations in the individual intrinsic levels from the average level of 
subjects receiving the same diet under the same conditions. 
b) Each time period has a specific effect on the variable, which is independent 
of the individual and the diet. This time effect, which includes all 
environmental influences acting equally upon the level of the variable, is 
additive to the individual intrinsic level. Between-period variation refers 
to the deviations of the effects of the various periods from the mean 
effect of all the periods in the experiment. 
c) If a period of sufficient length has been chosen, then each diet has a 
specific effect on the variable, which is independent of the individual and 
the time. The diet effect is additive to the individual intrinsic level. 
Between-diet variation refers to the deviations of the effects of the 
various diets from the mean effect of all the diets used in the experiment. 
d) The difference between the observed and the expected value of the variable, 
when a specified diet is given to a particular subject at a specified time, 
is referred to as the residual term. This term comprises all further 
unexplained variations within a subject on a constant diet under stable 
conditions. Within-subject variation refers to the dispersion of the 
individual residual terms, and includes both laboratory and biological 
within-subject variation. 
Any apparent differences in time effects from individual to 
individual and/or diet to diet, or any apparent differences in 
diet effects from individual to individual and/or time to time, 
will be incorporated into the residual term. 
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e) The deviations of the individual intrinsic level, the time term and 
the diet term from their respective means, and the residual term are 
mutually independent and have normal distributions with zero means and 
finite variances. 
According to the model described, the variation in results obtained in an 
experiment comparing the effects of several diets, will depend on within-
-subject variation and may depend on variations between subjects, diets and 
periods. If an experiment is planned to compare the effects of diets, the 
researcher will be interested in the amount of uncontrolled variation in 
results of subjects receiving the same diets. This amount of variation depends 
on within-subject variation and may also extend to that occurring between 
subjects and between periods. It is clear that the within-subject variation is 
difficult to eliminate from an experiment, and designs should be sought in 
which the effects of the other sources of variation on the diet comparisons 
are absent or balanced out,and in which such variation can be eliminated from 
the uncontrolled variation. The resulting residual amount of uncontrolled 
variation is measured by the residual standard deviation. 
In the model described, it is assumed that the value of the variable for 
one individual in one period is independent of the diet given to the same 
individual in preceding periods. Sometimes it may be preferable to accept the 
overlap of diet effects and to deal with it in the design of the experiment 
and in the analysis of the data. This is possible, provided that it is 
reasonable to introduce a simple modification to the model. In the modified 
model, when a specified diet is given to a particular subject at a specified 
time, the value of the variable is considered as: 
(a quantity \ /a quantity \ /a quantity \ /a quantity depending on j + [ depending on j + j depending on I + | depending on the the subject / Vthe diet / Vthe time / ^preceding diets 
When such carry-over effects are assumed, experimental designs and the methods 
of analysing the results may become complicated (see Cox: Ch 13, and 
Cochran & Cox: Ch 4.6). Some difficulties which may arise in these situations 
are discussed in the following section. 
3. DESIGNS FOR EXPERIMENTS COMPARING THE EFFECTS OF DIFFERENT DIETS 
3.1 Designs for experiments in which each subject receives one only of tne test 
diets and all subjects receive their diets simultaneously 
In this type of design, each subject is given one only of the test diets 
and which all subjects receive precisely at the same time. It is clear that 
possible time trends have no effect on the experiment. Simultaneous designs 
have several advantages. Any number of diets may be used and the total 
duration of the experiment is, in principle, limited to one test period only. 
Within the simultaneous designs completely randomised designs and randomised 
blocks can be distinguished. 
3.1.1 Completely randomised designs 
In these designs the diets are allotted to the subjects completely by 
chance. An important advantage of such designs is that statistical analysis 
is relatively simple, even when the results from some subjects are missing (for an 
lysis of variance of one-way classifications, see Snedecor & Cochran: Ch 4 + Ch 10 
In dietary trials it is not uncommon that results on some subjects are lost, 
or do not become available (e.g. because of cessation of participation), or 
have to be discarded (e.gr. because of insufficient adherence to the diets). 
Completely randomised designs can be modified in several ways, 
depending on whether the value of the variable is measured only at the end of 
the test period (Figure 1, Model l),or at both the beginning and end of the 
test period (Figure 1, Model 2 ) , or, whether in addition to both measurements 
the test period is preceded by a control period during which all the subjects 
receive the same control diet (Figure 1, Model 3). 
Model 1: The results of each diet are averaged and the difference between means 
is used as an estimate of the true difference between the diets. Since 
the diets are allotted to the subjects by chance, an attempt is 
made to balance out the effect of the variation between subjects from 
the diet comparisons. For example, it is most unlikely that subjects 
with high intrinsic levels are concentrated in one group only. The 
principal objection to the design is that the whole of the between-
-subject variation falls into the uncontrolled variation, and thus 
into the standard error of the estimates of diet differences. 
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Model 2: In this design, the change in value of the variable over the test 
period is calculated for each subject. The differences between group 
means of the changes are used as estimates of diet differences. The 
important advantage of this design when compared to the preceding one 
Control Test 
period period 
Description 
Model 1 
Model 2 
Model 3 
X 
X 
X 
1 
t 
1 
1 
c 
A 
B 
C 
A 
B 
C 
t 
t 
t t 
Measurement is made at the 
end of test period only. 
Diets are allotted to sub-
jects by chance. The number 
of subjects per diet is not 
necessarily the same for 
each diet. 
Measurements are made at both 
the beginning and end of test 
period. Diets are allotted to 
subjects by chance. The number 
of subjects per diet is not 
necessarily the same for 
each diet. 
Measurements are made at both 
the beginning and end of test 
period. Test period is 
preceded by control period. 
Diets are allotted to subjects 
by chance. The number of 
subjects per diet is not 
necessarily the same for 
each diet. 
FIG. 1. Examples of completely randomised designs for comparison of three 
test diets: A, B,and C. The X diet is a control diet. Measuring 
points are indicated by arrows. 
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is that between-subject variation is eliminated from the 
uncontrolled variation. The residual amount of uncontrolled variation 
is estimated from the observed dispersion of the individual changes 
over the test period. A disadvantage may be that diets prior to the 
first measurement are uncontrolled, and accordingly, part of the 
variation in the results at the beginning of the experiment will be 
due to the fact that the habitual diets of the subjects differ. This 
variation will be included within the total uncontrolled variation in 
the individual changes during the test period. The subjects are 
allotted to the diets by chance, and therefore an attempt is 
made to balance out the possible effects of uncontrolled diets from 
the diet comparisons. 
Example: Walker et ai. (1960) compared the effects of a vegetable 
protein diet and an animal protein diet on the serum cholesterol 
level in 12 subjects. Six subjects were assigned at random to each 
diet. The cholesterol level was determined at various times including 
the commencement of the diet and after five weeks (completely 
randomised design, Model 2). Mean absolute levels at the commencement 
and after 5 weeks were (mean ± SD): 189 ± 28 and 161 ± 18 mg/dl for 
the vegetable protein diet, and 182 ± 43 and 142 t 19 mg/dl for the 
animal protein diet. For each subject the change during the test period 
was calculated and analysis of variance revealed that the observed 
difference between the vegetable and animal protein diet of 12 mg/dl 
reached statistical significance (P < 0.025). If only final measurements 
had been made (completely randomised design, Model 1), then the diet 
difference would have been estimated as +19 mg/dl. In spite of the 
randomization, the mean initial levels of the groups differed by 
+7 mg/dl. This would have resulted in an overestimation of the diet 
difference had only final measurements been made (systematic error). 
Furthermore, the whole of the between-subject variation would have been 
included in the uncontrolled variation; the standard deviation obtained 
from analysis of variance would have been approximately 19 mg/dl, and 
the standard error of the estimate of the diet difference would have 
been approximately 11 mg/dl (SE = SD\/(l/n1 + l/n2)). Only a difference 
of approximately 29 mg/dl would have reached statistical significance 
at the 2\% significance level. It should be noted that the variation in 
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results at the beginning of the experiment is much larger than at the 
end. This may have been caused by uncontrolled diets prior to the first 
measurement. 
Model 3: This design is similar to Model 2, except that the test period is 
preceded by a period of controlled diets. Possible effects of 
uncontrolled diets prior to the test period are thus eliminated from 
the experiment. 
Example: Van Raaij et al. (1980), compared the effects of a casein, a 
soy protein and a mixed casein/soy protein diet on the serum cholesterol 
levels in 69 subjects. All subjects received a control 
diet (one of the test diets) for 10 days after which the subjects were 
divided into three groups each receiving one of the test diets. 
Cholesterol levels were determined at the beginning and at the end of 
the test period (Model 3). Mean values were (mean ± SD): 152 ± 27 and 
149 ± 24 mg/dl for the casein group (n=25); 153 ± 24 and 150 ± 25 mg/dl 
for the mixed casein/soy group (n=20); and 153 ± 23 and 150 ± 23 mg/dl 
for the soy group (n=24). The change during the test period was calculated 
for each subject; mean changes were (mean ± SD) -3 ± 14, -3 ± 13, and 
-3 ± 10 mg/dl, respectively. 
Analysis of variance of a one-way classification (individual changes 
in level of serum cholesterol during test period) 
Source of Degrees of Sum of Mean F value P value 
Variation Freedom Squares Squares 
Diets t-l= 2 
Residuals £n.-t= 66 
Total £1^-1= 68 
2 
10269 
10271 
1 
156 
0.006 Not significant 
The pooled estimate of the residual standard deviation was only 12.5 
mg/dl (=VÏ56"); the standard error of the estimate of the difference 
between the casein and soy diet has been calculated to be approximately 
3.6 mg/dl; this means that in this experiment an observed difference 
of approximately 7.2 mg/dl would have reached statistical significance 
at the 5% significance level. 
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3.1.2 Randomised blocks 
This type of design with simultaneous application of test diets may be 
useful when the value of the variable can be measured only at the end of the 
test period. It should be remembered that the main objection to Model 1 of the 
completely randomised designs, is that the whole of the between-subject 
variation falls into the uncontrolled variation. If however, the values of 
the variable are highly correlated with known characteristics of the subjects, 
then the subjects can be grouped into blocks on the basis of these characteris-
tics. All the subjects in a block are expected to yield similar values for 
tne variable if the diets are equivalent in 
effect. The order in which diets are assigned to subjects within each block is 
randomised (Figure 2). The differences between diet means are used as estimates 
for the true diet differences. The effect of variation between blocks is 
eliminated in the diet comparisons because diet comparisons are made within 
blocks of similar subjects. The variation between blocks can also be eliminated 
from the uncontrolled variation by an appropriate method of analysis (analysis 
of variance for two-way classification: diets and blocks, see Snedecor & 
Cochran: Ch 11). The success of this design depends on skillful grouping of 
the subjects into similar sets or blocks. When there is no obvious prior 
knowledge to enable an appropriate grouping, then the completely randomised 
design (Model 1) should be used. 
It should be clearly recognized that between-subject variation may arise 
from many peculiarities of the individual subjects and that grouping into 
blocks according to one or more obvious features is unlikely to eliminate all 
of the between-subject variation. Furthermore, the analysis depends essentially 
on the balanced nature of the design. Although there are very sophisticated 
methods available for estimating missing values in this type of design, the 
requirement of a balanced pattern of results may be a disadvantage. 
3.2 Designs for experiments in which the subjects receive different diets 
consecutively 
In this type of designs each subject receives all the diets in sequence 
( Figures 3 and 4). The design can be constructed so that all subjects receive 
the diets in the same order or in various orders. The value of the variable is 
measured at the end of each test period. The most important advantage of these 
type of designs is that any between-subject variation is automatically 
eliminated from the experiment because each subject is his own control. 
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Block number Test 
period 
Description 
Measurement is made at the 
end of test period only. 
Subjects are grouped into 
similar sets or blocks. 
Within each block, diets 
are allotted to subjects 
by chance. 
B 
FIG. 2. An example of a design with randomised blocks for comparison of 
three test diets A, B, and C. The measuring point is indicated 
by an arrow. 
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Less subjects will be needed than with the simultaneous designs because diets 
are compared within the same subject. A disadvantage may be the greater duration 
of the total experiment. 
3.2.1 Single order of diets design 
The simplest design for consecutive application of test diets is that in 
which all subjects receive the diets in the same order (Figures 3 and 4). 
The differences between diet means are used as estimates of diet differences. 
The results of the various diets are obtained during different periods. The 
effects of time trends cannot be separated from diet effects because there is 
no control group in this design. 
Example: Holmes et ai. (1980) compared the effects of a beef diet, 
and a soy diet, on the serum cholesterol levels in 12 subjects. All 
subjects received the beef diet for three weeks followed by the soy 
diet for a period of four weeks (single order of diets design). 
Values were (mean ± SD): 241 ± 38 and 235 ± 43 mg/dl for the beef 
and soy diet, respectively. The estimate of the diet difference of 
6 mg/dl did not reach statistical significance. No control group was 
used in the experiment and time trends were not eliminated from the 
diet comparison . 
3.2.2 Single Latin square design ( Figure 4) 
The disadvantage of the preceding design is that time effects cannot be 
eliminated from the experiment. It is reasonable to expect some time trends 
between periods, and it is desirable to balance out not only variation between 
subjects but also variation arising from time trends. 
When both between-subject variation and variation arising from time trends have 
to be balanced out, then the Latin square principle is indicated. 
In general, a txt Latin square is an arrangement of t letters so that each letter 
occurs once in each row and once in each column. The rows represent subjects, 
and the columns periods. The diets are randomised over the rows and columns 
according to a certain procedure (Cochran & Cox: Ch 4.33). 
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Test 
Deriod 
Test 
period 
Description 
Single order 
of diets 
* t 
All subjects receive diets 
in same order. 
Combined Latin 
squares 
A B 
t t 
Subjects are divided into n 
groups of two similar sub-
jects. A group of similar 
subjects is used for each 
square. Within each square, 
diet sequences are allotted 
to subjects by chance. 
Cross-over 
A B 
B 1 A 1 
• t 
Subjects are divided at 
random into two equal groups. 
Each group receives one of 
the diet sequences. 
FIG. 3. Examples of consecutive designs for comparison of two test diets: A and 
B. Measuring points are at the end of each test period and are 
indicated by arrows. 
Diet differences are estimated by comparing the diet means. It is clear that 
these estimates are free from systematic effects of between-subject variation 
and that effects of time trends are balanced out from diet comparisons. These 
sources of variation can also be eliminated from the uncontrolled variation, 
and the residual standard deviation is usually obtained from analysis of 
variance (for a three-way classification; see Snedecor & Cochran: Ch 11). 
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Test 
period 
Test 
period 
Test 
period 
Description 
Single order 
of diets 
Single Latin 
square 
t t t 
A B C 
B C A 
C 1 A | B 
t t t 
All subjects receive 
diets in same order. 
Three subjects are used. 
Diet sequences are 
allotted to subjects by 
chance. 
Combined Latin 
squares A | B c 
B 1 C A 
C 1 A | B 
t • • 
Subjects are divided 
into n groups of three 
similar subjects. A group 
of similar subjects is 
used for each square. 
Randomisation of diets is 
done independently for 
each square. Within each 
square, diet sequences 
are allotted to subjects 
by chance. 
Cross-over A B C 
B C A 
t t 
Subjects are divided 
randomly into three 
equal groups. Each group 
receives one of the diet 
sequences. 
FIG. 4. Examples of consecutive designs for comparison of three test diets: 
A, B and C. Measuring points are at the end of each test period and are 
indicated by arrows. 
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Example: Snedecor and Cochran (Ch 11.8) cite an experiment in which 
the effect of three diets on the milk yield in cows was investigated. 
Variation in milk yield in cows is normally large and when successive 
diets are given to the same cows, a change in milk production over 
time must be taken into account. A Latin square design was used to 
eliminate both types of variation in this experiment. 
Experimental design 
Cow 1 
Cow 2 
Cow 3 
I 
A: 608 
B: 715 
C: 940 
Period 
II 
B: 715 
C: 1,087 
A: 766 
III 
C: 844 
A: 766 
B: 832 
The rows represent cows, and the columns represent the successive periods 
durina lactation. The three animals in the square were chosen as they were 
most likely to have similar lactation curves and to be at corresponding 
points on the curve at the commencement of the experiment. In other 
words, time effects (milk trend effects) would most likely be 
similar for each animal. The variable was the milk yield in pounds for 
a 6-week period. 
Analysis of variance of a 3-way classification (milk yield in 
pounds for a 6-week period) 
Source of Degrees of Sum of Mean F value P value 
Variation Freedom Squares Squares 
Periods 
Cows 
Diets 
Residuals 
Total 
t-l=2 
t-1-2 
t-l=2 
(t-l)(t-2)=2 
txt-l=8 
5,900 
47,214 
103,436 
4,843 
161,386 
2,950 
23,607 
51,718 
2,422 
21.4 P <0.05 
The mean results were 695, 811 and 957 for the diets A, B and C, 
respectively. Analysis of variance revealed a significant diet effect. 
The residual standard deviation (SD) is estimated to be 49 ( = \/2,422) 
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and is based on 2 degrees of freedom (df). The standard error of 
the difference between two means, \J2SD /t, is 40. The 5% value of 
Student's t with 2 df is 4.303. Thus, only the difference between 
Diet A and C reached statistical significance. 
The small squares provide only a few degrees of freedom for the estimation 
of the residual variance ( df = (t-l)(t-2)). This fact precludes the use of 
single 2x2 squares, while single 3x3 or 4x4 squares are seldom used for this 
reason. However, more than one square may be included in the same experiment 
(combined Latin squares and cross-over designs). Although methods for calculating 
missing values and modified test procedures are available, the requirement 
of a balanced pattern of results may be a disadvantage in human trials. 
3.2.3 Combined Latin squares design 
The experiments described using the single Latin square can be extended 
with additional subjects (but always by a multiple of t) by adding more 
squares. In the combined Latin squares design each txt square is randomised 
independently and a group of similar subjects is allocated to each square. The 
reason for this is that balancing of columns in the Latin square removes the 
effect of a common time trend. If the time trends are appreciably different 
for the subjects within the same square, the residual variance is 
inflated. 
Example: The experiment cited by Snedecor and Cochran (Ch 11.8) could 
have been extended by adding more squares to the design. A 3x3 Latin 
square could have been used for each group of similar cows. It is 
immaterial if the time effects (common trends in milk yield) are 
different in the various squares, but it is important that as far 
as possible any trends that exist are identical for all animals in the 
same square. Diet differences can be estimated by comparing the diet 
means. An estimate of the residual variance can be made from the ana-
lysis of variance for a four-way classification namely, diets, sub-
jects, periods and squares, and based on (t-l)(rt-r-l) degrees of 
freedom, where r is the number of squares. 
The combined Latin squares desiqn can onlv be used when the extent of time 
trends for a given subject can be estimated in advance. 
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3.2.4 Cross-over design 
This design is the simplest extention of the Latin square principle. The 
number of subjects, which must be a multiple of the number of diets (t), are 
divided at random into t equal groups, each receiving one of the sequences of 
the diets. The results on each diet are averaged, and diet differences are 
estimated by comparing diet means. The estimate of the residual variance is 
usually obtained from analysis of variance. 
Example: Carroll et al. (1978) compared the effects of a mixed protein 
diet with a plant protein diet on the serum cholesterol levels in 10 
healthy women. A cross-over design was used, involving 2 groups of 5 
subjects each. The cholesterol level was determined at the end of each 
period (Figure 3, cross-over design). The results for the first group 
of subjects were 175 and 161 mg/dl on the mixed protein and plant 
protein diet respectively, and 161 and 166 mg/dl for the second group 
on the plant protein and mixed protein diet, respectively. The 
difference between the plant protein and mixed protein diet was 
estimated as (161+161-175-166)/2=-9.5 mg/dl. Analysis of variance 
revealed a significant diet effect. 
Analysis of variance for a three-way classification (levels of serum 
cholesterol) 
Source of 
Variation 
Periods 
Subjects 
Diets 
Residuals 
Total 
Degrees of 
Freedom 
t-l=l 
rt-l=9 
t-l=l 
(t-l)(rt-2)=8 
rtt-l=19 
Sum of 
Squares 
92 
L3.644 
433 
410 
14,579 
Mean 
Squares 
92 
1,752 
433 
51 
F ratio 
1.8 
34.2 
8.4 
P value 
Not sign. 
<0.01 
<0.05 
The residual standard deviation obtained from analysis of variance was 
7.1 mg/dl (l/öTj based on 8 df.. The standard error of the estimate of 
the diet difference is 3.2 mg/dl (SE = SD^/z/rT, where n is the number 
of subjects on each diet, and the 5% value of Student's t with 8 df 
is 2.306. Thus, an observed difference of about 7.4 reaches statistical 
significance. 
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3.3 Carry-over effects in designs of experiments for consecutive application 
of diets 
In the preceding designs it is assumed that each test diet has no effect 
in periods subsequent to that in which it is given. Occasionally however, the 
absence of carry-over effects cannot be assumed, and a diet effect is 
characterised by a direct effect in the period in which it is given, and by a 
residual effect in the following period. In this case, a design in which 
diets follow each other the same number of times should be used (for methods 
of obtaining suitable arrangements, see Cox Ch 13.3 and Cochran & Cox: 
Ch 4.6). When, for example, two diets are compared in a cross-over design, 
this condition is already met (Figure 3); each diet follows the other once 
only. However, when three diets are to be compared in a cross-over design, 
the design shown in Figure 4 is not appropriate. It is necessary then, 
to consider pairs of squares simultaneously (Fiqure 5, Example 1). 
In Example 1 (Figure 5) each diet follows the other except itself the same 
number of times. However, the values for variables obtained on a specified diet 
are influenced by the residual effects of all diets except the values obtained 
in the first period. Assuming that the specified diet has a large positive 
residual effect and the other diets do not, then the mean value on this diet is 
suppressed in relation to the other diets. It is possible to overcome this 
difficulty by introducing a preliminary period in which the same diet is given 
as in the first period, but in which no measurements are made. Thus each diet 
is preceded by all the test diets the same number of times (Figure 5, Example 2), 
and the design is balanced out for carry-over effects (for methods for 
adjusting diet means for residual effects, see Cox: 13.3). The effects of carry-
-over can also be eliminated from the uncontrolled variation by using an 
appropriate method of analysis. An example is given by Cochran and Cox (Ch 4.62a). 
Another method of eliminating carry-over effects is to separate each 
experimental period by a period in which a control or standard diet is given. 
These additional periods should be of sufficient duration for any effect of the 
earlier diets to be dissipated. The disadvantage is that the total 
duration of the experiment is substantially increased. 
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Control Test Test Test 
period period period period 
_ J 
Description 
Example 1 
Example 2 
B C A 
c A B 
C B A 
A C B 
t t t 
A A B C 
B B C A 
C C A B 
C C B A 
A A C B 
B B | A | C 
t t t 
Each diet 
follows each 
other the 
same number 
of times 
Each diet 
follows each 
other including 
itself, the 
same number 
of times 
FIG. 5. Examples of consecutive designs for comparison of three test diets: 
A, B, and C, when carry-over effects cannot be assumed to be absent. 
Measuring points are indicated by arrows. 
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4. COMPARISON OF THE DESIGNS 
In general, most of the uncontrolled variation in the results of a 
variable in human nutritional studies arises from the peculiarities of in-
dividual subjects, that is the between-subject variation. Thus designs should 
be sought in which this source of variation can be eliminated as far as 
possible from the experiment. Therefore, designs such as Model 1 of the 
completely randomised designs are not particularly suitable. When only one 
measurement can be made on each subject, efforts can be made to eliminate 
part of the variation between subjects by using a design with randomised 
blocks. In all other designs discussed, between-subject variation is elimina-
ted by using each subject as its own control but it is necessary to make 
more than one measurement on each subject. 
Since the effects of uncontrolled diets prior to the experiment are 
eliminated in Model 3 of the completely randomised design when compared with 
Model 2, the first is the better. However, the total duration of the experi-
ment is longer. The advantage of the simultaneous designs is that the total 
duration of the experiment is limited to only one test period (Model 2) or 
to one control plus one test period (Model 3). Many diets can be compared 
simultaneously and analysis of the results is simple, even when data on 
subjects are missing. The disadvantage, however, is that a relatively large 
number of subjects is needed because each subject receives one only test diet. 
The consecutive design, in which all subjects receive the diets in the 
same order (single order of diets design), is not appropriate because time 
effects cannot be eliminated from the experiment since no control group 
is involved. Possible effects of habituation on the experimental condition 
(experimental stress) also belong to time effects. The effects of time trends 
are balanced out in the other consecutive designs and can be eliminated by 
means of an appropriate method of analysis. It should be noted firstly that 
the single Latin square design is appropriate only when a relatively large 
number of diets are to be compared (in general, more than four). Secondly, 
the combined Latin squares design is useful only when time trends are dis-
similar for each subject, and when the size of the time trends can be pre-
dicted for each subject. The advantage of the consecutive designs is that 
fewer subjects are needed than in simultaneous designs because diet compari-
sons can be made within subjects. On the other hand, the duration of the 
experiment may be substantially increased. Furthermore, analysis of the results 
depends on their balanced pattern, and the design and method of analysis may 
become complicated when carry-over effects are present. 
103 
In summary, the decision as to the final design to be used in an experiment 
will depend on several factors such as: whether one only or several measure-
ments are to be made on each subject; the availability of subjects; the number 
of diets to be compared; the possible duration of the whole experiment; 
whether some values are likely to be missing or not; and whether carry-over 
effects may be expected. In practice, the decision will also depend on the 
availability of equipment and staff and on financial resources. 
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APPENDIX II 
CARRYING OUT A NUTRITIONAL EXPERIMENT: THE 
TRIAL WITH MIDDLE-AGED VOLUNTEERS 
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In this appendix the planning, preparation and conduct of nutritional trials 
with human subjects are discussed with special reference to the trial with 
middle-aged volunteers (Chapter 3). Funding, decisions concerning the experi-
mental protocol, and ethical aspects of carrying out such a study are discussed. 
An outline is given of the practical work undertaken in the subsequent phases 
of the experiment, the staff involved and the total cost of the study. Burden 
and inconvenience to the participants are also discussed. 
1. FUNDING 
The experiment with middle-aged subjects was a part of a larger project 
which included all the experiments described in this thesis. The protocol for 
the whole project which was to be of three years duration, contained the broad 
outline of the planned experiments together with probable total cost and an 
outline of the scientific and social significance. On the basis of this propo-
sal the Agricultural University provided funds for a Ph.D. student (the author) 
and allocated space and other facilities. The experiments were financed by a 
grant from the Netherlands Institute for Dairy Research (NIZO). 
2. PROTOCOL 
In drawing up a protocol for a nutritional experiment with human subjects, 
a decision has first to be made on the following: the diets to be compared; the 
types of observations to be made; the required duration of the test periods; 
and the type of subjects to be used. These issues can be regarded as technical 
questions peculiar to the subject matter of the experiment. The decisions made 
for the present study were based on the general information available and on 
the results of the previous study with young volunteers (Chapter 2). The final 
choice of the type of subjects to be used, that is healthy middle-aged 
volunteers, was also influenced by the fact that it was known that a reasonable 
number of normocholesterolemic subjects were readily available. 
An experimental design was chosen in which each subject received one only 
of the test diets which were to be given simultaneously to all the subjects. 
The test period was preceded by a control period in which all the subjects 
received the same control diet. In this type of design more subjects are 
required than in designs in which each subject receives all test diets conse-
cutively (see Appendix I). However, the design has several advantages: the 
total duration of the experiment is restricted to one only control and one 
only test 
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period, possible carry-over effects of the control diet are balanced out, and 
the analysis of the results is simple, even when data on subjects are missing 
(see Appendix I). In regard to one of the important variables under investiga-
tion, the concentration of cholesterol in serum, the required number of 
subjects on each diet was determined on the basis that an appropriate power of 
the significance test used could be obtained (see Chapter 2). 
Other decisions concerned the method of introducing the planned dietary 
modifications, and the food supply. In order to make the test diets acceptable 
to the subjects over several months, and that deviation from usual food habits 
be minimal, it was decided to use common foods wherever possible. Products 
resembling usual foods were developed in order to introduce the protein 
preparations under investigation into the diets. It was decided to provide the 
subjects with almost complete daily diets, so that protein effects would not be 
masked by effects of uncontrolled dietary components. 
All the above issues, together with a detailed description of the 
conduct of the experiment, the method of analysing the results, 
the staff and equipment required, and total cost were included in the protocol. 
The final protocol was produced by the author and two staff members of the 
Department of Human Nutrition. Helpful advice was also given by experts outside 
the Department. 
3. ETHICAL ASPECTS 
Certain ethical problems arise in nutritional t r ials with humans. 
(i) Risks for the subjects 
It is clear that subjects should only participate in a nutritional trial 
when there are no foreseeable risks. The possible consequences of eating the 
diets, possible temporary physiological alterations, and the procedures used 
such as the takinq of blood samples, should be considered fully. 
(ii) Informed consent 
The consent of the subjects may be assumed in studies carried out with 
volunteers, however the ethical value of consent depends on the information 
provided. The subjects should be given adequate information on: the aims of 
the study; relevance of the study; the design and methods used; the risks and 
inconveniences to the subjects; and the right to cease participation at the 
time desired. Such information should be provided both in written and oral 
form; it must be correct, complete and comprehensible and should not contain 
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misleading euphemisms. 
(Hi) Choice of subjects 
Are the subjects, for example, recruited from vulnerable groups? 
(iv) Aims, design and methods of the study 
It is unethical to carry out a study of which it is clear that relevant 
results cannot be obtained, either because of the aims of the study or the 
design (methods, statistical model). 
The scientific and technical acceptability of the present study was 
evaluated by a number of staff members of the Department of Human Nutrition. 
The risks to the subjects, the informed consent and the choice of the 
subjects were evaluated by an external ethical committee which consisted of 
2 nutritionists, 2 medical practitioners and a sociologist. The committee 
approved the proposed protocol. 
4. CARRYING OUT THE EXPERIMENT 
4.1. Preparatory period (6 months) 
4.1.1. Development of special food products 
In the experiment, protein preparations (casein, soy protein 
isolate, and soy protein concentrate) 
were to be added to the diets as products resembling usual foods. As such 
products were not available commercially and as the expertise and equipment 
to develop these products were not available in the Department, several firms 
and institutions were approached to develop and prepare these products for the 
experiment (Chapters 2 and 3). Although stringent sensory demands were not made, 
the products had to be acceptable for continuous consumption over several 
months. Therefore, they were tested by taste-panels. They were also chemically 
analysed in the Department, and their compositions added to a computerised food 
composition table. It took between 4 to 6 months to develop the products to a 
satisfactory standard for the experiment. 
The products included brown bread, gluten-free bread, and foods similar to 
milk and yoghurt. Half of the protein in the brown bread consisted of test 
protein; the protein in the gluten-free bread and in the milk beverages 
consisted of test protein alone. The milk and yoghurt products were incorporated 
into soups, sauces, desserts and sandwich spreads. Cheese was used in the casein 
diet because practically the only protein it contains is casein. A gelated 
product was prepared from soy isolate as a counterpart for cheese in the 
isolate diet, and a commercial textured product was used in the concentrate 
diet. Butterfat was added to both soy diets to balance the fat in cheese. 
The gelated and textured soy products were added to sauces and sandwich 
spreads (see also Chapter 3). 
4.1.2. Recruitment of subjects 
As the success of human studies is largely dependent on the subjects, the 
selection and motivation of subjects is of the utmost importance. About three 
months prior to the experiment advertisements were placed in local newspapers. 
Posters were also placed on bulletin boards in many of the Departments of the 
Agricultural University, and in institutions and public buildings in and near 
Wageningen (Figure 1). Prospective participants were sent an extensive 
information brochure (Figure 2) about the experiment, including the aim and 
relevance of the study, the protocol and methods to be used, the inconveniences 
participants might expect, and finally what would be done with the results. It 
was made clear that the participants were free to cease participating at any 
time they desired. In the preparation of this information care was taken in 
regard to the comprehensibility of the contents and to ensure that misleading 
statements were not included. Those who retained interest in participating 
after reading the brochure were invited to attend a meeting at which further 
information was given. Several of these meetings were held at which the 
information contained in the brochure was discussed, slides of previous 
experiments were shown, and questions answered. A volunteer was accepted for 
the experiment only if he/she had attended one of these meetings. By this proce-
dure it was hoped to screen out those who were weakly motivated. Such experiments 
are too costly to spend time with participants who might leave the study in 
mid-course because they are bored or disillusioned. In addition, insufficient 
adherence to the diets invalidates the results. 
Although the participants were not offered payment, the diets were free of 
charge. Since 1974, several controlled nutritional trials have been carried 
out by the Department, mainly with students from the Agricultural University. 
The present study was the first study to be carried out with middle-aged volun-
teers (30 to 60 years). The main motivation for participation in the student 
experiments was the financial advantage of free meals and the conveniences such 
as no shopping and no preparation of hot meals on weekdays. These factors played 
a minor role in the motivation of middle-aged volunteers, although some partici-
Photo 1. Specially developed brown and gluten-free bread. Half of the 
protein in the brown bread consisted of protein from 
caseinate (left), or soy isolate (centre), or soy concentrate 
(right). The protein in the gluten-free bread consisted of 
test protein alone. 
Photo 2. Specially developed analogues of milk and yoghurt. The protein 
in these products consisted of test protein alone. The 
analogues of milk and yoghurt were incorporated into sandwich 
spreads, desserts, sauces and soups. Cheese was used in the 
casein diet. A gelated soy isolate product and a commercial 
textured soy concentrate product were used in the isolate and 
concentrate diet, respectively. These soy products were added 
to sauces and sandwich spreads. 
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pants stressed the conveniences. While not systematically investigated, it 
appeared on inquiry that the main motives in the present study were quite 
diverse, varying from mere curiosity to desire to learn. 
Un VAKGROEP HUMANE VOEDING 
De vakgroep Husana Voeding verricht onderzoek naar de rol van 
de voeding bij het ontstaan vui hart- en vaatilekten 
Zij bestudeert hiertoe onder andere het verband tuisen de 
voeding en het cholesterolgehalte In het bloed 
De vakgroep Humane Voeding v raag t 
VRIJWILLIGERS 
l e e f t i j d 3 0 - 6 0 j a a r 
v o o r e e n 
VOEDINGSPROEF 
3 9 s e p t - 1 4 n o v . 1980 ( 7 weken ) 
invloed van plantaardig en dierlijk ei*it. 
" 1 de coniplete d a g e l l j t , 
- p a k k e t aan bij : 
efon isch : 08ÎTO - 82503 
FIG. 1. Poster for recruitment of 
subjects. 
INFORMATIE 
VOEDINGSPROEF 
na jaa r 1980 
^L ï\ 
h\ 
proteïnorix 
\^^**^ÀJL. 
FIG. 2. Front cover of the information 
brochure. The emblem 
PROTEINORIX was used throughout 
the experiment as the logo of the 
experiment. 
Some of the reasons given for participation were: to become more conscious 
of my own diet; to feel what it means to have a strictly controlled diet, as is 
the case in some diseases; to learn something about my own body; and to have 
social contacts. Dedication of one's body to Science was mentioned by almost 
everyone but only as a second motive. 
The subjects were recruited within 6 weeks of placing the advertisements. 
After a preliminary investigation, 61 subjects were finally accepted for the 
actual experiment including: 13 married couples, 16 who were married but 
participated without their spouse, and 19 were unmarried. 
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4.1.3. Preparatory work for food supply 
Apart from 1.0 MJ (240 kcal) per day, all of the food eaten by the subjects 
was supplied daily in quantities according to individual energy requirement. 
In order to estimate individual energy intake, the subjects were asked to note 
and weigh all the foods and drinks consumed during three consecutive days prior 
to the experiment (see 4.1.4. Preliminary investigation). The subjects were 
classified into 25 energy groups on the basis of their habitual energy intake, 
beginning with 4.7 MJ per day, and increasing by intervals of 0.6 MJ. For each 
energy group the number of grams of each macro-nutrient was calculated to 
ensure that the overall composition of the diets in terms of percentages of 
energy was similar for all energy groups, and similar to the planned composition 
of the diets. The absolute quantities of macronutrients were subsequently 
transposed into grams of common foods and the specially developed products 
(see Table 1). The whole procedure necessitated many discussions concerning the 
feasibility of the planned diet compositions and required much inventiveness on 
the part of the dieticians. Each day the subjects were required to select 1.0 
MJ from a list of foods containing practically no protein and, of which, the 
fat content and fatty acid composition had been carefully evaluated. These 
foods are referred to as 'free foods'. This choice was, in fact, the only 
freedom the subjects were allowed in the composition of their total diet. 
A point system was devised to rate these foods. With the aid of this system, 
the participants could easily calculate how much of each food could be eaten 
in order to achieve 1.0 MJ per day. A show case with some of the free foods 
was present, and the subjects were free to take out desired foods. 
Information was prepared on stencils about the diets to be provided, and a 
booklet on the preparation of hot meals during the weekend was also prepared. 
(The ingredients were provided for hot meals during the weekend; see 4.2.2. 
Preparation and supply of daily diets). Guidelines for compiling dietary records 
and menus were also set out. A stringent coding system was developed for the 
collection of blood and diet samples. 
4.1.4. Preliminary investigation 
About 6 to 8 weeks prior to the actual experiment, all subjects underwent a 
preliminary investigation. They visited the Department of Human Nutrition twice. 
On the first occasion, a blood sample was taken after an overnight fast, blood 
pressure was measured and anthropometric measurements were carried out. All 
subjects were asked to complete at home a brief general (p.128), and a medical 
questionnaire (p.126-127). They were required to note and weight all the foods and 
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Table 1 
EXAMPLES OF DAILY FOOD SUPPLY FOR SUBJECTS ON THE CASEIN AND SOY PROTEIN DIETS3 
Energy group 
Energy intake (MJ per day) 
Casein diet Soy protein diets 
6 
7.7 
10 
10.1 
6 10 
7.7 10.1 
Breakfast 
and lunch 
Dinner 
Food item 
Brown bread (slices) 
Gluten-free bread (slices) 
Margarine (g) 
Sandwich spread (g) 
Meat (slices)e'£ 
Sugar (bag)c 
Soupb (g) 
Potatoes (g) 
Other vegetables (g) 
Soy sauce (g) 
(or Casein sauce (g) 
plus cheese (slice)) 
Egg yolk (g) 
Salad (g) 
Dessert (g) 
6 
2 
20 
50 
1 
2 
175 
75 
150 
-
100 
2 
15 
30 
100 
8 
2 
30 
75 
2 
4 
200 
150 
175 
-
125 
2 
20 
30 
175 
6 
2 
25 
50 
1 
2 
200 
75 
150 
125 
-
-
15 
30 
100 
8 
2 
40 
75 
2 
4 
200 
150 
175 
150 
-
-
20 
30 
175 
Snacks Fruit" 
Juicec 
a) Food provided for subjects. In addition to these items, subjects were 
allowed to choose 1.0 MJ/day of food from a list of low-protein products. 
Subjects were allowed to consume unlimited quantities of tea, coffee, 
selected low-calorie beverages, and up to 6 g of coffee whitener per day. 
b) This is a special product containing test protein. 
c) Sugar was provided as sugar, apple syrup, honey, apple juice or grapefruit 
juice, as determined by individual preference. Sugar was supplied in bags 
containing 6 g. 
d) The amount of fruit varied with the type of fruit provided, and differed 
from one energy group to another. 
e) For vegetarians,meat was replaced by egg protein and butter. 
f) Slices were carefully standardised. 
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drinks consumed during a three-day period (a small dietary weighing scale was 
provided for each subject). On the second visit, the participants produced a 
morning urine specimen and the food records were discussed with a dietician. 
The blood and urine samples were analysed immediately, and the habitual energy 
intake of each subject was estimated from the food records. At the completion of 
the preliminary investigation, each subject received a summary of his/her own 
measurements together with an explanatory comment. On the basis of the 
measurements taken (blood Hb, erythrocyte sedimentation rate, blood pressure, no 
detectable glucose or protein in urine) and the medical questionnaire, a 
medical practitioner determined whether there were any reasons to prevent any of 
the subjects participating in this study. Two subjects were requested to with-
draw from further participation because of food allergies. A further 4 subjects 
decided to withdraw for their own reasons. The preliminary investigation was 
completed about two weeks prior to the experiment. Sixty-one subjects began the 
actual experiment. 
4.1.5. Space 
The ground plan of the Department of Human Nutrition given in Figure 3 
indicates the amount of space that was available for the experiment. Not all 
the rooms indicated were occupied continuously throughout the experiment, but 
they were essential for satisfactory execution of the experiment. Large 
cooling and freezing rooms for storage of food and the two extra portions of 
the diets which were set aside for use in the animal experiments (4.2.3), were 
available in a building adjacent to the Department. 
4.2. The experiment (2 months) 
4.2.1. Food purchases 
Most foods were purchased and delivered in bulk every two weeks, with the 
exception of fresh foods which were purchased from and delivered by the same 
shopkeepers throughout the experiment. The protein preparations were delivered 
in bulk, and the required amount of each protein preparation for the whole 
experiment was derived from the same process batch. Special breads and milk and 
yoghurt products were prepared and delivered weekly, while the gelated product 
from soy isolate was prepared and delivered on two occasions during the experi-
ment. One dietician was responsible for all food orders. All financial matters 
were controlled by the Administrative Officer of the Department. 
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FIG'. 3. Ground plan of the Department of Human Nutrition, indicating the 
rooms available for the experiment (scale 1 : 400). At the time of 
the experiment the Department was still housed in the Transitorium 
Building. 
A. Seminar room 
- meetings (4.1.2.) 
- social events (4.2.8.) 
B. Laboratory 
- blood sampling (4.1.4., 4.2.4.) 
C. Office 
- storage packaging materials (4.2.2.) 
- collection of double portions of 
test diets (4.2.3.) 
D. Office 
- co-ordination centre 
- information centre 
- preparing food packages (4.2.2.) 
- collection of food records (4.2.6.) 
E. Dining room 
- hot meals and coffee (4.2.2.) 
- breakfast (4.2.4.) 
F. Kitchen 
- preparation of hot meals (4.2.2.) 
- supply of hot meals (4.2.2.) 
G. Cloackroom 
- weight measurement (4.2.5.) 
- anthropometric measurements (4.1.4.) 
- show case for free foods (4.1.3.) 
H. Laboratory 
- blood pressure measurement (4.1.4., 
4.2.4.) 
I. Wall rack for food packages 
- prepared food packages (4.2.2.) 
J. Information board 
K. Notice board for dinner cards (4.2.2.) 
L. Terminal connected to the computer (4.4.) 
M. Laboratory for blood analysis (4.3.) 
N. Laboratory for food analysis (4.3.) 
0. Toilets 
P. Entrance/Exit/Stairs 
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4.2.2. Preparation and supply of daily diets 
On weekdays, the hot meals were prepared at the Department by three 
dieticians, and served in the evening. At the entrance to the kitchen a card for 
each subject showing the required amounts of soup, potatoes or rice, legumes 
and dessert was mounted on a notice board. On arrival for dinner, the subject 
took his/her card, and proceeded along an improvised railed enclosureto where 3 
dieticians provided the hot meals. Thus all ingredients of the hot meal were 
weighed out for each person in quantities appropriate to his or her energy 
needs. 
All other foods were also weighed out for each subject and provided daily 
as packages. In the weekends, the participants were required to prepare the 
hot meals themselves and food for the weekend, including ingredients for the 
hot meals, was provided each Friday. The food was provided in plastic boxes 
of 30x20x15 cm. Perishable foods were placed in a small styrofoam box with a 
cooling element. In general, all the food supplied as packages could be placed 
in one box, except on Fridays, when a second box or an extra bag was required. 
All foods were packed separately. Various types of packaging materials were 
used. The prepared food packages were placed in a wall rack in which each 
subject had a separate compartment. The food packages were taken out by the 
subjects after dinner. 
During the experiment, when a participant considered that he was receiving 
too much or too little food, or when a subject showed a change in body weight 
of more than 2 kg during a 2-week period, the subject was placed in another 
energy group. The estimated habitual intake of energy did not appear to be 
satisfactory as most subjects changed energy group during the first few weeks 
of the experiment. However, without a preliminary estimation of the individual 
energy intakes, changes would have occurred much more frequently, and much 
practical work is involved in placing individuals in another energy group. 
Only a few subjects were transferred to another energy group because of large 
changes in body weight. 
4.2.3. Collection of two extra portions of the test diets 
Throughout the experiment, two extra portions of each test diet were 
collected daily and frozen (hot meals and food packages). After completion 
of the experiment, the food was homogenised, freeze-dried, and analysed, 
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Photo 3. Food daily provided as food package to a participant 
consuming 10.1 MJ (2400 kcal) per day. 
Photo 4. Complete daily diet for a participant consuming 
10.1 MJ (2400 kcal) per day. 
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Photo 5. Food for the weekend including ingredients for the hot 
meals for a participant consuming 10.1 MJ (2400 kcal) per day. 
Photo 6. The food was provided in plastic boxes. Perishable foods 
were placed in a small styrofoam box with a cooling element. 
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and used in the animal experiments described in Chapter 4. 
4.2.4. Morning visits 
The participants visited the Department on 6 occasions between the hours of 
07.00-10.00 a.m. at times nominated by the subjects themselves on a list posted 
on the notice board. They brought with them morning urine specimens,and blood 
samples were taken following an overnight fast. Breakfast was provided in the 
Department. There were no defaulters. 
4.2.5. Body weight 
Each Tuesday immediately prior to dinner, body weight was measured without 
shoes and heavy clothes. 
4.2.6. Food records 
One day a week chosen at random, each participant weighed and recorded his 
or her food intake. A dietary weighing scale was provided. The following day 
the records were discussed with one of the research team. 
4.2.7. Diaries 
At the beginning of the experiment the participants received a diary in 
which they noted each day: type and amount of free food chosen; whether there 
had been any non-adherence to the diet; any illness; or intake of medicine. 
Entries were required as to the days on which blood was collected and days on 
which the subject was expected to complete a 24 hr food record. Examples of 
pages of the diary are given on page 129. From the diaries the exact intakes 
of energy and nutrients from the free foods were calculated. It was decided 
to eliminate the results of 2 subjects from the analysis on the basis of the 
information supplied regarding illness and the intake of medicine. 
4.2.8. Conduct of the subjects 
As previously mentioned, the success of a human study depends largely on 
the interest and conscientious co-operation of the subjects. The motivation 
of the subjects throughout the experiment is a source of permanent concern for 
the research team. It is important that the subjects feel that they are 
continuously well informed and that they are convinced that the research team 
will do everything possible to present information, is willing to answer 
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questions and solve problems. One member of the research team at least was 
freed of other duties to talk with participants during dinner. The author was 
involved in the experiment as a participant, and was always present in the 
dining room at that time. In addition,information was posted on the notice 
board, and there was also a weekly news-sheet (Figure 4). Relationships 
between subjects and the subjects and the research team are extremely 
important in the maintenance of 
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FIG. A. Front page of the weekly 
news-sheet 
morale. Development of rapport, 
companionship, and loyalty among 
subjects is vital in the maintenance 
of determination to carry the study 
to successful completion. In this 
respect the day-to-day contacts 
during the evening meal are very 
important. It is also essential that 
members of the research team are 
able to relate to and sympathise 
with subjects. It was very much 
appreciated by the participants that 
one member was involved in the 
experiment as a participant. Since 
most of them were interested in 
nutrition topics, several evening 
meetings were organised and guest 
speakers, selected by the participants, 
were invited to attend. 
4.3. Collection of data (4 months) 
The results of blood analyses became available within four months following 
completion of the experiment. The two extra portions of the test diets 
were homogenised, freeze-dried and analysed, and used in the animal 
experiments. 
The actual nutrient intake for each individual throughout the 
experiment was calculated from the food records using a computerised food 
composition table supplemented with the analyses of the special products. 
When all the data were available, each participant received his or her own 
values, together with an explanatory comment. A complete description of the 
results of the study has been promised to the subjects. 
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Throughout the experiment erythrocyte sedimentation rate was slightly but 
persistently elevated (20 to 30 mm/h) in 5 subjects, while another 6 subjects 
showed a slightly elevated blood pressure (diastolic between 95 and 105 mmHg 
or systolic between 150 and 160 mmHg). All these subjects were advised to 
contact their own medical practitioner. 
4.4. Analysis and interpretation of the data (6 months) 
The results were analysed with the DEC-1090 computer system of the 
Agricultural University using programmes derived from SPSS (Nie NH, et al. 
Statistical Packages for Social Sciences. 2nd ed. New York: McGraw-Hill Inc., 
1975). All the data obtained were stored on computer tape. 
5. STAFF INVOLVED AND TOTAL COST OF THE STUDY 
5.1. Staff 
In total, the experiment and the analysis of the results took about 18 
months. During the last 6 months only one nutritionist (author) was involved 
full-time in the analysis of the results and writing up the data for 
publication. During the first 12 months when all the practical work was in 
hand many people were involved. It is difficult to give a complete list 
because some people were external to the Department (e.g. for developing and 
preparing the special food products). The following, entirely from within the 
Department, were involved in the practical work for this particular experiment: 
1 nutritionist, full-time for 12 months (author) 
5 dieticians, 2 full-time for 12 months and 3 part-time (30 hr/week) for 
2 months during experiment 
8 technicians, 8 technicians including 3 medical analysts were involved 
for shorter or longer duration; they undertook the blood 
sampling and blood analyses (12 months full-time for one 
technician) and the homogenising, freeze-drying and 
analyses of the food products and double portions (6 
months full-time for one technician). Their scientific 
guidance was not the responsibility of the nutritionist 
but of 2 staff members of the Department. 
2 doctoral students, full-time for 6 months, commencing one month prior to 
experiment; apart from their involvement in all the 
practical work throughout the experiment, the students 
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analysed and interpreted part of the results obtained; 
1 medical practitioner, full-time for 2 days during the preliminary investigation, 
and on standby throughout experiment. 
Apart from the staff involved in practical activities, a number of people 
from within and without the Department acted as advisors both in the planning 
and execution of the study. 
5.2. Cost expendable materials 
The Department has at its disposal a well-equipped clinical and chemical-
-analytical laboratory, and all analytical techniques used were already 
available. At the time of the experiment a research kitchen, and an improvised 
dining room where about 40 subjects could have dinner simultaneously,were made 
available. (In the Department's new building, there is a very well-equipped 
research kitchen complete with dining room, where 60-70 subjects may have 
dinner at the same time). Furthermore, all the equipment for anthropometric 
measurements and blood pressure measurements, and dietary weighing scales,were 
present. Although some new equipment had been purchased prior to the experiment 
the costs given below are of the expendable materials used in this particular 
study. 
Dfl. 41,000 
Costs of expendable materials (1980) 
* 
Food, including special products 
Laboratory materials (test tubes, 
chemicals, test kits, needles, etc.) 
Packaging for food 
Computer costs 
Postage and stationery 
Travelling expenses research team 
Miscellaneous 
Total 
*) It should be noted that the cost of the specially 
developed bread was Dfl. 19,000 and that the other 
special products were either gratuitous or were 
delivered at the cost of the ingredients used. 
D f l . 
D f l . 
D f l . 
D f l . 
D f l . 
D f l . 
D f l . 
8,500 
1,500 
3,000 
1,000 
1,000 
2,500 
58,500 
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5.3. Financial resources 
The main costs of the study were the salaries of the staff involved. The 
nutritionist, some of the technicians and the medical practitioner were paid 
by the Agricultural University. The dieticians were paid by a grant from the 
Netherlands Institute for Dairy Research (NIZO), while analytical work was 
partly financed by grants from the Netherlands Heart Foundation. Most of the 
expendable items in the study were also paid by NIZO. 
6. BURDEN AND INCONVENIENCE TO THE SUBJECTS 
The activities required of the participants are summarised in Table 2. No 
account is made of travelling time. Furthermore, it is assumed that the daily 
preparation of the bread meals and that of the hot meals in the weekend, did 
not take more time than usual. The activities and the inconveniences had been 
discussed extensively in the information brochures and during the meetings with 
the participants. Therefore,it is not surprising that almost the total number 
of the subjects completed the experiment successfully; only 2 out of 61 subjects 
decided upon early withdrawal. In general, routine activities such as the daily 
visits to the Department, compilation of diaries or food records, carrying food 
packages, were not considered onerous. For a few people who lived more than 
20 km from the Department,and a few women who also prepared hot meals at home 
for husband and children, the last weeks of the experiment became burdensome. 
A few problems did arise. The participants had to eat all the food supplied, 
and apart from a relatively small amount of free foods nothing extra was 
allowed. Many participants found the diets, which were in general well 
accepted, had become monotonous after a few weeks despite the efforts of the 
dieticians to vary them as much as possible. Many participants had underrated 
the disruption of their social activities. The subjects who participated 
without their partner found it disadvantageous to be separated from 
the other family members at mealtimes. The married couples and the single 
people regretted that they could not have dinner with friends for such a long 
time. Therefore, each participant was allowed to invite a guest several times 
durinq the experiment. It is better to recommend that people should partici-
pate in an experiment as a group, couple or with friends. Other restric-
tions on social life are in relation to problems arising when visiting friends; 
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the participants had to take their own foods with them and had to refuse any 
food offered. In this respect, it should be clearly recognized that when 
relatives or friends become irritated by the demands of the experiment, 
pressures to relax their endeavours will undoubtedly be experienced by the 
subjects. 
Table 2 
SUMMARY OF ACTIVITIES REQUIRED OF THE PARTICIPANTS 
Phase of the study and 
place of activities 
Preliminary investigation 
Department of Human 
Nutrition 
Activity Duration 
Home 
Actual experiment 
Department of Human 
Nutrition 
Home 
FIRST VISIT: 
blood sample, blood pressure, 
anthropometric measurements 
SECOND VISIT: 
morning urine specimen, 
discussion of food records 
medical and general 
questionnaires 
3-day food record 
WEEKDAY EVENINGS: 
eat dinner , collect food 
packages ; discuss food 
records once a week; 
body weight measurements 
once a week 
6 MORNING VISITS: 
blood sample; 
morning urine specimen and 
measurement of blood pressure 
on two occassions 
24 hr food record once a week 
daily dairy 
1 to 1J hr 
hr 
1 to 1J hr/day 
| to 1| hr/day 
hr per visit 
| to 1 hr/record 
10 minutes/day 
*) Each day the subjects were expected to consume the total amount of food 
provided plus the amount of 'free foods'. 
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